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Ring-opening reactions of epoxides and aziridines have been extensively studied. The 
influence of different protecting groups on the hydroxyl group in the ring-opening 
reactions of cis- and trans- 3-hydroxy-1,2-cycloalkane epoxides with aromatic amines 
was studied. It was shown that Yb(OTf)3 in toluene was a mild catalyst for regioselective 
ring-opening, to give β-anilino cycloalkanols in good yields. Heating the reaction mixture 
accelerated the rate of the reaction, albeit at the expense of yield. The aniline moiety was 
regioselectively added at the carbon furthest from the hydroxyl or ether group to yield a 
single regioisomer. The same trend was also observed with 3-azidocyclohex-1-ene 
epoxides and the corresponding 3-carbamates. The reaction time became shorter when 
acetonitrile was used as solvent, possibly due to the homogeneous medium. 
Ytterbium(III) triflate has also been used as the catalyst for the regioselective 
ring-opening of unactivated aziridines in cyclohexanes having an azide or benzyl ether 
substituent. Azide ion or aniline forms the corresponding trans-products giving access to 
vicinal diamines in good yields. 
A racemic ω-alkoxy p-methoxy benzyl ether HDAC inhibitor has been prepared in 8 
synthetic steps (26% overall yield) from 1-((tert-butyldiphenylsilyl)oxy)hept-6-en-2-ol. 
This is an improvement over the published method (9 steps, 16% overall yield). The 
cross-metathesis method proved to be efficient and practical in this strategy, and 
alkylation using p-methoxybenzyl trichloroacetimidate in the presence of Sc(OTf)3 
improved the overall yield of the synthesis.  
An amino alcohol that contains all the core carbons, functional groups and the required 
stereochemistry present in pactamycin was obtained starting from L-threonine over 27 
steps. The methodology described in this thesis allows for a synthesis of this key 
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Cette thèse consiste en trois thèmes résumés dans les paragraphes ci-dessous. 
L’influence de différents groupements protecteurs du groupe hydroxyle lors des réactions 
d’ouverture des cis- et trans- 3-hydroxy-1,2-époxycycloalcanes a été étudiée. Il a été 
montré que Yb(OTf)3 constituait un catalyseur doux pour l’ouverture régiosélective de 
cycles afin d’obtenir les β-anilino cycloalcanols correspondants avec de bons rendements. 
Le chauffage du milieu réactionnel dans le toluène comme solvant a permis d’augmenter 
la cinétique de la réaction, au dépend du rendement. La partie aniline a été 
régiosélectivement introduite en position vicinale du groupe hydroxyle ou éther afin 
d’obtenir un unique régioisomère. La même tendance a été observée avec les époxydes 
du 3-azidocyclohex-1-ène et du 3-carbamate correspondant. Le temps de réaction a été 
réduit lorsque Yb(OTf)3  a été dissous dans l’acétonitrile. Le triflate d’ytterbium (III) a 
également été utilisé comme catalyseur pour l’ouverture de cycle régiosélective 
d’aziridines non-activées sur des cyclohexanes portant des substituants azotures ou éthers 
de benzyle. L’ion azoture ou l’aniline forment les produits trans correspondants, donnant 
alors accès à des diamines vicinales avec de bons rendements. 
Un éther ω-alcoxy p-méthoxybenzylique racémique, inhibiteur de HDAC, a été ainsi 
préparé en huit étapes synthétiques (rendement total de 26%) à partir du 
1-((tert-butyldiphénylsilyl)oxy)hept-6-èn-2-ol. Ceci représente un progrès par rapport à la 
précédente méthode (9 étapes, rendement total de 16%). La métathèse croisée se montre 
particulièrement efficace et pratique dans cette stratégie et l’alkylation par le 
trichloroacétimidate de p-méthoxybenzyle en présence de Sc(OTf)3 améliore le 
rendement global de la synthèse. 
Un aminoalcool présent dans la pactamycine et contenant le squelette carboné, les 
groupements fonctionnels et la stéréochimie requise a été synthétisé en 27 étapes à partir 
de la L-thréonine. La méthodologie décrite dans cette thèse permet la synthèse de cet 
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1.1 Ring-opening of cycloalkane epoxides with aromatic amines 
1.1.1 Introduction 
Epoxides are among the most versatile intermediates in organic synthesis. In addition, 
a number of biologically significant molecules contain epoxides within their structures1. 
Ring-opening reactions of epoxides have been extensively studied with a large number of 
nucleophiles2, such as halides, alkoxides, thioalkoxides, azides, etc as well as carbon- 
based nucleophiles leading to β-substituted alcohols.   
β-Amino alcohols are important intermediates as unnatural amino acids3 and as chiral 
auxiliaries4 in asymmetric processes. The aminolysis of epoxides is one of the most 
common practical methods for the preparation of β-amino alcohols 5.  
1.1.2 Epoxide formation  
A classical method to prepare epoxides is the peroxidation of an olefin, also known as 
the Prilezhaev reaction6. In 1959, Henbest and Wilson observed that upon treatment with 
perbenzoic acid, 2-cyclohexen-1-ol affords the syn-epoxy alcohol as the predominant 
product. The stereochemical outcome of this transformation was rationalized based on a 
transition structure largely involving the "butterfly mechanism"7 as shown in Figure 1.1. 
The interaction of the nucleophilic alkene with the electrophilic peracid was postulated 
relying on the formation of a hydrogen bond formed between the hydroxyl group and one 
of the peracid oxygens leading to delivery of the reagent to the olefin face syn to the 
hydroxyl group.  
 
Figure 1.1  Butterfly Mechanism 
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In the case of allylic ethers, no such interaction is available with common peracids, and 
anti epoxidation is mainly observed. However, epoxidation with trifluoroperacetic acid 
(TFPA)8 or perbenzimidic acid [Ph-C(=NH)OOH], generated in situ from PhCN and 
H2O2 (Payne reaction)9, usually lead to the syn epoxides10. The transition state models for 
both cases are shown in Figure 1.2. 
 
Figure 1.2  Transition state of epoxidation 
1.1.3 Epoxide opening reactions 
The nucleophilic opening of epoxides has been studied extensively since it provides a 
suitable route to the formation of C-C, C-N, C-O or C-S σ-bonds1. The ring-opening of 
epoxides by amines can form β-amino alcohols, a useful building block in the synthesis 
of natural products. Despite many studies on regio- and stereoselectivity in epoxide 
opening reactions11, the opening of epoxy alcohols and the corresponding ethers with 
aromatic anilines12 has received less attention13. 
The classical method for the preparing of β-amino alcohols is direct aminolysis of 
epoxides at elevated temperature with excess of amine14, which is not only detrimental to 
other functional groups, but also to the control of regioselectivities. Several catalysts have 
been used in order to overcome these problems. These include the use of:  1) metal 
salts 15  (lithium, sodium, magnesium and calcium), 2) metal amides 16  (lithium, 
magnesium, lead, tin, and amide cuprate), 3) metal alkoxides17 (DIPAT, Ti(OiPr)4, 4) 
metal triflates18 (lithium, copper, Ph4SbOTf), 5) alumina19 , 6) microwave assisted 
solvent-free montmorillonite clay20, 7) transition metal halides21 (TaCl5, ZrCl4, VCl3, 
ZnCl2), 8) rare earth metal halides22 (SmI2(THF)2, CeCl3.7H2O), 9) transition metal salts 
4 
 
under solvent-free conditions23, 10) ionic liquids24, and 11) Bi(OTf)3 and Bi(TFA)3 under 
microwave irradiation25 and 12) hetero poly acids26. Some of these methods suffer from 
one or more limitations such as the use of costly chemicals, refluxing temperatures, inert 
atmosphere conditions, low regioselectivity, side reactions, etc.  
The growing popularity of lanthanide salts in organic synthesis stems from their ease 
of handling, robustness towards moisture and air, as well as unique reactivity and 
selectivity. Over the past few years, lanthanide trifluoromethanesulfonates (triflates), 
Ln(OTf)3 have been used as Lewis acid to activate a variety of reactions27 including 
epoxide opening reactions. 
Research objective: In conjunction with an ongoing project toward the total synthesis of 
pactamycin (see Chapter 3), we explored the opening of an epoxide in a model 
cyclopentane ring with a variety of anilines. We were therefore led to study the reaction 
in five and six-membered ring model compounds as outlined in this Chapter. 
1.1.4 Results and discussion 
1.1.4.1 Synthesis of model epoxides 
The model epoxides were formed by oxidizing the unsaturated alcohols with 
m-chloroperbenzoic acid (m-CPBA)28, one of the most commonly used, commercially 
available oxidants in the epoxidation of simple alkenes. The trans- and cis-isomers were 
separated by flash column chromatography. All epoxides used in this study were racemic.  
The m-CPBA oxidation of the unsaturated alcohol 1.1, which was obtained by Luche 
reduction 29  of 3-methylcyclopent-2-enone, afforded an 8:1 mixture of cis-1.2 and 
trans-1.2 epoxy alcohols. When m-CPBA oxidation was performed on the TES protected 
unsaturated alcohol 1.3, an 1:3 mixture of epoxides cis-1.4 and trans-1.4 could be 
separated by flash chromatography. Epoxides 1.6 and 1.8 were obtained by the same 




Scheme 1.1  Five-membered ring epoxide formation 
Epoxides cis-1.9 and trans-1.9 were obtained in a ratio of 8:1 cis/trams respectively by 
directed oxidation of 2-cyclohexenol with m-CPBA. Treatment of 2-cyclohexenol with 
BnBr/NaH afforded the allylic benzyl ether 1.10, which was oxidized with m-CPBA to 
give an 1:2 mixture of the benzylated cis-1.11 and trans-1.11 epoxides. 2-Cyclohexenol 
was protected by TES group to give 1.12, which was oxidized with m-CPBA to afford an 
1:10 mixture of cis-1.13 and trans-1.13 epoxy alcohol ethers (Scheme 1.2).  
 
Scheme 1.2  Six-membered ring epoxide formation 
3-Bromocyclohexene was treated with sodium azide to form 3-azido cyclohexene30 
1.14, which was oxidized with m-CPBA to give cis-1.15 and trans-1.15 epoxy azides as 
an 1:1 separable mixture. Treatment of 3-methylcyclohexenone under Luche reduction 
conditions afforded 3-methylcyclohexenol 1.16, which was treated with 
6 
 
diphenylphosphoryl azide (DPPA), diisopropyl azodicarboxylate (DIAD) and PPh3 
(Mitsunobu reaction31) to form the 3-azido-1-methylcyclohexene 1.17. Oxidation with 
m-CPBA gave epoxy azide 1.18 (Scheme 1.3). 
 
Scheme 1.3  Azido cyclohexane epoxide formation 
The N-Boc-protected allylic amine 1.19, prepared from 3-bromocyclohexene with 
di-tert-butyl imidodicarbonate (Boc2NH) 32, was oxidized to the corresponding epoxides 
cis-1.20 and trans-1.20 with m-CPBA in a ratio of 3:1. Treatment of 1.14 with PPh3 and 
H2O (Staudinger reaction33) afforded allylic amine 1.21, which was acetylated to give 
1.22, then oxidized with m-CPBA to afford 1.23 (Scheme 1.4). 
 
Scheme 1.4  NHBoc and NHAc epoxide formation 
7 
 
1.1.4.2 Epoxide opening reactions with anilines 
1.1.4.2.1 Five-membered ring epoxide opening with anilines  
Reaction of five-membered ring cis-epoxy alcohols and the corresponding TES ethers 
in the presence of 10 mol% Yb(OTf)3 were studied. In each case, attack took place at the 
epoxide carbon atom furthest from the substituent to give trans-1,2-anilino cycloalkane 
alcohols as shown in Table 1.1. The introduction of anilines occurred with inversion of 
configuration at C-3 (The numbers in the structures are for simplification). Reaction 
media were heterogeneous in toluene, see p21.  
 
Table 1.1  Five-membered ring cis-epoxy alcohol/TES ether opening reactions 
Entry Epoxide R1 R2 Product Time (day) Yield (%)a 
1 cis-1.2 H H 1.24a 2 76 
2 cis-1.2 H Cl 1.24b 3 74 
3 cis-1.2 H Br 1.24c 3 73 
4 cis-1.2 H OMe 1.24d 1.5 72 
5 cis-1.4 TES H 1.25a 8 70 
6 cis-1.4 TES Cl 1.25b 11 69 
7 cis-1.4 TES Br 1.25c 11 68 
8 cis-1.4 TES OMe 1.25d 5 71 
a. Yields are for isolated compounds. 
In Table 1.2 are listed the results for the opening of five-membered ring trans-epoxy 




Table 1.2  Five-membered ring trans-epoxy alcohol/TES ether opening reactions 
Entry Epoxide R1 R2 Product Time (day) Yield (%)a 
1 trans-1.2 H H 1.26a 2 75 
2 trans-1.2 H Cl 1.26b 3 71 
3 trans-1.2 H Br 1.26c 3 74 
4 trans-1.2 H OMe 1.26d 2 73 
5 trans-1.4 TES H 1.27a 3 72 
6 trans-1.4 TES Cl 1.27b 4 75 
7 trans-1.4 TES Br 1.27c 4 70 
8 trans-1.4 TES OMe 1.27d 2 74 
a. Yields are for isolated compounds. 
Usually, unsymmetrical epoxides undergo regioselective addition of the nucleophiles 
to the less substituted carbon15. However, all the anilines were added to the more 
substituted position in the case of five-membered ring epoxy alcohols and ethers (Tables 
1.1, 1.2). An X-ray structure confirmed the regioselectivity of addition for 1.26d (Figure 
1.3).  
 
Figure 1.3  X-ray of 1.26d 
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We therefore assumed that the other analogues gave the same regioselectivity. For the 
trans-epoxy TES ether 1.27d, cleavage of the TES group gave 1.26d, thus confirming the 
regioselectivity in the epoxy alcohols series as well (Tables 1.1, 1.2, entries 1-4). 
For the products of the cis-epoxy alcohols, exemplified by 1.24c, treatment with 2,2- 
dimethoxypropane and a catalytic amount PTSA afforded the protected diol 1.28. Diol 
1.24c could be cleaved with silica gel supported NaIO434 to the dialdehyde 1.24e 
(Scheme 1.5). 
 
Scheme 1.5  The regioselectivity of the opening reactions of cis-epoxy alcohols 
It is thought that this type of epoxide opening reaction is a borderline SN2 reaction35, in 
which the nucleophile is further away than usual from the site of attack. The driving force 
of the reaction is provided more by transfer of electrons from carbon to oxygen than from 
nucleophile to carbon. In the presence of a Lewis acid, it is supposed that the C-2 carbon 
carries a fractional positive charge in the transition state, in which bond breaking is more 
important than bond making (Figure 1.4). Therefore electron donating substituents 
stabilize the positive charge and facilitate the bond breaking. Conversely, electron 









Figure 1.4  The borderline SN2 mechanism of epoxide opening reaction 
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Among the two conformations of cis-1.2 (cis-1.2A and cis-1.2B), the latter can also 
engage the Lewis acid Yb(OTf)3 and the epoxide oxygen in bidentate fashion (cis-1.2D to 
cis-1.2E). Nucleophilic attack at C-3 of cis-1.2F in a chair-like six-membered ring in a 
borderline SN2 type modality may also be enhanced by the inductive effect of the methyl 
group in the bond-breaking step (Scheme 1.6). As a result, the C-3 regioselectivity was 
observed in all cases. 
 
Scheme 1.6  Possible mechanism for the regioselectivity for epoxy alcohol cis-1.2 
In the case of the silyl ethers (Table 1.1, entries 5-8), SN2 attack of the anilines also 
takes place at C-3, possibly by activation of the epoxide oxygen atom. Conformations 
related to cis-1.4B may be less favored for OTES ether due to the steric bulk of the silyl 
group36. The epoxide opening reaction of the cis-epoxy TES ether took much longer time 
than the corresponding hydroxyl isomers. This may be due to the ineffective coordination 
to the Yb(OTf)3 as in cis-1.4B due to the bulk of the TES ether (Scheme 1.7). 
 
Scheme 1.7  The regioselectivity of epoxide opening of cis-1.4 
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The corresponding trans-epoxy alcohol, exemplified by trans-1.2 (Table 1.2, entries 
1-4) reacted at a similar rate compared to the cis-isomers, which indicates that activation 
of the epoxide oxygen without a bidentate chelation is equally effective for the cleavage 
reaction (Scheme 1.8). 
 
Scheme 1.8  The regioselectivity of epoxide opening for epoxy alcohol trans-1.2 
In the OTES trans-series (Table 1.2, entries 5-8), the pseudo equatorial ether 
orientations trans-1.4B is favored. Coordination occurs mostly on the epoxide oxygen 
and attack is favored at C-3 (Scheme 1.9) for the reasons discussed above in conjunction 















Scheme 1.9  The regioselectivity of epoxide opening for epoxy TES ether trans-1.4 
We then studied the epoxide opening of a regioisomer having the methyl group at C-2. 
Opening still occurred at C-3 (Scheme 1.10). The regioisomeric C-2 ring-opening 
product would have given a symmetrical molecule, easily distinguished by 1H and 13C 
NMR. The reason for this selectivity remains to be explained. 
 
Scheme 1.10  Epoxide opening reaction of 1.8 with p-anisidine 
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From Tables 1.1 and 1.2, we could see that when there was an electron withdrawing 
group (Cl, Br) on the para position of the aniline, the epoxide opening reactions time 
became longer. Conversely an electron donating group (OMe) led to shorter reaction time. 
However, the reaction time of the trans-epoxy TES ether (Table 1.2, entries 5-8) was 
much less than the cis-isomer, possibly due to a more efficient coordination of Yb(OTf)3 
with the epoxide oxygen than the corresponding cis-isomer.  
It has been reported that the opening of 1-(benzyloxy)-cyclopentane 2,3-epoxides with 
various nucleophiles can be subject to variable results depending on the nature of the 
nucleophile and the presence or absence of chelating agents37. For example, Crotti and 
coworkers reported that in the absence of a chelating agent, attack is favored mostly at 
C-3, the carbon furthest away from the electronegative ether substituent. While in the 
presence of a chelating agent, C-2 is preferentially attacked (Scheme 1.11). 
 
Scheme 1.11  Regioselectivity of epoxide opening under chelation or non-chelating 
conditions 
It has been postulated that the electron-withdrawing nature of the ether group cannot 
stabilize the epoxide carbon atom as the bond-breaking event is in progress and the 
nucleophile attacks at the distal carbon C-3 carbon atom (Scheme 1.11, A). When 
chelation takes place, a chair-like chelate can be attacked at the stereoelectronically more 
favored C-2, overriding the inductive effect of the ether substituent. 
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The exclusive epoxide ring-opening at C-3 in our C-3 methyl substituted analogues in 
the presence of Yb(OTf)3 can be rationalized based on the electron-withdrawing hydroxyl 
or ether group and the stabilizing effect of the C-3 methyl group on the developing 
positive charge as the bond breaking event is in progress. Consequently a borderline SN2 
type reaction results with the aniline attacking at the more substituted carbon extremity of 
the epoxide (Scheme 1.6). 
These results are contrary to those reported by Crotti, where chelation through a 
chair-like intermediate (Scheme 1.11, B) favors attack at C-2. Evidently, in our case, the 
electrondonating ability of the C-3 methyl group overrides other factors. This means to 
hold true whether or not the hydroxyl group is free or substituted. 
Attack at C-3 in the case of the C-2 methyl epoxide 1.8 may be guided by a 
stereoelectronically more favorable trajectory in a chair-like chelate (Scheme 1.10). 
1.1.4.2.2 Six-membered ring epoxide opening with anilines 
 Recently, a chelation-controlled aminolysis of cyclitol epoxide with Yb(OTf)3 was 
reported by Serrano12b, regioselective attack at C-2 was interpreted as a result of a 
stereocontrolled trans-diaxial opening 38  of A through an “all-axial” conformation 
stabilized by lanthanide chelation (Scheme 1.12).  
 
Scheme 1.12  All-axial conformation that stabilized by Yb(OTf)3 chelation 
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A simplified model by the same author indicated that at least three coordination sites 
were needed for an effective chelation-controlled Yb(OTf)3 catalysis to give the C-2 
regioselectivity (Scheme 1.13).  
 
Scheme 1.13  Regioselectivity under chelation conditions in the presence of Yb(OTf)3 
We studied the opening of cis- and trans- six-membered ring epoxides with different 
anilines as shown in Tables 1.3 and 1.4. 
  In this case, we studied the effect of an alcohol, TES and benzyl ethers on the 
regioselectivity of epoxide opening with anilines in the presence of Yb(OTf)3. 
 
Table 1.3  Six-membered ring cis-epoxide opening reactions with aromatic amines 
Entry Epoxide R1 R2 Product Time (day) Yield (%)a
1 cis-1.9 H H 1.30a 1.5 79 
2 cis-1.9 H Cl 1.30b 2 74 
3 cis-1.9 H Br 1.30c 2 74 
4 cis-1.9 H OMe 1.30d 1 75 
5 cis-1.9 H F 1.30e 2 73 
6 cis-1.11 OBn H 1.31a 2 71 
7 cis-1.11 OBn Cl 1.31b 2 70 
8 cis-1.11 OBn Br 1.31c 2 69 
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9 cis-1.11 OBn OMe 1.31d 1 72 
10 cis-1.13 TES H 1.32a 3 74 
11 cis-1.13 TES Cl 1.32b 3 70 
12 cis-1.13 TES Br 1.32c 3 70 
13 cis-1.13 TES OMe 1.32d 2 73 
a. Yields are for isolated compounds. 
  Results for the trans-epoxide are shown in Table 1.4. 
 
Table 1.4  Six-membered ring trans-epoxide opening reactions with aromatic amines 
Entry Epoxide R1 R2 Product Time (day) Yield (%)a
1 trans-1.9 H H 1.33a 1.5 72 
2 trans-1.9 H Cl 1.33b 2 73 
3 trans-1.9 H Br 1.33c 2 77 
4 trans-1.9 H OMe 1.33d 1 77 
5 trans-1.9 H F 1.33e 2 75 
6 trans-1.11 Bn H 1.34a 3 72 
7 trans-1.11 Bn Cl 1.34b 3 68 
8 trans-1.11 Bn Br 1.34c 3 69 
9 trans-1.11 Bn OMe 1.34d 2 70 
10 trans-1.13 TES H 1.35a 4 71 
11 trans-1.13 TES Cl 1.35b 4 72 
12 trans-1.13 TES Br 1.35c 4 70 
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13 trans-1.13 TES OMe 1.35d 3 73 
a. Yields are for isolated compounds. 
In all cases, the aniline moiety was introduced at C-3 to give the trans-products in 
good yields. In general, electron donating groups on the anilines led to relatively shorter 
reaction times (Table 1.3, entries 4, 9, 13). An X-ray crystal study of 1.34b confirmed the 
relative stereochemical assignment (Figure 1.5). After cleavage of the benzyl group of 
1.34b by hydrogenation on Pd/C, and the cleavage of the TES group of 1.35b with TBAF, 
the NMR data of the obtained epoxy alcohols were identical to 1.33b. For the cis-epoxy 
alcohol, the C-3 regioselectivity could be determined by NMR analysis. The products 
arising from a C-2 opening could have been easily distinguished from their C-3 opening 
regioisomers, since both 1H and 13C NMR would have been simplified due to the 
symmetry of the molecule. The same trends were found in the case of the 
trans-six-membered epoxy alcohols and ethers. Reaction times for the TES ethers were 
longer compared to the cis-series (Table 1.4, entries 10-13). 
 
Figure 1.5  X-ray of 1.34b  
The reason of the C-3 regioselectivity of the cis-epoxy alcohols and benzyl ethers 
could be rationalized on conformational grounds exemplified by cis-1.9 and cis-1.11 
(Scheme 1.14). In accordance with the Fürst-Plattner rule39, the attack of the nucleophile 
on the chelate structure cis-1.9C should occur at the C-3 carbon to yield the initially 
formed diaxial product M. For chelate structure cis-1.9E, attack should occur at the C-2 
carbon to yield the diequatorial product N. Crotti and coworkers have found that the C-2 
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selectivity depended largely on the type of the nucleophile. When strong nucleophile, 
such as PhSH, H- were used, the C-2 selectivity was increased40. For aniline, resonance of 
the N lone pair with the adjacent Л system decreases the availability of the lone pair and 
makes it a poorer nucleophile. Complete C-3 regioselectivity was observed.       
 
Scheme 1.14  Mechanism of the regioselectivity of cis- six-membered epoxy 
alcohols/benzyl ethers 
The C-3 regioselectivity of the cis-epoxy TES ethers could be explained due to 1,3-non 
bonded diaxial strain effect in the trajectory of attack of the aniline. Complete C-3 
regioselectivity was observed. 
The ring-opening reaction time of cis-epoxy TES ethers cis-1.13 was a little longer 
than the corresponding free hydroxyl isomer cis-1.9, possible due to the inefficient 
coordination of the epoxide and the Yb(OTf)3 and the steric bulk of the adjacent TES 
ether. However, the epoxide opening reaction time of the epoxy benzyl ether cis-1.11 
were almost the same as their corresponding hydroxyl isomers, possibly because OBn 




Scheme 1.15  The coordination of the cis-epoxy TES ethers 
1.1.4.2.3 Effect of ring size  
A comparative study was done in the epoxide ring-opening of cis-five and 
six-membered ring epoxides with aniline and p-anisidine (Table 1.5). In general, 
reactions were a little faster in the six-membered series (Table 1.5, entries 3, 4). As 
expected, reactions with the electron donating aniline analogue were relatively faster.  
 
Table 1.5  Effect of ring size 
Entry n R Compound Yield (%)a Time (day) 
1 1 H 1.36a 70 2 
2 1 OMe 1.36b 72 1.5 
3 2 H 1.30a 79 1.5 
4 2 OMe 1.30d 75 1 
a. Yields are for isolated compounds. 
1.1.4.2.4 Six-membered ring-opening of azide epoxides with anilines 
In order to diversity the effect of substituent, we explored the opening of 
3-azido-1,2-cyclohexane epoxides. Treatment with various anilines afforded good yields 
of the trans-opening products with the previously observed regioselectivity. In general, 



















Regioselective opening at C-3 was observed based on an X-ray analysis as shown in 
Figure 1.6. 
 
Figure 1.6  X-ray of 1.37 
 
 
Table 1.6  Epoxy azide opening reactions with different anilines 










4 1.40 2 78 
a. Yields are for isolated compounds. 
The regioselectivity of the ring-opening of 3-azidocyclohex-1-ene epoxide was 
confirmed by single-crystal X-ray analysis of 1.42 (Figure 1.7), which was prepared from 
1.18 (Scheme 1.16).  
Scheme 1.16  Preparation of 1.42 
 
Figure 1.7  X-ray of 1.42  
 
  The epoxide opening reactions of the corresponding NHBoc and NHAc epoxides were 




Scheme 1.17  Epoxide ring-opening reactions of epoxy NHBoc and NHAc 
1.1.4.2.5 Effects of reaction temperature and solvent  
 
  The results of varying the temperature in the cyclohexane epoxide series and the 
solubility of the Yb(OTf)3 in the toluene are shown in Table 1.7. Heating the reaction 
mixture accelerated the rate of the reaction, albeit at the expense of yield.  
Table 1.7  Different reaction temperatures 
Entry Catalyst Temperature Solubility Time (h) Yield (%)a
1 Yb(OTf)3 (10%) rt 7 mg/100mL 48   71 
2 Yb(OTf)3 (10%) 40 oC 12 mg/100mL 20   66 
3 Yb(OTf)3 (10%) 80 oC 17 mg/100mL 6   54 
a. Yield are for isolated compounds 
We also studied the nature of the solvent in which the Lewis acid was soluble, thus 





Table 1.8  Different solvents 
Entry Solvent Time (day) Yield (%)a 
1 toluene 4 71 
2 CH3CN 2 73 
3 aniline 2 70 
a. Yields are for isolated compounds 
  It should be noted that the epoxide opening reactions were efficient even though the 
medium was heterogeneous in toluene. Thus, the small amount of dissolved Yb(OTf)3 
appears to be sufficient to activate the epoxide oxygen atom with or without chelation. 
However, the higher solubility in acetonitrile resulted in relatively shorter reaction time 
but did not improve the yield. In a control experiment, it was shown that Yb(OTf)3 was 
not coordinated to the acetonitrile (1H, 13C, 19F NMR with CD3CN)  
1.1.4.2.6 Different catalysts 
Different catalysts were tried for the epoxide ring-opening reactions as shown in Table 
1.9. There are a number of reports in the literature describing the opening of epoxides in 
the presence of different catalysts such as the ones listed. 
 
Table 1.9  Different catalysts 
Entry Catalyst Solvent Time  Yield (%)a
1 SnCl211 (10%) CH3CN 5 days 61 
2 CuSO418 (10%) Toluene 4 h 32 
3 VCl321 (10%) DCM 7 h 71 
4 LiClO412(10%) CH3CN 24 h 33 
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5 Yb(OTf)312 (10%) Toluene 24 h 77 
6 ---- Toluene 4 days 11 
7 H3PMo12O4026 H2O 10 days 10 
a. Yields are for isolated compounds. 
Among these, the most efficient catalyst was CuSO4 in toluene, followed by VCl3.  
1.1.5 Conclusion  
The influence of different protecting groups on the hydroxyl group in the ring-opening 
reactions of cis- and trans- 3-hydroxy-1,2-cycloalkane epoxides with aromatic amines 
was studied. It was shown that Yb(OTf)3 was a mild catalyst for regioselective 
ring-opening affording β-anilino cycloalkanols in good yields. The aniline moiety was 
regioselectively added at the carbon furthest from the hydroxyl or ether group to yield a 
single regioisomer. The reaction time became shorter when Yb(OTf)3 was dissolved in 
acetonitrile. 
The same trend was also observed with 3-azidocyclohex-1-ene epoxides and the 
corresponding 3-carbamates. 
1.2 Ring-opening of cycloalkane aziridines  
1.2.1 Introduction 
Aziridines1, the nitrogen analogues of epoxides, are synthetically important compounds. 
Furthermore, some natural products that contain an aziridine ring such as mitomycin C, 
exhibit both anti-tumor and antibiotic activity41.  
Due to the diminished electronegativity of nitrogen compared to oxygen, ring-opening 
reactions of aziridines are less facile than the corresponding reactions of epoxides. The 
reactivity of this strained heterocyclic ring system is dependent upon the nature of the 
substituent on the nitrogen atom. Electron withdrawing groups enhance the reactivity of 
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the ring. A number of nucleophilic ring-opening reactions have been studied on such 
activated aziridines with various nucleophiles42. Fewer examples are known for the 
ring-opening of non-activated aziridines (N-alkyl or aryl) mainly due to their lack of 
reactivity. 
1.2.2 Aziridine formation 
Compared to the diversity of the procedures used for the preparation of the analogous 
epoxides, the scope of the synthetic methods available for the preparation of aziridines is 
rather narrow. Classical methods for the synthesis of N-aryl aziridines are: 1) Ring 
closure of N-aryl amino alcohol by Gabriel and Wenker synthesis43. 2) Addition of 
carbenoids to imines or addition of nitrenoids to electron deficient alkenes catalyzed 
either by Lewis acid or transition metal complexes44. 3) The cyclodehydration of N-alkyl 
amino alcohol using triphenylphosphine dihalide and diethoxytriphenylphosphorane45.  
1.2.3 Aziridine opening reactions 
Several nucleophilic ring-opening reactions have been studied on activated and 
non-activated aziridines (N-alkyl or aryl)46. The ring-opening reaction of aziridines with 
nitrogen nucleophiles such as the azide47 ion and aromatic amines48 have special 
significance, because the products are azido amines and vicinal diamines, which have 
varied applications in organic synthesis49. The ring-opening reactions of mainly activated 
aziridines by amines have been reported in the presence of lanthanide triflates as 
catalysts50. While working on epoxide cleavage reactions with aromatic amines, we 
discovered that aziridines were efficiently cleaved with aromatic amines in the presence 
of Yb(OTf)3. 
1.2.4 Results and discussion  
1.2.4.1 Synthesis of model aziridines 
All the aziridines (1.45a, 1.45b, 1.46a, 1.46b, 1.47a, 1.47b) were formed by reaction 
of N-aryl amino alcohols with p-toluenesulphonyl chloride (p-TsCl) under phase transfer 




Scheme 1.18  Aziridine formation 
1.2.4.2 Aziridine opening with azide 
Generally, the vicinal azidoamines are prepared by ring-opening reactions of aziridines 
with azide. Singh and co-workers had46 reported that non-activated aziridine could be 
opened with TMSN3 in the absence of Lewis acid, and with NaN3 in the presence of 
CuCl2.2H2O52. Another report describes the ring-opening of aziridines with TMSN3 by 
using TBAF as a trigger53. However, all these methods failed to open the aziridine azide 





CuCl2 .2H2O (50 mol%), NaN3










Scheme 1.19  Attempted aziridine opening reactions 
When the reaction of 1.45a was carried out in the presence of 50 mol% Yb(OTf)3 
instead of CuCl2.2H2O at rt, a 10% yield of 1.48a was obtained after stirring 2 days. 
When heated to 80 oC, the reaction gave a yield of 77%. While treating 1.45a and 1.45b 
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with TMSN3, a similar result was observed (Scheme 1.20). NMR analysis indicated 
regioselective opening at C-3. 
 
Scheme 1.20  Aziridine opening reactions with NaN3 and TMSN3 
The need for a large amount of Yb(OTf)3 is due to the diminish by considering 
coordinating ability of the aziridine nitrogen. The regioselectivity could be explained 
that the conformation 1.45aD was less stable than conformation 1.45aC, based on a 
diaxial opening of the aziridine at the C-3 in chair conformation corresponding to 
1.45aC (Scheme 1.21).  
 
Scheme 1.21  The regioselectivity of the cis-aziridine azide opening reactions 
When the azide group on the six-membered ring was replaced by a benzyl ether (1.46a, 
1.46b), the aziridine opening reaction with TMSN3 required 70 mol% Yb(OTf)3 as 
catalyst (Scheme 1.22). The reason was not clear, although the oxophilic Yb(OTf)3 may 
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be coordinated by the OBn in spite of the electron donating ability of the p-methoxy 
group on the aryl ring. The regioselective attack at C-3 was confirmed by an X-ray 
analysis of 1.49b (Figure 1.8). 






Figure 1.8  X-ray of 1.49b 
The opening of trans-aziridine benzyl ether (1.47a, 1.47b) with TMSN3, also afforded 
the C-3 opening product 1.50a, 1.50b (Scheme 1.23). This could be rationalized in the 
same manor as discussed for the epoxide analogues.  
Scheme 1.23  Trans-aziridine benzyl ether opening reactions with TMSN3 
1.2.4.3 Aziridine opening with aniline 
The aziridine ring-opening reactions with aniline were studied, for which there were 
only few examples in the literature48. The reaction could be performed at rt and low 
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catalyst loading (10 mol%) giving C-3 regioselectivity (Scheme 1.24) , which was proved 






























1.47a 1.52  






Figure 1.9  X-ray of 1.51 
1.2.5 Conclusions  
Yb(OTf)3 has been used as the catalyst for the regioselective ring-opening of 
unactivated aziridines in cyclohexanes having an azide or benzyl ether substituent. Azide 





1.3 Experimental procedures 
General Experimental Notes 
All original data are available from Professor Stephen Hanessian, Université de Montréal. 
All yields reported are isolated yields except where indicated. The regio- stereoselectivity 
was determined by NMR and/or X-Ray.  
All commercially available reagents were used without further purification. All reactions 
were performed under argon atmosphere and monitored by thin-layer chromatography 
or/and MS. 
Spectra of nuclear magnetic resonance of proton (1H NMR) and carbon-13 (13C NMR) 
were recorded on a Bruker AV-300 (300 MHz)，400 (400 MHz) in a deuterated solvent 
as indicated with CDCl3 (H, δ=7.27 ppm；C, δ=77.23 ppm) or CD3OD (H, δ=4.87, 3.31 
ppm；C, δ=49.15 ppm) as the internal reference. Chemical shifts (δ) and coupling 
constants (J) are expressed in ppm (part per million) and Hz (Herz), respectively. When 
necessary, assignments were aided by DEPT, COSY, NOESY, HMBC and HMQC 
correlation experiments. All chemical shifts are measured from the center of the resolved 
peaks, the unresolved multiplet and broad peaks are normally indicated as a range. 
Low- and high-resolution mass spectra were recorded using fast atom bombardement 
(FAB) or electrospray techniques.  
Infrared spectra (IR) were recorded on a Perkin-Elmer FTIR Paragon 1000 with a KBr 
pellet. 
Optical rotations were recorded in a 1 dm cell at 20 oC (PerkinElmer 343). 
The X-Ray diffraction measurements were performed by Dr. Michel Simard and Dr. 




Anhydrous Reaction Conditions 
The glass vessels, luer lock syringes, needles and stirring bars were oven-dried at 
110-140 oC or flame-dried with a propane torch, and cooled to rt under a current of dry 
argon. Micro-syringes were dried under vacuum using an oil pump at rt for at least 2 
hours prior to use. 
Chromatography 
Flash chromatography was performed using (40-60 μm) silica gel at increased pressure.  
Thin layer chromatography (TLC) was performed using commercial precoated 
glass-backed Sillca Gel 60 F254 plates with a layer thickness of 250 µm (E. Merck). 
Visualization was performed by ultraviolet light and/or by staining with ceric ammonium 
molybdate, potassium permanganate. The technique was used to follow the course of 
reactions, to determine the suitable solvent system for flash chromatography, a mixture of 
ethyl acetate-hexane on v/v basis, as indicated, was used as eluant.  
TLC visualization 
UV 254 lamp was used to view TLC plates with UV light active compounds. To develop 
plates, they were dipped into the stain solution and heated to develop the colored spots. 
(a) CAM (Molybdate-ceric solution) 
This solution was prepared by dissolving 2.5 g of (NH4)6Mo7O24.4H2O and 1.0 g of 
Ce(SO4)2 in a solution of 90 mL of distilled water and 10 mL of concentrated H2SO4. 
(b) Potassium Permanganate   
This stain is prepared by dissolving 3 g of KMnO4 and 20 g of K2CO3 in 5 mL of 5% 




Hexane, ethyl acetate and dichloromethane were distilled to remove any nonvolatile 
material for chromatography and general use.  
Anhydrous solvents such as THF, ether, DCM and toluene were taken from the SDS 
(Solvent Delivery System). 
1.3.1 Representative procedures 
The procedure of the Luche reduction (method A) 
Sodium boron hydride (1.2 equiv.) was added portion-wise to a stirred solution of enone 
and CeCl3.7H2O (1.5 equiv.) in MeOH (4 mL/mmol enone) at 0 oC. The resulting 
suspension was allowed to warm to rt and stirred at rt for 2 h. Saturated NH4Cl was added 
to the suspension, and the layers were separated. The aqueous layer was extracted with 
DCM and the combined organic layers were washed with water, dried over Na2SO4 and 
concentrated under reduced pressure, the residue was purified by flash column 
chromatography (ethyl acetate/hexanes) to give the corresponding enol. 
General epoxidation procedure (method B) 
To a solution of the corresponding cyclohexene or cyclopentene in DCM (4 mL/mmol 
olefin), was added m-CPBA (2.0 equiv.) at 0 oC in small portions. The solution was 
allowed to warm to rt and stirred vigorously for 3-5 h. The resulting suspension was 
filtered, and the solute was washed with saturated solutions of sodium bisulfate and 
NaHCO3, and finally with brine. The solution was dried over Na2SO4, and concentrated 
under reduced pressure, the residue was purified by flash column chromatography (ethyl 
acetate/hexanes) to give the corresponding epoxides.  
General procedure for the epoxide opening reactions (method C) 
To a stirred solution of the epoxide (1 mmol) in toluene (3 mL), was added Yb(OTf)3 (10 
mol%) and the aniline analogue (1.5 equiv.). The suspension was stirred at rt until total 
conversion (TLC check). The reaction mixture was concentrated under reduced pressure, 
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and the residue was purified by the flash column chromatography (ethyl acetate/hexanes) 
to give the corresponding amino alcohols. 
General aziridine formation procedure (method D) 
To a stirred solution of the N-ary-β-amino alcohol (0.05 mol) in benzene (50 mL), was 
added p-toluenesulfonyl chloride (0.06 mol), tetrabutylammonium hydrogensulphate (0.2 
equiv.) and 50% aqueous solution of NaOH (5 mL). After stirred at rt for 3 days, the 
reaction mixture was extracted twice with ethyl acetate (25 mL × 2). The organic layers 
were combined, washed several times with water and brine, dried over Na2SO4, and 
concentrated under reduced pressure to a residue, that was purified by the flash column 
chromatography to give the corresponding aziridines. 
General aziridine opening reaction procedure (method E) 
To a stirred solution of the N-aryl aziridine (0.2 mmol) in toluene (3.5 mL), Yb(OTf)3 
(70 mmol% or 10 mmol%) and TMSN3 (5 equiv.) or aniline (1.2 equiv.) were added. The 
reaction mixture was stirred untill total conversion was observed by TLC at 80 oC or at rt, 
quenched with H2O and extracted with DCM twice. The combined organic layers were 
dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by 
flash column chromatography, eluting with ethyl acetate/hexane, evaporation of the 
collected fractions afforded the corresponding azido amine or diamine product. 




Compound 1.1 was prepared according to the general procedure (method A) starting 
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from the 3-methylcyclopentenone (13.0 g, 135.2 mmol), CeCl3.7H2O (39.2 g, 202.8 
mmol) and NaBH4 (5.1 g, 135.2 mmol) in MeOH (300 mL) at 0 oC. Purification by the 
flash column chromatography with ethyl acetate/hexane (1:4) as eluant afforded 1.1 (10.6 
g, 80%) as a colorless oil. (The NMR data are identical with the literature)54 
1H NMR (300 MHz CDCl3): δ 5.51-5.47 (m, 1H), 4.60 (s, 1H), 2.47-2.35 (m, 1H), 
2.32-2.22 (m, 1H), 2.18-2.09 (m, 1H), 1.78 (s, 3H), 1.76-1.74 (m, 1H). 
 
 
Compounds cis-1.2 and trans-1.2 were prepared according to the general procedure 
(method B) starting from 1.1 (5 g, 51.0 mmol), m-CPBA (25 g, 102 mmol) in DCM (150 
mL) at 0 oC. Purification by the flash column chromatography with ethyl acetate/hexane 
(1:9) as eluant afforded cis-1.2 (1.56 g, 27%), and trans-1.2 (300 mg, 5%) as a colorless 
oils. 
(±) (1R,2R,5S)-5-Methyl-6-oxabicyclo[3.1.0]hexan-2-ol (cis-1.2) 
1H NMR (400 MHz CDCl3): δ 4.27 (t, J=7.8 Hz, 1H), 3.31 (d, J= 1.3 Hz, 1H), 2.03-1.91 
(m, 2H), 1.8 (br, 1H), 1.61-1.50 (m, 1H), 1.44 (s, 3H), 1.34-1.24 (m, 1H).    
13C NMR (100 MHz CDCl3): δ 74.0, 65.5, 64.0, 30.5, 29.2, 18.2. 
(±) (1R,2S,5S)-5-Methyl-6-oxabicyclo[3.1.0]hexan-2-ol (trans-1.2) 
1H NMR (400 MHz CDCl3): δ 4.20 (d, J= 5.4 Hz, 1H), 3.14 (s, 1H), 1.82 – 1.73 (m, 2H), 
1.68 – 1.54 (m, 1H), 1.54 – 1.47 (m, 1H), 1.44 (s, 3H).     






To a stirred solution of the starting alcohol (2.86 g, 27 mmol) in DCM (150 mL), was 
added Et3N (8.1 mL, 54 mmol) and TESCl (5.9 mL, 32.4 mmol) at 0 oC. After stirring for 
3 h, the reaction mixture was quenched with saturated NH4Cl and extracted with DCM 3 
times. The combined organic layers were dried over Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash column chromatography with ethyl 
acetate/hexane (3 :97) as eluant, to give 1.3 (5.15 g, 83%) as colorless oil. (The NMR 
data are identical with the literature)55 
1H NMR (300 MHz CDCl3): δ 5.33 (q, J= 1.6 Hz, 1H), 4.85-4.83 (m, 1H), 2.37-2.31 (m, 
1H), 2.25-2.19 (m, 1H), 2.15-2.06 (m, 1H), 1.74-1.69 (m, 1H), 1.71 (s, 3H), 1.03 (t, J= 
7.9 Hz, 9H), 0.63 (q, J = 7.9 Hz, 6H).                                    
 
 
Compounds cis-1.4 and trans-1.4 were prepared according to the general procedure 
(method B), starting from 1.3 (5 g, 23.5 mmol), m-CPBA (11.5 g, 47.1 mmol) in DCM 
(150 mL) at 0 oC. Purification by the flash column chromatography with ethyl 
acetate/hexane (1:99) as eluant afforded cis-1.4 (620 mg, 12%), and trans-1.4 (1.85 g, 
35%) as a colorless oils. 
(±) Triethyl((1R,2R,5S)-5-methyl-6-oxabicyclo[3.1.0]hexan-2-yloxy)silane (cis-1.4) 
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1H NMR (300 MHz CDCl3): δ 4.25-2.30 (t, J=7.1 Hz, 1H), 3.17 (s, 1H), 1.91-1.95 (m, 
1H), 1.71-1.77 (m, 1H), 1.46-1.56 (m, 2H), 1.42 (s, 3H), 0.96 (t, J=7.9 Hz, 9H), 0.63 (q, 
J=7.5 Hz, 6H). 
13C NMR (75 MHz CDCl3): δ 74.0, 65.3, 62.3, 30.2, 28.5, 18.2, 6.9, 4.9. 
(±) Triethyl((1S,2R,5R)-5-methyl-6-oxabicyclo[3.1.0]hexan-2-yloxy)silane (trans-1.4) 
1H NMR (400 MHz CDCl3): δ 4.28-4.27 (d, J=5.2 Hz, 1H), 3.12 (d, J=0.9 Hz, 1H), 
1.86-1.80 (m, 2H), 1.68-1.65 (m, 1H), 1.51 (s, 3H), 1.54-1.48 (m, 1H), 0.93 (t, J=7.9 Hz, 
9H), 0.62 (q, J=8 Hz, 6H). 




Compound 1.5 was prepared according to the general procedure (method A) starting 
from the cyclopentenone (0.8 g, 8.3 mmol), CeCl3.7H2O (4.84 g, 12.5 mmol) and NaBH4 
(377 mg, 10 mmol) in MeOH (35 mL) at 0 oC. Purification by the flash column 
chromatography with ether/petane (1:3) as eluant afforded the enol 1.5 (603 mg, 78%) as 
a colorless oil. 
1H NMR (300 MHz CDCl3): δ 5.91-5.89 (m, 1H), 5.78-5.74 (m, 1H), 4.79 (dd, J=8.2, 6.7 






Compound 1.7 was prepared according to the gereneral procedure (method A) starting 
from the 2-methylcyclopentenone (400 mg, 4.16 mmol), CeCl3.7H2O (2.33 g, 6.25 mmol) 
and NaBH4 (189 mg, 5 mmol) in MeOH (20 mL) at 0 oC. Purification by the flash 
column chromatography with ether/petane (1:3) as eluant afforded the enol 1.7 as a 
colorless oil (204 mg, 50%). (The NMR data are identical with the literature)56 
1H NMR (300 MHz CDCl3): δ 5.53 (s, 1H), 4.57-4.54 (m, 1H), 2.40-.2.26 (m, 3H), 1.86 









Compound 1.8 was prepared according to the general (method B) starting from the 
2-methyl cyclopentenol (100 mg, 1.2 mmol), m-CPBA (414 mg, 2.4 mmol) in DCM (5 
mL). Purification by the flash column chromatography with ethyl acetate/hexane (2:8) as 
eluant afforded 1.8 (75 mg, 55%) as a colorless oil. (The NMR data are identical with the 
literature)57 
1H NMR (400 MHz CDCl3): δ 4.07-4.03 (t, J=7.8 Hz, 1H), 3.33 (s, 1H), 2.02-1.96 (m, 
2H), 1.65-1.61 (m, 1H), 1.50 (s, 3H), 1.33-1.27 (m, 1H). 
 
 
Compounds cis-1.9 and trans-1.9 were prepared according to the general procedure 
(method B) starting from cyclohexenol (5 g, 51 mmol), m-CPBA (25 g, 102 mmol) in 
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DCM (150 mL) at 0 oC. Purification by the flash column chromatography with ethyl 
acetate/hexane (1:9) as eluant afforded cis-1.9 (3.1 g, 53%), and trans-1.9 (400 mg, 7%) 
as colorless oils. (The NMR data are identical with the literature)58 
(±) (1S,2S,6R)-7-Oxabicyclo[4.1.0]heptan-2-ol (cis-1.9) 
1H NMR (400 MHz CDCl3): δ 4.05-4.01 (m, 1H), 3.37 (t, J=3.4 Hz, 1H), 3.33 (t, J=3.8 
Hz, 1H), 1.60-1.56 (m, 3H), 1.48-1.46 (m, 2H), 1.31-1.28 (m, 1H). 
(±) (1S,2R,6R)-7-Oxabicyclo[4.1.0]heptan-2-ol (trans-1.9) 
1H NMR (300 MHz CDCl3): δ 3.97-3.94 (m, 1H), 3.21-3.20 (m, 1H), 3.05 (d, J=3.2, 0.5 




To a stirred solution of the cyclohexenol (5 g, 51 mmol) in anhydrous THF (50 mL), 
NaH (4.08 g of a 60% dispersion in mineral oil, 102 mmol) was added, followed by 
benzyl bromide (6 mL, 51 mmol). After stirring at 60 oC for 18 h, the reaction mixture 
was cooled to 0 oC, treated with water was to destroy excess hydride, diluted with ether 
and evaporated to afford a residue, which was purified by filtration through a short silica 
gel column, with elution using petroleum ether, evaporation of the collected fractions 
gave 3-benzyloxycyclohexene 1.10 (8.2 g, 85%) as a colorless liquid. 
1H NMR (300 MHz CDCl3): δ 7.31-7.45 (m, 5H), 5.88-5.97 (m, 2H), 4.62, 4.68 (dd, 
J=13.3, 12.0 Hz, 2H), 3.92-3.97 (m, 1H), 1.58-1.67 (m, 1H), 1.80-1.97 (m, 3H), 
2.00-2.05 (m, 1H), 2.11-2.17 (m, 1H). 
13C NMR (75 MHz CDCl3): δ 139.2, 131.0, 128.5, 128.4, 128.2, 127.8, 127.7, 127.5, 72.3, 





Compounds cis-1.11 and trans-1.11 were prepared according to the general procedure 
(method B) starting from 1.10 (1 g, 5.3 mmol), m-CPBA (1.8 g, 106 mmol) in dry DCM 
(20 mL) at 0 oC. Purification by the flash column chromatography with ethyl 
acetate/hexane (1:4) as eluant afforded cis-1.11 (410 mg, 37%), and trans-1.11 (136 mg, 
13%) as colorless oils. (The NMR data are identical with the literature)59 
(±) (1S,2R,6S)-2-(Benzyloxy)-7-oxabicyclo[4.1.0]heptane (cis-1.11) 
1H NMR (300 MHz CDCl3): δ 7.27-7.42 (m, 5H), 4.66-4.75 (s, 2H), 3.79-3.84 (m, 1H), 
3.27-3.33 (m, 2H), 1.80-1.85 (m, 2H), 1.50-1.71 (m, 3H), 1.15-1.31 (m, 1H).    
13C NMR (75 MHz CDCl3): δ 138.8, 128.5, 127.8, 127.7, 74.8, 70.3, 54.2, 53.6, 25.1, 
23.2, 19.8. 
(±) (1R,2R,6R)-2-(Benzyloxy)-7-oxabicyclo[4.1.0]heptane (trans-1.11) 
1H NMR (400 MHz CDCl3): δ 7.31-7.42 (m, 5H), 4.67 (s, 2H), 3.74-3.77 (m, 1H), 
3.24-3.26 (m, 1H), 3.19-3.20 (m, 1H), 2.02-2.06 (m, 1H), 1.79-1.87 (m, 2H), 1.49-1.51 
(m, 1H), 1.27-1.34 (m, 2H).     





To a stirred solution of cyclohexenol (700 mg, 7.1 mmol) in DCM (30 mL), Et3N (2 
mL, 14.2 mmol) and TESCl (1.4 mL, 8.5 mmol) were added at 0 oC. After stirring for 3 h, 
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the reaction mixture was quenched with H2O (15 mL) and extracted with DCM (20 mL × 
2). The combined organic layers were dried over Na2SO4, concentrated under reduced 
pressure and the residue was purified by flash column chromatography, eluting with ethyl 
acetate/hexane (1:3) as eluant to give 1.12 (1.1 g, 73%) as a colorless oil. 
1H NMR (400 MHz CDCl3): δ 5.80-5.76 (m, 1H), 5.68-5.64 (m, 1H), 4.24 (s, 1H), 
2.04-1.77 (m, 4H), 1.64-1.54 (m, 2H), 0.99 (t, J=7.9 Hz, 9H), 0.64 (q, 7.8 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 131.3, 129.5, 66.6, 32.8, 25.2, 19.9, 7.1, 5.1. 
 
 
Compounds cis-1.13 and trans-1.13 were prepared according to the general procedure 
(method B) starting from 1.12 (980 mg, 4.6 mmol), m-CPBA (1.59 g, 9.2mmol) in DCM 
(30 mL) at 0 oC. Purification by the flash column chromatography with ethyl 
acetate/hexane (2:98) as eluant afforded cis-1.13 (115 mg, 11%), and trans-1.13 (620 mg, 
59%) as colorless oils. 
(±) ((1S,2R,6S)-7-Oxabicyclo[4.1.0]heptan-2-yloxy)triethylsilane (cis-1.13) 
1H NMR (300 MHz CDCl3): δ 4.05-3.99 (m, 1H), 3.26-3.24 (m, 1H), 3.3 (t, J=4.1 Hz, 
1H), 1.81-1.77 (m, 2H), 1.59-1.27 (m, 2H), 1.02-0.99 (m, 2H), 0.96 (t, J=7.9 Hz, 9H), 
0.66 (q, J=8.0 Hz, 6H).    
13C NMR (75 MHz CDCl3): δ 69.7, 56.5, 54.8, 28.4, 22.8, 20.7, 7.1, 5.1.  
(±) ((1R,2R,6R)-7-Oxabicyclo[4.1.0]heptan-2-yloxy)triethylsilane (trans-1.13) 
1H NMR (400 MHz CDCl3): δ 3.95-3.92 (t, J=6.9 Hz, 1H), 3.16 (s, 1H), 2.98-2.97 (d, 
J=3.6 Hz, 1H), 1.92-1.73 (m, 1H), 1.72-1.69 (m, 2H), 1.23-1.19 (m, 1H), 1.18-1.15 (m, 
2H), 0.95 (t, J=8.0 Hz, 9H), 0.61 (q, J=8.0 Hz, 6H). 






To a solution of 3-bromocyclohexene (10 g, 62.5 mmol) in CCl4 (100 mL), a solution 
of NaN3 (14.2 g, 218.5 mmol) in H2O (100 mL) was added. After stirring this 
heterogeneous mixture vigorously for 48 h at rt, the CCl4 layer was separated and the 
aqueous layer was extracted with CCl4. The combined organic layers were dried over 
Na2SO4 and concentrated under reduced pressure to give 3-azidocyclohexene 1.14 (6.9 g, 
90%) as a colorless oil, which was used without further purification. 
IR: 2102 cm-1 
1H NMR (400 MHz CDCl3): δ 5.97-6.01 (m, 1H), 5.69-5.72 (m, 1H), 3.87 (s, 1H), 
1.65-2.07 (m, 6H). 
13C NMR (100 MHz CDCl3): δ 132.7, 124.8, 56.0, 28.7, 24.8, 19.3. 
 
 
Compounds cis-1.15 and trans-1.15 were prepared according to the general procedure 
(method B) starting from 3-azidocyclohex-1-ene (3 g, 24.4 mmol), m-CPBA (12 g, 48.8 
mmol) in DCM (80 mL) at 0 oC. Purification by the flash column chromatography with 
ethyl acetate/hexane (2:98) as eluant afforded cis-1.15 (840 mg, 25%) and trans-1.15 
(860 mg, 25%) as colorless oils.  
IR: 2100.9 cm-1 
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(±) (1R,2R,6S)-2-Azido-7-oxabicyclo[4.1.0]heptanes (cis-1.15) 
1H NMR (400 MHz CDCl3): δ 3.59-3.61 (m, 1H), 3.33-3.35 (m, 1H), 3.28-3.30 (m, 1H), 
1.85-1.90 (m, 2H), 1.62-1.70 (m, 3H), 1.30-1.31 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 58.1, 54.0, 53.7, 24.4, 22.7, 20.0. 
(±) (1S,2R,6R)-2-Azido-7-oxabicyclo[4.1.0]heptanes (trans-1.15) 
1H NMR (400 MHz CDCl3): δ 3.79-3.82 (t, J=6.8 Hz, 1H), 3.20 (s, 1H), 3.056-3.065 (d, 
J=3.6 Hz, 1H), 1.96-2.02 (m, 1H), 1.74-1.88 (m, 2H), 1.44-1.46 (m, 1H), 1.28-1.33(m, 
2H). 




Compound 1.16 was prepared according to the general procedure (method A) starting 
from 3-cyclohexenone (630 mg, 5.73 mmol), CeCl3.7H2O (3.2 g, 8.6 mmol) and NaBH4 
(260 mg, 6.9 mmol) in MeOH (25 mL) at 0 oC. Purification by the flash column 
chromatography with ethyl acetate/hexane (1:2) as eluant afforded the enol 1.16 (510 mg, 
80%) as a colorless oil. 
1H NMR (300 MHz CDCl3): δ 5.48 (s, 1H), 4.16 (s, 1H), 1.97-1.82 (m, 2H), 1.84 – 1.71 
(m, 2H), 1.68 (s, 3H), 1.58-1.47 (m, 2H). 






Compound 1.18 was prepared according to the general procedure (method B) starting 
from 3-azidocyclo-1-methylhex-1-ene (100 mg, 0.8 mmol, prepared according the 
literature60 from 1.16), m-CPBA (280 mg, 1.6 mmol) in DCM (10 mL) at 0 oC. 
Purification by the flash column chromatography with ethyl acetate/hexane (5:95) as 
eluant afforded trans-1.18 (35 mg, 28%) as a colorless oil. 
IR: 2100 cm-1 
1H NMR (400 MHz CDCl3): δ 3.61-3.57 (m, 1H), 3.18 (d, J=1.7 Hz, 1H), 1.92-1.84 (m, 
1H), 1.77-1.58 (m, 4H), 1.37 (s, 3H), 1.32-1.28 (m, 1H). 




To a solution of 3-bromocyclohexene (970 mg, 6.0 mmol) in diglyme (15 mL), 
Cs2CO3 (2.6 g, 8.0 mmol), LiI (15 mg, 0.11 mmol) and Boc2NH (437 mg, 2.0 mmol) 
were added. After stirring at rt for 3 days, the reaction mixture was treated with brine (30 
mL) and extracted with DCM twice. The combined organic layers were concentrated 
under reduced pressure. The residue was purified by flash column chromatography, 
eluting with ethyl acetate/hexane (1:9) as eluant, to give the intermediate product. This 
intermediate was dissolved in DCM (15 mL) and TFA (0.3 mL, 4 mmol). After stirring 
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overnight at rt, the reaction mixture was treated drop wise with 1.0 N NaOH to adjust the 
pH to 8-9. The reaction mixture was extracted with DCM. The combined organic layers 
were dried over Na2SO4 and concentrated under reduced pressure, to a residue which was 
purified by flash column chromatography, eluting with ethyl acetate/hexane (1:9), to give 
carbomate 1.19 (245 mg, 62%) as a yellow oil. (The NMR data are identical with the 
literature)61 
1H NMR (400 MHz CDCl3): δ 5.71-5.67 (m, 1H), 5.51-5.48 (m, 1H), 4.69-4.67 (m, 1H), 
1.89-1.86 (m, 2H), 1.78-1.75 (m, 1H), 1.55-1.50 (m, 2H), 1.43-1.34 (m, 1H), 1.18 (s, 
9H). 
13C NMR (100 MHz CDCl3): δ 154.7, 129.7, 127.8, 78.4, 45.3, 29.3, 27.9, 24.3, 19.2. 
 
 
Compounds cis-1.20 and trans-1.20 were prepared according to the general procedure 
(method B) starting from 1.19 (500 mg, 2.54 mmol), m-CPBA (876 mg, 5.10 mmol) in 
DCM (9 mL). Purification by flash column chromatography eluting with ethyl 
acetate/hexane (1:9) afforded cis-1.20 (330 mg, 61%), and trans-1.20 (36 mg, 7%) as 
colorless oils (trans-1.20 comes out first, then the cis-1.20). 
(±) tert-Butyl (1R,2R,6S)-7-oxabicyclo[4.1.0]heptan-2-ylcarbamate (cis-1.20) 
1H NMR (400 MHz CDCl3): δ 5.12-5.10 (d, J=8.8 Hz, 1H), 3.90-3.86 (m, 1H), 3.16-3.12 
(m, 2H), 1.73-1.69 (m, 2H), 1.44-1.37 (m, 2H), 1.33 (s, 9H), 1.13-1.26 (m, 2H). 
13C NMR (100 MHz CDCl3): δ 155.3, 79.1, 54.3, 46.8, 28.3, 28.1, 26.3, 23.0, 18.9. 
(±) tert-Butyl (1S,2R,6R)-7-oxabicyclo[4.1.0]heptan-2-ylcarbamate (trans-1.20) 
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1H NMR (400 MHz CDCl3): δ 4.74-4.73 (m, 1H), 3.90-3.89 (m, 1H), 3.18-3.17(m, 1H), 
3.07-3.06 (d, J=3.6 Hz, 1H), 2.05-1.99 (m, 1H), 1.82-1.73 (m, 2H), 1.46 (s, 9H); 
1.39-1.35 (m, 2H); 1.16-1.11 (m, 1H). 




To a solution of azide 1.14 (125 mg, 1.0 mmol) in dry THF (3 mL), Ph3P (288 mg, 1.1 
mmol) was added. After stirring at rt for 24 h, H2O (2 mL, 2 mmol) was added to the 
reaction mixture, which was stirred for another 24 h and extracted with DCM. The 
combined organic layers were concentrated under reduced pressure. The residue was 
purified by flash column chromatography, eluting with ethyl acetate/hexane (2:8), to give 
1.21 (90 mg, 93%) as a yellow oil. 
1H NMR (400 MHz CD3OD): δ 6.11-6.08 (m, 1H), 5.73 (dd, J=8.4, 1.7 Hz, 1H), 
3.83-3.82 (m, 1H), 3.36 (s, 1H), 2.14-2.09 (m, 3H), 1.88-1.86 (m, 1H), 1.72-1.65 (m, 
2H). 






Cyclohex-2-enamine (90 mg, 0.93 mmol) was added to acetic anhydride (2 mL) After 
stirred at rt for 2 days, the reaction mixture was concentrated under reduced pressure, the 
residue was purified by flash column chromatography, eluting with  ethyl 
acetate/hexane (2:8), to give 1.22 (73 mg, 56%) as a pale yellow solid. 
1H NMR (400 MHz CDCl3): δ 5.87-5.83 (m, 1H), 5.60-5.56 (m, 1H), 5.45 (br, 1H), 
4.87-447(m, 1H), 2.02-1.99 (m, 2H), 1.86(s, 3H), 1.68-1.43 (m, 4H). 
13C NMR (100 MHz CDCl3): δ 169.5, 131.2, 127.9, 44.9, 29.7, 25.0, 23.7, 19.9. 
 
 
(±) N-((1R,2R,6S)-7-Oxabicyclo[4.1.0]heptan-2-yl)acetamide  
Compounds 1.23 was prepared according to the general procedure (method B) starting 
from 1.22 (210 mg, 1.62 mmol), m-CPBA (570 mg, 3.3 mmol) in DCM (9 mL) at 0 oC. 
Purification by flash column chromatography eluting with ethyl acetate/hexane (3:7) gave 
1.23 (150 mg, 59%) as pale yellow oil. 
1H NMR (400 MHz CD3OD): δ 4.23-4.21 (m, 1H), 3.27-3.25 (m, 1H), 3.22-3.20 (m, 1H), 
1.99 (s, 3H), 1.94-1.89 (m, 1H), 1.83-1.75 (m, 1H), 1.60-1.51 (m, 2H), 1.41-1.31 (m, 
2H). 
13C NMR (100 MHz CD3OD): δ 173.0, 55.3, 55.2, 47.9, 26.5, 24.1, 22.7, 20.7. 
1.3.3 Epoxides opening reactions 
Compounds 1.24a-d and 1.26a-d were prepared according to the general procedure 
(method C) starting from cis-1.2 and trans-1.2 (50 mg, 0.44 mmol), Yb(OTf)3 (28 mg, 
0.04 mmol) and corresponding aniline (1.5 eq). Purification by the flash column 
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chromatography with ethyl acetate/hexane (2:8) as eluant afforded the corresponding 
epoxide opening reaction product. 
 
 
(±) (1R,2S,3R)-3-Methyl-3-(phenylamino)cyclopentane-1,2-diol (1.24a) 
1H NMR (400 MHz CDCl3): δ 7.19-7.15 (m, 2H), 6.76-6.73 (m, 3H), 4.32-4.26 (m, 1H), 
4.00 (d, J=5.6 Hz, 1H), 3.16 (br, NH, OH, 3H), 2.12-2.05 (m, 2H), 1.82-1.68 (m, 2H), 
1.37 (s, 3H). 
13C NMR (100 MHz CDCl3): δ 146.1, 129.3, 118.2, 116.2, 78.9, 72.4, 62.9, 37.4, 30.5, 
20.2. 
HRMS (ESI) calc. for C12H18NO2 : [M+H+], 208.13321; found: [M+H+], 208.13286. 
(±) (1R,2S,3R)-3-(4-Chlorophenylamino)-3-methylcyclopentane-1,2-diol (1.24b) 
1H NMR (400 MHz CDCl3): δ 7.11-7.08 (m, 2H), 6.67-6.64 (m, 2H), 4.30-4.26 (td, J = 
3.9, 5.7 Hz, 1H), 3.96 (d, J=5.6 Hz, 1H), 3.35-3.09 (br, NH, OH, 3H), 2.11-2.03 (m, 2H), 
1.78-1.67 (m, 2H), 1.32 (s, 3H). 
13C NMR (100 MHz CDCl3): δ 144.8. 129.1, 122.9, 117.1, 79.0, 62.9, 37.5, 30.0, 29.5, 
20.0.  
HRMS (ESI) calc. for C12H17ClNO2 : [M+H+], 242.09423; found: [M+H+], 242.09443. 
(±) (1R,2S,3R)-3-(4-Bromophenylamino)-3-methylcyclopentane-1,2-diol (1.24c) 
1H NMR (400 MHz CDCl3): δ 7.23-7.21 (m, 2H), 6.61-6.59 (m, 2H), 4.29-4.25 (td, J= 
3.7, 5.9 Hz, 1H), 3.95 (d, J=5.6 Hz, 1H), 3.60-3.11 (br, NH, OH, 3H), 2.12-2.03 (m, 2H), 
1.78-1.67 (m, 2H), 1.33 (s, 3H). 
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13C NMR (100 MHz CDCl3): δ 145.3, 132.0, 117.0, 109.7, 78.9, 72.4, 62.8, 37.6, 30.3, 
20.0. 
HRMS (ESI) calc. for C12H17BrNO2 : [M+H+], 286.04372; found: [M+H+], 286.04369. 
(±) (1R,2S,3R)-3-(4-Methoxyphenylamino)-3-methylcyclopentane-1,2-diol (1.24d) 
1H NMR (400 MHz CDCl3): δ 6.75 (m, 4H), 4.29-4.24 (m, 1H), 3.89 (d, J=5.8 Hz, 1H), 
3.74 (s, 3H), 3.27 (br, NH, OH, 3H), 2.14-2.05 (m, 1H), 1.97-1.91 (m, 1H), 1.75-1.63 (m, 
2H), 1.26 (s, 3H). 
13C NMR (100 MHz CDCl3): δ 153.8, 139.2, 120.2, 115.0, 78.9, 71.9, 63.8, 55.8, 36.3, 
30.3, 20.3. 
HRMS (ESI) calc. for C13H20NO3 : [M+H+], 238.14377; found: [M+H+], 238.14379. 
 
 
(±) (1R,2R,3S)-3-Methyl-3-(phenylamino)cyclopentane-1,2-diol (1.26a) 
1H NMR (400 MHz CDCl3): δ 7.18-7.14 (m, 2H), 6.83-6.73 (m, 2H), 6.70-6.68 (m, 1H), 
4.89 (br, NH, OH, 3H), 3.96 (q, J=7.4 Hz, 1H), 3.84 (d, J=10 Hz, 1H), 2.15-1.99 (m, 2H), 
1.88-1.81 (m, 1H), 1.68-1.59 (m, 1H), 1.20 (s, 3H).    
13C NMR (100 MHz CDCl3): δ 134.5, 129.3, 119.6, 117.6, 84.5, 76.4, 61.6, 34.5, 28.1, 
20.2. 
HRMS (ESI) calc. for C12H18NO2 : [M+H+], 208.13321; found: [M+H+], 208.13273. 
(±) (1R,2R,3S)-3-(4-Chlorophenylamino)-3-methylcyclopentane-1,2-diol (1.26b) 
1H NMR (400 MHz CDCl3): δ 7.10-7.08 (m, 2H), 6.60-6.64 (m, 2H), 4.45-4.23 (br, NH, 
OH, 3H), 3.99 (q, J=7.6 Hz, 1H), 3.90 (d, J=7.6 Hz, 1H), 2.09-1.97 (m, 2H), 1.86-1.78 
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(m, 1H), 1.64-1.58 (m, 1H), 1.16 (s, 3H).   
13C NMR (100 MHz CDCl3): δ 144.4, 129.2, 124.2, 118.3, 84.5, 76.3, 61.2, 34.5, 27.9, 
20.2. 
HRMS (ESI) calc. for C12H17ClNO2 : [M+H+], 242.09423; found: [M+H+], 242.09414. 
(±) (1R,2R,3S)-3-(4-Bromophenylamino)-3-methylcyclopentane-1,2-diol (1.26c) 
1H NMR (400 MHz CD3OD): δ 7.19-7.17 (m, 2H), 6.69-6.66 (m, 2H), 4.25 (br, NH, OH, 
3H), 3.94 (q, J=7.7 Hz, 1H), 3.83 (d, J=6.8 Hz, 1H), 2.07-1.96 (m, 2H), 1.87-1.82 (m, 
1H), 1.67-1.61 (m, 1H), 1.22 (s, 3H). 
13C NMR (100 MHz CD3OD): δ 147.1, 132.6, 118.7, 110.1, 85.2, 78.4, 62.4, 36.5, 29.6, 
20.6. 
HRMS (ESI) calc. for C12H17BrNO2 : [M+H+], 286.04372; found: [M+H+], 286.04347. 
(±) (1R,2R,3S)-3-(4-Methoxyphenylamino)-3-methylcyclopentane-1,2-diol (1.26d) 
1H NMR (400 MHz CD3OD): δ 6.84-6.87 (m, 2H), 6.79-6.77 (m, 2H), 4.3 (br, NH, OH, 
3H), 3.95 (q, J=6.8 Hz, 1H), 3.77 (d, J=6.5 Hz, 1H), 3.73 (s, 3H), 2.07-1.99 (m, 2H), 
1.73-1.68 (m, 1H), 1.61-1.55 (m, 1H), 1.14 (s, 3H). 
13C NMR (100 MHz CD3OD): δ 156.1, 140.1, 122.9, 115.4, 84.9, 77.9, 64.0, 56.1, 35.3, 
29.6, 20.9. 
HRMS (ESI) calc. for C13H20NO3 : [M+H+], 238.14377; found: [M+H+], 238.14361. 
Compounds 1.25a-d and 1.27a-d were prepared according to the general procedure 
(method C) starting from cis-1.4 or trans-1.4 (50 mg, 0.22 mmol), Yb(OTf)3 (14 mg, 0.02 
mmol) and the corresponding aniline (1.5 eq). Purification by the flash column 
chromatography with ethyl acetate/hexane (1:9) as eluant afforded the corresponding 





(±) (1S,2R,5R)-2-Methyl-2-(phenylamino)-5-(triethylsilyloxy)cyclopentanol (1.25a) 
1H NMR (300 MHz CDCl3): δ 7.13-7.27 (m, 2H), 6.45-6.77 (m, 3H), 4.29-4.34 (m, 1H), 
3.91 (t, J=6.3 Hz, 1H), 3.00-2.98 (m, 1H), 2.00-2.14 (m, 2H), 1.62-1.79 (m, 3H), 1.34 (s, 
3H), 0.98 (t, J=7.9 Hz, 9H), 0.64 (q, J=7.6 Hz, 6H).         
13C NMR (75 MHz CDCl3): δ 146.6, 129.3, 117.8, 115.8, 79.1, 73.3, 62.7, 38.0, 31.2, 
20.0, 6.9, 5.0. 
HRMS (ESI) calc. for C18H32NO2Si : [M+H+], 322.21968; found: [M+H+], 322.21966. 
(±) (1S,2R,5R)-2-(4-Chlorophenylamino)-2-methyl-5-(triethylsilyloxy)cyclopentanol 
(1.25b)  
1H NMR (300 MHz CDCl3): δ 7.08-7.13 (m, 2H), 6.86-6.71 (m, 2H), 4.26-4.31 (m, 1H), 
3.87 (t, J=5.9 Hz, 1H), 2.97-2.99 (m, 1H), 2.05-2.08 (m, 2H), 1.67-1.73 (m, 2H), 
1.33-1.29 (m, 1H), 1.31 (s, 3H), 0.98 (t, J=7.9 Hz, 9H), 0.64 (q, J=7.6 Hz, 6H).       
13C NMR (75 MHz CDCl3): δ 145.2, 129.1, 122.5, 116.8, 79.0, 73.3, 62.8, 38.0, 31.1, 
19.9, 6.9, 4.9. 
HRMS (ESI) calc. for C18H31ClNO2Si : [M+H+], 356.17995; found: [M+H+], 356.18071. 
(±) (1S,2R,5R)-2-(4-Bromophenylamino)-2-methyl-5-(triethylsilyloxy)cyclopentanol 
(1.25c) 
1H NMR (400 MHz CDCl3): δ 7.23-7.25 (m, 2H), 6.64-6.66 (m, 2H), 4.29-4.32 (m, 1H), 
3.88 (t, J=6.7 Hz, 1H), 2.98-3.01 (m, 1H), 2.05-2.09 (m, 2H), 1.69-1.74 (m, 2H), 
1.31-1.33 (m, 1H), 1.33 (s, 3H), 0.98 (t, J=7.9 Hz, 9H), 0.66 (q, J=7.9 Hz, 6H).    
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13C NMR (100 MHz CDCl3): δ 145.7, 132.0, 117.3, 109.6, 79.0, 73.4, 62.8, 38.0, 31.1, 
19.9, 6.9, 5.0.  
HRMS (ESI) calc. for C18H31BrNO2Si : [M+H+], 400.1302; found: [M+H+], 400.13182. 
(±)(1S,2R,5R)-2-(4-Methoxyphenylamino)-2-methyl-5-(triethylsilyloxy)cyclopentanol 
(1.25d) 
1H NMR (400 MHz CDCl3): δ 6.75-6.80 (m, 4H), 4.32-4.36 (m, 1H), 3.85 (m, 1H), 3.77 
(s, 3H), 2.95-2.93 (m, 1H), 1.98-2.11 (m, 2H), 1.67-1.74 (m, 2H), 1.30-1.28 (m, 1H), 
1.29 (s, 3H), 1.00 (t, J=7.9 Hz, 9H), 0.66 (q, J=7.8 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 153.2, 140.1, 119.2, 114.7, 79.0, 77.7, 63.5, 55.9, 37.1, 
31.3, 14.3, 6.9, 4.9. 
















(±) (1R,2S,5R)-2-Methyl-2-(phenylamino)-5-(triethylsilyloxy)cyclopentanol (1.27a) 
1H NMR (400 MHz CDCl3): δ 7.20-7.16 (m, 2H), 6.78-6.74 (m, 3H), 4.03-3.98 (q, J=6.9 
Hz, 1H), 3.90 (d, J=6.5 Hz, 1H), 2.18-2.21 (m, 1H), 2.03-2.01 (m, 1H), 1.90-1.85 (m, 
1H), 1.69-1.66 (m, 1H), 1.33 (s, 3H), 1.33-1.34 (m, 1H), 1.01 (t, J=8 Hz, 9H), 0.66 (q, 
J=8.0 Hz, 6H).       
13C NMR (100 MHz CDCl3): δ 146.5, 129.2, 118.2, 116.4, 85.1, 77.8, 60.9, 34.8, 29.5, 
20.8, 7.0, 5.1. 





1H NMR (400 MHz CDCl3): δ 7.12-7.10 (m, 2H), 6.67-6.65 (m, 2H), 3.98 (q, J= 6.9 Hz, 
1H), 3.86 (t, J=6.3 Hz, 1H), 2.16-2.10 (m, 1H), 2.04-1.97 (m, 1H), 1.87-1.83 (m, 1H), 
1.67-1.63 (m, 1H), 1.30 (s, 3H), 1.00 (t, J=7.5 Hz, 9H), 0.64 (q, J=8.0 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ145.1, 129.1, 122.9, 117.3, 85.1, 77.8, 60.9, 34.9, 29.5, 
20.6, 7.0, 5.1. 
HRMS (ESI) calc. for C18H31ClNO2Si : [M+H+], 356.17991; found: [M+H+], 356.18071. 
(±) (1S,2R,5S)-2-(4-Bromophenylamino)-2-methyl-5-(triethylsilyloxy)cyclopentanol 
(1.27c) 
1H NMR (400 MHz CDCl3): δ 7.28-7.23 (m, 2H), 6.60-6.63 (m, 2H), 3.98 (q, J=7.0 Hz, 
1H), 3.86 (dt, J=6.4, 3.9 Hz, 1H), 2.13-2.10 (m, 1H), 2.03-2.01 (m,1H), 1.88-1.83 (m, 
1H), 1.68-1.63 (m, 1H), 1.30 (s, 3H), 1.00 (t, J=3.2 Hz, 9H), 0.64 (q, J=7.8 Hz, 6H).     
13C NMR (100 MHz CDCl3): δ 145.5, 132.0, 117.7, 109.9, 85.1, 77.8, 50.9, 34.9, 29.5, 
20.6, 7.0, 5.1. 
HRMS (ESI) calc. for C18H31BrNO2Si : [M+H+], 400.13020; found: [M+H+], 400.13119. 
(±)(1R,2S,5R)-2-(4-Methoxyphenylamino)-2-methyl-5-(triethylsilyloxy)cyclopentanol 
(1.27d) 
1H NMR (400 MHz CDCl3): δ 6.78 (s, 4H), 3.99 (dt, J=6.5, 7.6 Hz, 1H), 3.84 (d, J=6.3 
Hz, 1H), 3.77 (s, 3H), 2.13-1.97 (m, 2H), 1.77-1.70 (m, 1H), 1.64-1.56 (m, 1H), 1.24 (s, 
3H), 0.99 (t, J=3.3 Hz, 9H), 0.64 (q, J=7.7 Hz, 6H).    
13C NMR (100 MHz CDCl3): δ 153.9, 139.6, 120.7, 114.7, 84.8, 77.7, 61.9, 55.8, 34.4, 
29.5, 21.0, 6.9, 5.0. 
















1.24c 1.28  
To a solution of 1.24c (20 mg, 0.07 mmol) in 2,2-DMP (1 mL) was added PTSA at rt. 
The reaction mixture was stirred overnight, and then concentrated under reduced pressure. 
The residue was purified by flash column chromatography, eluting with ethyl 
acetate/hexane (1:9), to give 1.28 (18 mg, 79%) as a brown oil. 
(3aS,4R,6aR)-N-(4-bromophenyl)-2,2,4-trimethyltetrahydro-3aH-cyclopenta[d][1,3]
dioxol-4-amine 
1H NMR (400 MHz CDCl3): δ 7.28-7.24 (m, 2H), 6.59-6.57 (m, 2H), 4.74 (t, J=4.5 Hz, 
1H), 4.49 (d, J=5.5 Hz, 1H), 1.98-1.51 (m, 4H), 1.44 (s, 3H), 1.35 (s, 3H), 1.28 (s, 3H). 
13C NMR (100 MHz CDCl3): δ 144.9, 131.9, 116.9, 110.4, 109.4, 83.8, 81.6, 63.5, 38.3, 
29.6, 26.4, 24.3, 19.4. 




Compound 1.29 was prepared according to the general procedure (method C) starting 
from 1.8 (50 mg, 0.44 mmol), p-anisidine (83 mg, 0.66 mmol), Yb(OTf)3 (27.3 mg, 0.04 
mmol) in toluene (3.5 mL). Purification by flash column chromatography with ethyl 
acetate/hexane (1:9) as eluant afforded 1.29 (70 mg, 67%) as a brown oil. 
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1H NMR (400 MHz CDCl3): δ 6.80-6.77 (m, 2H), 6.73-6.70 (m, 2H), 3.82 (t, J=8.8 Hz, 
1H), 3.76 (s, 3H), 3.74 (t, J=4 Hz, 1H), 2.99 (br, 3H), 2.43 – 2.18 (m, 1H), 2.10 – 1.90 (m, 
1H), 1.81 – 1.54 (m, 1H), 1.31 – 1.22 (m, 1H), 1.20 (s, 3H). 
13C NMR (100 MHz CDCl3): δ 152.4, 142.2, 115.2, 115.0, 79.8, 77.5, 61.7, 56.0, 28.5, 
28.0, 20.4. 
HRMS (ESI) calc. for C13H20NO3 : [M+H+], 238.1438; found: [M+H+], 238.1443. 
Compounds 1.30a-e and 1.33a-e were prepared according to the general procedure 
(method C) starting from cis-1.9 or trans-1.9 (50 mg, 0.44 mmol), Yb(OTf)3 (27 mg, 0.04 
mmol) and aniline (1.5 equiv.) in toluene (3 mL) at rt. Purification by the flash column 
chromatography with ethyl acetate/hexane (2:8) as eluant, afforded corresponding 
epoxides opening products. 
 
(±) (1R,2S,3R)-3-(Phenylamino)cyclohexane-1,2-diol (1.30a) 
1H NMR (400 MHz CDCl3): δ 7.33–7.09 (m, 2H), 6.96–6.63 (m, 3H), 4.31–4.04 (m, 1H), 
3.63 (dt, J=4.0 Hz, 1H), 3.38 (dd, J =2.8, 9.5 Hz, 1H), 3.15 (s, br, 3H), 2.27–2.03 (m, 1H), 
2.03–1.87 (m, 1H), 1.87–1.61 (m, 1H), 1.61–1.36 (m, 3H), 1.17–0.93 (m, 1H).  
13C NMR (100 MHz CDCl3): δ 147.7, 129.6, 118.8, 114.6, 75.9, 69.0, 54.2, 31.3, 30.2, 
19.1. 
HRMS (ESI) calc. for C12H18NO2 : [M+H+], 208.13321; found: [M+H+], 208.13314. 
(±) (1R,2S,3R)-3-(4-Chlorophenylamino)cyclohexane-1,2-diol (1.30b) 
1H- NMR (400 MHz CD3OD): δ 7.28–6.86 (m, 2H), 6.78–6.54 (m, 2H), 4.01 (dt, J =2.6, 
5.1 Hz, 1H), 3.55 (td, J =4.0, 8.9 Hz, 1H), 3.48 (dd, J =2.7, 8.5 Hz, 1H), 2.09–1.93 (m, 
1H), 1.90–1.77 (m, 1H), 1.76–1.63 (m, 1H), 1.59–1.43 (m, 2H), 1.25–1.07 (m, 1H).  
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13C NMR (100 MHz CD3OD): δ 148.8, 129.8, 122.1, 115.7, 75.7, 70.9, 54.7, 31.7, 30.9, 
20.0. 
HRMS (ESI) calc. for C12H17ClNO2 : [M+H+], 242.09423; found: [M+H+], 242.09468. 
(±) (1R,2S,3R)-3-(4-Bromophenylamino)cyclohexane-1,2-diol (1.30c) 
1H- NMR (400 MHz CD3OD ): δ 7.20-7.12(m, 2H), 6.77–6.43 (m, 2H), 3.93 (dd, J =2.8, 
5.8 Hz, 1H), 3.54 (dt, J =4.0, 8.9 Hz, 1H), 3.49 (dd, J =2.7, 8.5 Hz, 1H), 2.14–1.91 (m, 
1H), 1.88–1.76 (m, 1H), 1.70 (m, 1H), 1.60–1.40 (m, 2H), 1.25–1.10 (m, 1H).  
13C NMR (100 MHz CD3OD): δ 149.3, 132.8, 116.0, 108.8, 75.7, 70.9, 54.5, 31.7, 31.0, 
20.0. 
HRMS (ESI) calc. for C12H17BrNO2 : [M+H+], 286.04372; found: [M+H+], 286.04443. 
(±) (1R,2S,3R)-3-(4-Methoxyphenylamino)cyclohexane-1,2-diol (1.30d) 
1H- NMR (400 MHz CDCl3 ): δ 6.89–6.62 (m, 4H), 4.17 (dd, J =3.0, 5.8 Hz, 1H), 3.75 (s, 
3H), 3.54 (dt, J=3.9 Hz, 1H), 3.39 (dd, J =2.8, 9.6 Hz, 1H), 3.17-3.19 (m, 2H), 2.17–2.01 
(m, 1H), 1.95 (m, 1H), 1.82–1.62 (m, 1H), 1.57–1.36 (m, 2H), 1.13–0.96 (m, 1H).  
13C NMR (100 MHz CDCl3): δ 153.4, 141.1, 116.8, 115.1, 75.9, 68.9, 55.9, 55.8, 31.0, 
30.1, 19.3. 
HRMS (ESI) calc. for C13H20NO3 : [M+H+], 238.14377; found: [M+H+], 238.14416. 
(±) (1R,2S,3R)-3-(4-Fluorophenylamino)cyclohexane-1,2-diol (1.30e) 
1H- NMR (400 MHz CDCl3 ): δ 7.13–6.76 (m, 2H), 6.78–6.48 (m, 2H), 4.16 (d, J =2.7 
Hz, 1H), 3.52 (td, J =3.9, 10.9 Hz, 1H), 3.37 (dd, J =2.8, 9.5 Hz, 1H), 3.09 (s, 2H), 
2.14–2.00 (m, 1H), 2.02–1.84 (m, 1H), 1.85–1.61 (m, 1H), 1.61–1.35 (m, 2H), 1.12–0.86 
(m, 1H).  
13C NMR (100 MHz CDCl3): δ 157.8, 143.8, 116.1, 115.8, 75.9, 69.0, 55.2, 31.0, 30.2, 
19.2. 




















(±) (1R,2R,3S)-3-(Phenylamino)cyclohexane-1,2-diol (1.33a) 
1H NMR (400 MHz CD3OD): δ 7.28–6.91 (m, 2H), 6.72–6.57 (m, 3H), 3.47 (dd, J =4.4, 
9.0 Hz, 1H), 3.30–2.99 (m, 2H), 2.23–2.02 (m, 1H), 2.01–1.89 (m, 1H), 1.80–1.58 (m, 
1H), 1.59–1.22 (m, 2H), 1.22–0.97 (m, 1H).  
13C NMR (100 MHz CD3OD): δ 150.0, 130.2, 118.3, 115.0, 80.0, 75.2, 58.7, 34.1, 32.2, 
22.3. 
HRMS (ESI) calc. for C12H18NO2 : [M+H+], 208.13321; found: [M+H+], 208.13323. 
(±) (1R,2R,3S)-3-(4-Chlorophenylamino)cyclohexane-1,2-diol (1.33b) 
1H- NMR (400 MHz CD3OD ): δ 7.25–6.87 (m, 2H), 6.79–6.42 (m, 2H), 3.47 (ddd, J 
=4.7, 8.4, 10.8 Hz, 1H), 3.19 (t, J =8.9 Hz, 1H), 3.16–3.09 (m, 1H), 2.09–1.99 (m, 1H), 
2.00–1.90 (m, 1H), 1.76–1.64 (m, 1H), 1.45–1.26 (m, 2H), 1.18–1.03 (m, 1H).  
13C NMR (100 MHz CD3OD): δ 148.9, 129.9, 122.1, 115.7, 80.1, 75.2, 58.5, 34.0, 32.1, 
22.3. 
HRMS (ESI) calc. for C12H17ClNO2 : [M+H+], 242.09423; found: [M+H+], 242.09452. 
(±) (1R,2R,3S)-3-(4-Bromophenylamino)cyclohexane-1,2-diol (1.33c) 
1H NMR (400 MHz CD3OD): δ 7.33–6.92 (m, 2H), 6.85–6.26 (m, 2H), 3.44-3.49 (m, 
1H), 3.19 (t, J = 8.9 Hz, 1H), 3.13 (dt, J=4.0 Hz, 1H), 2.24–1.83 (m, 2H), 1.83–1.54 (m, 
1H), 1.49–1.24 (m, 3H), 1.24–1.03 (m, 1H).  




HRMS (ESI) calc. for C12H17BrNO2 : [M+H+], 286.04372; found: [M+H+], 286.0445. 
(±) (1R,2R,3S)-3-(4-Methoxyphenylamino)cyclohexane-1,2-diol (1.33d) 
1H NMR (400 MHz CDCl3): δ 7.31-6.24 (m, 4H), 3.72 (s, br, 3H), 3.74(s, 1H), 3.54 (td, J 
=4.7, 10.6 Hz, 1H), 3.20 (t, J =9.1 Hz, 1H), 3.02 (dt, J=3.9 Hz, 1H), 1.99 (m, 2H), 1.66 
(m, , 1H), 1.48–1.12 (m, 2H), 1.00 (m, 1H).  
13C NMR (100 MHz CDCl3): δ 153.2, 141.3, 116.7, 115.0, 79.4, 74.0, 59.3, 55.9, 32.2, 
31.1, 21.4. 
HRMS (ESI) calc. for C13H20NO3 : [M+H+], 238.14377; found: [M+H+], 238.14419. 
(±) (1R,2R,3S)-3-(4-Fluorophenylamino)cyclohexane-1,2-diol (1.33e) 
1H NMR (400 MHz CD3OD ): δ 6.98–6.76 (m, 2H), 6.77–6.58 (m, 2H), 3.47 (ddd, J =4.8, 
8.7, 10.8 Hz, 1H), 3.19 (t, J =9.0, 1H), 3.08 (ddd, J =4.0, 9.6, 11.1 Hz, 1H), 2.13–2.00 (m, 
1H), 2.02–1.91 (m, 1H), 1.81–1.61 (m, 1H), 1.49–1.21 (m, 2H), 1.20–1.03 (m, 1H). 
13C NMR (100 MHz CD3OD): δ 158.4, 146.4, 116.5, 116.1, 80.1, 75.2, 59.5, 34.1, 32.1, 
22.3. 
HRMS (ESI) calc. for C12H17FNO2 : [M+H+], 226.1238; found: [M+H+], 226.1245. 
Compounds 1.31a-d and 1.34a-d were prepared according to the general procedure 
(method C) starting from cis-1.11 or trans-1.11 (50 mg, 0.24 mmol), Yb(OTf)3 (15 mg, 
0.02 mmol) and aniline (1.5 equiv.) in toluene (3 mL) at rt. Purification by the flash 
column chromatography with ethyl acetate/hexane (1:9) as eluant afforded the 





(±) (1S,2R,6R)-2-(Benzyloxy)-6-(phenylamino)cyclohexanol (1.31a) 
1H NMR (400 MHz CDCl3): δ 7.43-7.33 (m, 5H), 7.22-7.18 (m, 2H), 6.78-6.71 (m, 3H), 
4.71 (dd, J=11.6, 28.0 Hz, 2H), 3.47-3.39 (m, 2H), 3.28-3.22 (m, 2H), 2.19-2.15 (m, 2H), 
1.79-1.75 (m, 1H), 1.38-1.28 (m, 2H), 1.18-1.09 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 148.0, 138.8, 129.4, 128.6, 127.9, 127.6, 118.2, 114.4, 
81.6, 78.0, 71.7, 57.7, 31.0, 29.6, 21.2. 
MS (ESI) m/z: 298.3 [M+H+]. 
(±) (1S,2R,6R)-2-(Benzyloxy)-6-(4-chlorophenylamino)cyclohexanol (1.31b) 
1H NMR (400 MHz CDCl3): δ 7.38-7.32 (m, 5H), 7.13-7.10 (m, 2H), 6.62-6.58 (m, 2H), 
4.61 (dd, J=11.7, 57.0 Hz, 2H), 3.92-3.90 (m, 1H), 3.57-3.46 (m, 2H), 2.21-2.16 (m, 1H), 
2.10-2.05 (m, 1H), 1.73-1.68 (m, 1H), 1.56-1.53 (m, 1H), 1.50-1.41 (m, 2H), 1.14-1.10 
(m, 1H). 
13C NMR (100 MHz CDCl3): δ 146.7, 138.5, 129.2, 128.6, 127.9, 127.8, 122.3, 115.0, 
77.3, 74.7, 71.3, 54.9, 31.1, 27.6, 18.9. 
HRMS (ESI) calc. for C19H23ClNO2 : [M+H+], 332.14142; found: [M+H+], 332.14118. 
(±) (1S,2R,6R)-2-(Benzyloxy)-6-(4-bromophenylamino)cyclohexanol (1.31c) 
1H NMR (400 MHz CDCl3): δ 7.40-7.33 (m, 5H), 7.28-7.24 (m, 2H), 6.58-6.55 (m, 2H), 
4.60 (dd, J=11.8, 57.7 Hz, 2H), 3.92-3.91 (m, 1H), 3.55-3.48 (m, 2H), 2.21-2.17 (m, 1H), 
2.11-2.07 (m, 1H), 1.73-1.67 (m, 1H), 1.56-1.39 (m, 2H), 1.18-1.08 (m, 1H). 
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13C NMR (100 MHz CDCl3): δ 147.2, 138.5, 132.0, 128.7, 127.9, 127.8, 115.4, 109.3, 
77.3, 74.7, 71.3, 54.8, 30.6, 27.5, 18.9. 
HRMS (ESI) calc. for C19H23BrNO2 : [M+H+], 376.39067; found: [M+H+],376.39074. 
(±) (1S,2R,6R)-2-(Benzyloxy)-6-(4-methoxyphenylamino)cyclohexanol (1.31d) 
1H NMR (400 MHz CDCl3): δ 7.40-7.28 (m, 5H), 6.82-6.80 (m, 2H), 6.71-6.69 (m, 2H), 
4.64 (dd, J=11.8, 41.0 Hz, 2H), 3.94-3.93 (m, 1H), 3.77 (s, 3H), 3.53-3.50 (m, 2H), 
2.28-2.18 (m, 1H), 2.09-2.04 (m, 1H), 1.74-1.67 (m, 1H), 1.56-1.40 (m, 2H), 1.18-1.10 
(m, 1H). 
13C NMR (100 MHz CDCl3): δ 152.7, 142.0, 138.8, 128.6, 127.8, 127.7, 116.0, 115.0, 
77.2, 74.9, 71.3, 55.9, 30.8, 27.7, 19.1. 
HRMS (ESI) calc. for C20H26NO3 : [M+H+], 328.19106; found: [M+H+], 328.19072. 
(±) (1S,2R,6R)-2-(Benzyloxy)-6-(4-fluorophenylamino)cyclohexanol (1.31e) 
1H NMR (400 MHz CDCl3): δ 7.40-7.32 (m, 5H), 6.93-6.88 (m, 2H), 6.66-6.62 (m, 2H), 
4.64 (dd, J=11.7, 46.8 Hz, 2H), 3.94-3.92 (m, 1H), 3.54-3.49 (m, 2H), 2.21-2.16 (m, 1H), 
2.10-2.05 (m, 1H), 1.77-1.67 (m, 1H), 1.56-1.51 (m, 1H), 1.48-1.40 (m, 1H), 1.19-1.10 
(m, 1H). 
13C NMR (100 MHz CDCl3): δ 157.4, 144.5, 138.7, 128.60, 127.8, 115.9, 115.6, 115.1, 
77.3, 74.8, 71.3, 55.5, 30.8, 27.7, 19.0. 
HRMS (ESI) calc. for C19H23FNO2 : [M+H+], 316.17073; found: [M+H+], 316.17151. 
 
 
(±) (1R,2R,6S)-2-(Benzyloxy)-6-(phenylamino)cyclohexanol (1.34a) 
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1H NMR (400 MHz CDCl3): δ 7.41-7.34 (m, 5H), 7.24-7.20 (m, 2H), 6.78-6.72 (m, 3H), 
4.65 (dd, J=11.6, 56.5 Hz, 2H), 3.95-3.94 (m, 1H), 3.65 (dt, J=4.0, 9.3, 1H), 3.56 (dd, 
J=2.6, 8.9 Hz, 1H), 2.26-2.22 (m, 1H), 2.11-2.06 (m, 1H), 1.77-1.70 (m, 1H), 1.58-1.42 
(m, 2H), 1.23-1.13 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 148.1, 138.7, 129.4, 128.6, 127.8, 127.7, 117.9, 114.0, 
77.3, 74.7, 71.3, 54.7, 30.7, 27.6, 19.0. 
MS (ESI) m/z: 298.1 [M+H+]. 
(±) (1R,2R,6S)-2-(Benzyloxy)-6-(4-chlorophenylamino)cyclohexanol (1.34b) 
1H NMR (400 MHz CDCl3): δ 7.45-7.33 (m, 5H), 7.16-7.13 (m, 2H), 6.62-6.59 (m, 2H), 
4.69 (dd, J=11.7, 31.4 Hz, 2H), 3.46-3.38 (m, 2H), 3.22-3.15 (m, 1H), 2.18-2.08 (m, 2H), 
1.76-1.73 (m, 1H), 1.41-1.23 (m, 2H), 1.14-1.03 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 146.4, 138.4, 128.8, 128.3, 127.62, 127.57, 121.9, 114.9, 
81.2, 77.3, 71.2, 57.1, 30.3, 29.1, 20.6. 
HRMS (ESI) calc. for C19H23ClNO2 : [M+H+], 332.14118; found: [M+H+], 332.14184. 
(±) (1R,2R,6S)-2-(Benzyloxy)-6-(4-bromophenylamino)cyclohexanol (1.34c) 
1H NMR (400 MHz CDCl3): δ 7.40-7.33 (m, 5H), 7.28-7.25 (m, 2H), 6.58-6.56 (m, 2H), 
4.69 (dd, J=11.6, 53.5 Hz, 2H), 3.46-3.37 (m, 2H), 3.22-3.16 (m, 1H), 2.20-2.11 (m, 2H), 
1.80-1.75 (m, 1H), 1.40-1.26 (m, 2H), 1.18-1.08 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 147.0, 138.5, 132.0, 128.6, 127.9, 115.7, 109.5, 81.5, 77.8, 
71.5, 57.3, 30.8, 29.3, 21.0. 
HRMS (ESI) calc. for C19H23BrNO2 : [M+H+], 376.091; found: [M+H+], 376.09067. 
(±) (1R,2R,6S)-2-(Benzyloxy)-6-(4-methoxyphenylamino)cyclohexanol (1.34d) 
1H NMR (400 MHz CDCl3): δ 7.42-7.28 (m, 5H), 6.81-6.79 (m, 2H), 6.72-6.69 (m, 2H), 
4.71 (dd , J=11.8, 33.6 Hz, 2H), 3.77 (s, 3H), 3.46-3.39 (m, 2H), 3.14-3.08 (m, 1H), 
2.17-2.12 (m, 2H), 1.78-1.71 (m, 1H), 1.40-1.26 (m, 2H), 1.18-1.08 (m, 1H). 
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13C NMR (100 MHz CDCl3): δ 153.1, 141.9, 138.9, 128.6, 128.0, 127.9, 116.7, 115.0, 
81.7, 78.2, 71.8, 59.3, 31.1, 29.8, 21.3. 
MS (ESI) m/z: 328.5 [M+H+]. 
Compounds 1.32a-d, and 1.35a-d were prepared according to the general procedure 
(method C) starting from cis-1.13 and trans-1.13 (50 mg, 0.22 mmol), Yb(OTf)3 (15 mg, 
0.02 mmol) and aniline (1.5 equiv.) in toluene (3 mL) at rt. Purification by the flash 
column chromatography with ethyl acetate/hexane (1:9) as eluant afforded corresponding 
epoxides opening products. 
 
 
(±) (1S,2R,6R)-2-(Phenylamino)-6-(triethylsilyloxy)cyclohexanol (1.32a) 
1H NMR (400 MHz CDCl3): δ 7.22-7.18 (m, 2H), 6.75-6.69 (m, 3H), 4.16-4.14 (m, 1H), 
3.58 (dt, J=4.0, 9.0 Hz, 1H), 3.43 (dd, J=2.7, 8.5 Hz, 1H), 2.22-2.15 (m, 1H), 1.87-1.70 
(m, 2H), 1.45-1.55 (m, 2H), 1.20-1.12 (m, 1H), 1.01 (t, J=15.8 Hz, 9H), 0.66 (q, J=24.2 
Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 148.4, 129.5, 117.9, 113.9, 75.4, 70.9, 54.3, 31.9, 30.6, 
18.9, 7.1, 5.2. 
HRMS (ESI) calc. for C18H32NO2Si : [M+H+], 322.21964; found: [M+H+], 322.21968. 
(±) (1S,2R,6R)-2-(4-Chlorophenylamino)-6-(triethylsilyloxy)cyclohexanol (1.32b) 
1H NMR (400 MHz CDCl3): δ 7.16-7.12 (m, 2H), 6.67-6.64 (m, 2H), 4.12-4.11 (m, 1H), 
3.67 (dt, J=3.6, 9.7 Hz, 1H), 3.43-3.37 (m, 1H), 2.14-2.09 (m, 1H), 1.96-1.89 (m, 1H), 
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1.80-1.74 (m, 1H), 1.55-1.45 (m, 2H), 1.22-1.15 (m, 1H), 1.00 (t, J=15.8 Hz, 9H), 0.66 (q, 
J=24.1 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 145.6, 128.6, 114.9, 114.6, 74.4, 69.1, 66.7, 55.3, 32.5, 
30.5, 7.9, 5.8. 
HRMS (ESI) calc. for C18H31ClNO2Si : [M+H+], 356.18151; found: [M+H+], 356.18071. 
(±) (1S,2R,6R)-2-(4-Bromophenylamino)-6-(triethylsilyloxy)cyclohexanol (1.32c) 
1H NMR (400 MHz CDCl3): δ 7.27-7.25 (m, 2H), 6.57-6.55 (m, 2H), 4.14-4.12 (m, 1H), 
3.50 (dt, J=4.0, 8.9 Hz, 1H), 3.39 (dd, J=2.7, 8.5 Hz, 1H), 2.16-2.12 (m, 1H), 1.86-1.80 
(m, 1H), 1.78-1.68 (m, 1H), 1.53-1.46 (m, 2H), 1.17-1.08 (m, 1H), 1.00 (t, J=15.8 Hz, 
9H), 0.66 (q, J=24.0 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 147.4, 132.1, 115.3, 109.2, 75.3, 71.0, 54.4, 31.9, 30.4, 
18.8, 7.1, 5.2. 
HRMS (ESI) calc. for C18H31BrNO2Si : [M+H+], 400.13095; found: [M+H+], 400.1302. 
(±) (1S,2R,6R)-2-(4-Methoxyphenylamino)-6-(triethylsilyloxy)cyclohexanol (1.32d) 
1H NMR (300 MHz CDCl3): δ 6.81-6.78 (m, 2H), 6.70-6.67 (m, 2H), 4.14-4.12 (m, 1H), 
3.76 (s, 3H), 3.48-3.37 (m, 2H), 2.15-2.10 (m, 1H), 1.82-1.64 (m, 2H), 1.53-1.43 (m, 2H), 
1.14-1.10 (m, 1H), 0.99 (t, J=15.8 Hz, 9H), 0.64 (q, J=24.0 Hz, 6H). 
13C NMR (75MHz CDCl3): δ 151.9, 141.1, 115.6, 114.6, 75.3, 70.9, 56.3, 55.9, 32.5, 31.1, 
19.6, 7.9, 5.7. 





(±) (1R,2S,6R)-2-(Phenylamino)-6-(triethylsilyloxy)cyclohexanol (1.35a) 
1H NMR (400 MHz CDCl3): δ 7.20-7.17 (m, 2H), 6.75-6.69 (m, 3H), 3.62-3.57 (m, 1H), 
3.32 (t, J=8.2, 1H), 3.23 (dt, J=3.9, 10.5 Hz, 1H), 2.20-2.15 (m, 1H), 1.95-1.92 (m, 1H), 
1.75-1.72 (m, 1H), 1.45-1.32 (m, 2H), 1.18-1.15 (m, 1H), 1.02 (t, J=15.8 Hz, 9H), 0.68 (q, 
J=24.0 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 148.2, 129.4, 118.1, 114.2, 79.2, 75.5, 57.2, 33.6, 31.2, 
21.2, 7.0, 5.3. 
HRMS (ESI) calc. for C18H32NO2Si : [M+H+], 322.22083; found: [M+H+], 322.21968. 
(±) (1R,2S,6R)-2-(4-Chlorophenylamino)-6-(triethylsilyloxy)cyclohexanol (1.35b) 
1H NMR (400 MHz CDCl3): δ 7.13-7.11 (m, 2H), 6.62-6.60 (m, 2H), 3.60-3.55 (m, 1H), 
3.30 (t, J=9.2 Hz, 1H), 3.19 (dt, J=4.0, 10.8 Hz, 1H), 2.15-2.12 (m, 1H), 1.95-1.92 (m, 
1H), 1.75-1.72 (m, 1H), 1.44-1.34 (m, 2H), 1.18-1.15 (m, 1H), 1.01 (t, J=15.8 Hz, 9H), 
0.67 (q, J=24.0 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 146.8, 129.2, 122.4, 115.2, 79.2, 75.5, 57.1, 33.5, 31.1, 
21.1, 7.0, 5.3. 
HRMS (ESI) calc. for C18H31ClNO2Si : [M+H+], 356.18071; found: [M+H+], 356.18072. 
(±) (1R,2S,6R)-2-(4-Bromophenylamino)-6-(triethylsilyloxy)cyclohexanol (1.35c) 
1H NMR (400 MHz CDCl3): δ 7.26-7.24 (m, 2H), 6.57-6.55 (m, 2H), 3.60-3.54 (m, 1H), 
3.30 (t, J=9.0 Hz, 1H), 3.18 (dt, J=4.0, 10.7 Hz, 1H), 2.15-2.11 (m, 1H), 1.95-1.92 (m, 
1H), 1.75-1.72 (m, 1H), 1.44-1.34 (m, 2H), 1.18-1.15 (m, 1H), 1.01 (t, J=15.8 Hz, 9H), 
0.67 (q, J=24.0 Hz, 6H). 
63 
 
13C NMR (100 MHz CDCl3): δ 147.2, 132.1, 115.6, 109.5, 79.2, 75.5, 57.0, 33.5, 31.0, 
21.1, 7.0, 5.3. 
HRMS (ESI) calc. for C18H31BrNO2Si : [M+H+], 400.13051; found: [M+H+], 400.1302. 
(±) (1R,2S,6R)-2-(4-Methoxyphenylamino)-6-(triethylsilyloxy)cyclohexanol (1.35d)  
1H NMR (400 MHz CDCl3): δ 6.80-6.77 (m, 2H), 6.71-6.67 (m, 2H), 3.76 (s, 3H), 
3.60-3.55 (m, 1H), 3.28 (t, J=9.6 Hz, 1H), 3.09 (dt, J=4.0, 11.0 Hz, 1H), 2.15-2.10 (m, 
1H), 1.94-1.90 (m, 1H), 1.74-1.69 (m, 1H), 1.47-1.28 (m, 2H), 1.19-1.09 (m, 1H), 1.01 (t, 
J=15.8 Hz, 9H), 0.67 (q, J=24.0 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 152.9, 142.1, 116.4, 115.0, 79.2, 75.5, 58.6, 56.0, 33.7, 
31.2, 21.3, 7.0, 5.3. 
HRMS (ESI) calc. for C19H34NO2 : [M+H+], 352.23070; found: [M+H+], 352.23025. 
 
 
Compounds 1.36a, 1.36b were prepared according to the general procedure (method C) 
starting from 1.6 (50 mg, 0.5 mmol), aninline (1.5 equiv.) and Yb(OTf)3 (31 mg, 0.05 
mmol) in toluene (3 mL) at rt. Purification by the flash column chromatography with 
ethyl acetate/hexane (1:9) as eluant afforded 1.36a, 1.36b as pale brown oils. 
(±) (1R,2S,3R)-3-(Phenylamino)cyclopentane-1,2-diol (1.36a) 
1H NMR (400 MHz CD3OD): δ 7.12-7.07 (m, 2H), 6.70-6.67 (m, 2H), 6.63-6.58 (m, 1H), 
4.07 (dd, J=3.3, 6.4 Hz, 1H), 3.78 (t, J=9.6 Hz, 1H), 3.71-3.65 (m, 1H), 2.39-2.27 (m, 
1H), 2.02-1.93 (m, 1H), 1.77-1.65 (m, 1H), 1.42-1.30 (m, 1H). 
13C NMR (100 MHz CD3OD): δ 150.1, 130.1, 118.1, 114.6, 79.2, 73.7, 60.1, 30.2, 29.0. 
MS (ESI) m/z: 194.6 [M+H+]. 
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(±) (1R,2S,3R)-3-(4-Methoxyphenylamino)cyclopentane-1,2-diol (1.36b) 
1H NMR (400 MHz CDCl3): δ 6.77-6.73 (m, 2H), 6.71-6.66 (m, 2H), 4.09-4.06 (q, J=5.5, 
6.4 Hz, 1H), 3.76 (t, J=9.7 Hz, 1H), 3.71 (s, 3H), 2.35-2.24 (m, 1H), 2.03-1.90 (m, 1H), 
1.76-1.64 (m, 1H), 1.38-1.29 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 9.0, 30.2, 56.3, 61.2, 73.7, 79.2, 115.9, 116.5, 144.1, 
153.8. 












toluene rt, 3 days
 
(±) (1S,2R,6R)-2-Azido-6-(4-chlorophenylamino)cyclohexanol 
Compound 1.37 were prepared according to the general procedure (method C) starting 
from cis-1.15 (50 mg, 0.36 mmol), Yb(OTf)3 (22 mg, 0.04 mmol) and aniline (1.5 equiv.) 
in toluene (3 mL) at rt. Purification by the flash column chromatography with ethyl 
acetate/hexane (1:9) as eluant afforded 1.37 (68 mg, 71%) as a brown solid. 
IR: 2102 cm-1 
1H NMR (400 MHz CDCl3): δ 7.14-7.11 (m, 2H), 6.63-6.61 (m, 2H), 4.08 (s, 1H), 
3.54-3.47 (m, 2H), 3.04 (s, br, 1H), 2.11-2.04 (m, 1H), 1.95-1.92 (m, 1H), 1.54-1.50 (m, 
3H), 1.08-1.03 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 146.2, 145.5, 129.3, 123.2, 75.5, 62.2, 54.8, 30.8, 28.5, 
19.6. 
HRMS (ESI) calc. for C12H16ClN4O : [M+H+], 267.10077; found: [M+H+], 267.10072. 
Compounds 1.38a 1.38b, 1.39, 1.40 were prepared according to the general procedure 
(method C) starting from trans-1.15 (50 mg, 0.36 mmol), Yb(OTf)3 (22 mg, 0.04 mmol) 
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and aniline (1.5 equiv.) in toluene (3 mL) at rt. Purification by the flash column 




(±) (1R,2R,6S)-2-Azido-6-(4-fluorophenylamino)cyclohexanol (1.38a) 
IR: 2103 cm-1 
1H NMR (400 MHz CDCl3): δ 6.92-6.88 (m, 2H), 6.66-6.63 (m, 2H), 3.37 (dt, J=4.7, 
10.2 Hz, 1H), 3.22 (t, J=9.3 Hz, 1H), 3.10 (dt, J=3.7, 8.1 Hz, 1H), 2.04 (dd, J =9.6, 21.5 
Hz, 2H), 1.75 (s, 1H), 1.40-1.28 (m, 2H), 1.08-1.03 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 157.6, 155.3, 143.8, 115.9, 115.8, 115.7, 77.8, 64.9, 59.4, 
30.7, 30.0, 21.9. 
HRMS (ESI) calc. for C12H16FN4O : [M+H+], 251.13027; found: [M+H+], 251.13066. 
(±) (1R,2R,6S)-2-Azido-6-(4-methoxyphenylamino)cyclohexanol (1.38b) 
IR: 2102 cm-1 
1H NMR (400 MHz CDCl3): δ 6.82-6.79 (m, 2H), 6.72-6.70 (m, 2H), 3.77 (s, 1H), 3.41 
(ddd, J =4.5, 9.3, 11.2 Hz, 1H), 3.29 (t, J=9.37 Hz, 1H), 3.10 (ddd, J = 4.0, 9.6, 11.6 Hz, 
1H), 2.90 (s, br, 1H), 2.12-2.04 (m, 2H), 1.80-1.78 (m, 1H), 1.40-1.37 (m, 2H), 1.10-1.06 
(m, 1H). 
13C NMR (100 MHz CDCl3): δ 153.5, 141.3, 117.0, 115.1, 78.1, 66.0, 60.4, 55.9, 30.9, 
30.2, 22.2. 





(±) 1-(3-((1S,2R,3R)-3-Azido-2-hydroxycyclohexylamino)phenyl)ethanone (1.39) 
IR: 2103 cm-1 
1H NMR (400 MHzCD3OD): δ 7.25-7.21 (m, 3H), 6.93-6.90 (m, 1H), 3.37-3.28 (m, 5H), 
2.55 (s, 3H), 2.09-1.97 (m, 2H), 1.78-1.71 (m, 1H), 1.52-1.41 (m, 1H), 1.36-1.26 (m, 1H), 
1.21-1.10 (m, 1H). 
13C NMR (100 MHz CD3OD): δ 199.7, 148.6, 137.4, 128.5, 117.6, 116.4, 111.5, 77.4, 
65.2, 56.9, 30.3, 29.8, 25.0, 21.1. 





IR: 2104 cm-1 
1H NMR (400 MHz CDCl3): δ 7.25–7.06 (m, 1H), 7.02–6.80 (m, 2H), 6.64-6.59 (m, 1H), 
3.81-3.75 (m, 1H), 3.67–3.35 (m, 4H), 3.35–3.18 (m, 2H), 2.26–1.94 (m, 2H), 1.79-1.77 
(m, 1H), 1.63 (s, 3H), 1.37-1.41 (m, 2H), 1.29 (dd, J = 1.6, 6.0 Hz, 3H), 1.21 (dd, J = 4.2, 
5.9 Hz, 3H), 1.12-1.06 (m, 1H).  
13C NMR (100 MHz CDCl3): δ 147.3, 147.2, 146.6, 129.1, 115.8, 115.7, 113.5, 113.3, 
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111.6, 111.4, 107.9, 79.3, 78.3, 78.1, 77.9, 64.9, 58.5, 58.4, 30.9, 30.8, 30.1, 29.0, 22.0, 
17.2, 17.1, 16.6. 




Compound 1.41 was prepared according to the general procedure (method C) starting 
from 1.18 (25 mg, 0.16 mmol), Yb(OTf)3 (10 mg, 0.02 mmol) and aniline (1.5 equiv.) in 
toluene (1.5 mL) at rt. Purification by the flash column chromatography with ethyl 
acetate/hexane (1:9) as eluant afforded 1.41 (29 mg, 69%) as a brown oil. 
IR: 2103 cm-1 
1H NMR (400 MHz CDCl3): δ 6.93-6.89 (m, 2H), 6.76-6.73 (m, 2H), 4.03 (d, J=3.9 Hz, 
1H), 3.85 (d, J=1.8 Hz, 1H), 1.85-1.70 (m, 5H), 1.56-1.53 (m, 1H), 1.28 (s, 3H).  
13C NMR (100 MHz CDCl3): δ 156.8, 141.5, 121.8, 115.8, 115.6, 74.1, 58.2, 33.3, 25.0, 
23.5, 19.3. 
MS (ESI) m/z: 265.2 [M+H+]. 
 
 
  To a solution of 1.41 (20 mg, 0.08 mmol) in dry DCM (2 mL), was added Ac2O (11 μL, 
0.11 mmol), Et3N (21 μL, 0.15 mmol) and DMAP (9 mg, 0.01 mmol) at 0 oC, then the 
reaction mixture was allowed to warm up to rt and stirred for 4 h. The reaction mixture 
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was diluted with water (2 mL), and the organic layer was separated, the aqueous layer 
was extracted with DCM. The combined organic layers were dried over Na2SO4, 
concentrated under reduced pressure, the residue was purified by flash column 
chromatography with ethyl acetate/hexane (1:9) as eluant, to afford 1.42 (19 mg, 81%) as 
a brown solid. 
IR: 2103 cm-1 
1H NMR (400 MHz CDCl3): δ 6.95-6.89 (m, 2H), 6.78-6.74 (m, 2H), 5.46 (s, 1H), 
3.95-3.91 (m, 1H), 2.18 (s, 3H), 1.85-1.72 (m, 5H), 1.63-1.60 (m, 1H), 1.18 (s, 3H). 
13C NMR (100 MHz CDCl3): δ 170.6, 156.4, 144.3, 120.8, 116.0, 115.8, 74.0, 57.9, 57.2, 
34.5, 25.2, 23.4, 21.2, 19.5. 
HRMS (ESI) calc. for C15H20FN4O2 : [M+H+], 307.15648; found: [M+H+], 307.15671. 
 
 
(±) tert-Butyl (1R,2S,3R)-3-(4-bromophenylamino)-2-hydroxycyclohexylcarbamate 
Compound 1.43 was prepared according to the general procedure (method D) starting 
from cis-1.20 (50 mg, 0.23 mmol), Yb(OTf)3 (15 mg, 0.02 mmol), 4-bromoaniline (59 
mg, 0.35 mmol) in toluene (3 mL). Purification by the flash column chromatography with 
ethyl acetate/hexane (3:7) as eluant gave 1.43 (60 mg, 68%) as a brown oil. 
1H NMR (400 MHz CD3OD): δ 7.20-7.16 (m, 2H), 6.63-6.59 (m, 2H), 3.79 (m, 1H), 3.72 
(m, 1H), 3.50 (dd, J=4.7, 9.3 Hz, 1H), 1.99-1.89 (m, 1H), 1.68-1.62 (m, 2H), 1.58-1.53 
(m, 2H), 1.43 (s, 9H), 1.42-1.39 (m, 1H). 
13C NMR (100 MHz CD3OD): δ 155.0, 148.8, 132.8, 55.0, 51.0, 28.9, 28.5, 27.3, 20.6. 






Compound 1.44 was prepared according to the general procedure (method C) starting 
from 1.23 (30 mg, 0.19 mmol), Yb(OTf)3 (12 mg, 0.02 mmol), p-anisidine (48 mg, 0.39 
mmol) in toluene (2 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (4:6) as eluant gave 1.44 (40 mg, 74%) as a brown oil. 
1H NMR (400 MHz CDCl3): δ 6.77-6.74 (m, 2H), 6.63-6.61 (m, 2H), 6.20 (s, 1H), 4.21 (s, 
1H), 3.73 (s, 3H), 3.70-3.68 (m, 1H), 3.58 (br, 2H), 3.36-3.34 (m, 1H), 2.05-2.00 (m, 4H), 
1.82-1.74 (m, 1H), 1.63-1.46 (m, 3H), 1.36-1.23 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 171.6, 152.9, 141.2, 116.0, 115.1, 72.7, 56.0, 55.8, 49.5, 
27.7, 23.7, 19.5. 
HRMS (ESI) calc. for C15H23N2O3 : [M+H+], 279.1703; found: [M+H+], 279.1707. 














NaOH (50% aq. solution)
benzen/H2O, rt
 
Compounds 1.45a, 1.45b were prepared according to the general procedure (method D) 
starting from 1.38a, 1.38b (65 mg, 0. 26 mmol), p-TsCl (60 mg, 0.31 mmol), 
t-Bu4NHSO4 (18 mg, 0.05 mmol) and 50% NaOH (0.2 mL) in benzene (2 mL). 
Purification by the flash column chromatography with ethyl acetate/hexane (2:8) as 
eluant afforded 1.45a and 1.45b. 
(±) (1S,2R,6S)-2-Azido-7-(4-fluorophenyl)-7-azabicyclo[4.1.0]heptane (1.45a 43%) 
IR: 2102 cm-1 
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1H NMR (400 MHz CDCl3): δ 7.00-6.92 (m, 4H), 3.63-3.60 (m, 1H), 2.49-2.46 (m, 2H), 
2.00-1.99 (m, 1H), 1.94-1.90 (m, 1H), 1.78-1.70 (m, 3H), 1.37-1.25 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 159.9, 157.6, 150.4, 150.3, 121.7, 121.6, 115.8, 115.6, 
57.7, 42.3, 40.7, 25.1, 23.1, 21.1. 
HRMS (ESI) calc. for C12H14FN4 : [M+H+], 233.1197; found: [M+H+], 233.11994. 
(±) (1S,2R,6S)-2-Azido-7-(4-methoxyphenyl)-7-azabicyclo[4.1.0]heptane (1.45b, 
50%)  
IR: 2101 cm-1 
1H NMR (400 MHz CDCl3): δ 7.00-6.96 (m, 2H), 6.83-6.79 (m, 2H), 3.78 (s, 3H), 
3.62-3.57 (m, 1H), 2.48-2.43 (m, 2H), 2.01-1.99 (m, 1H), 1.94-1.90 (m, 1H), 1.77-1.70 
(m, 3H), 1.32-1.29 (m, 1H), 
13C NMR (100 MHz CDCl3): δ 155.4, 147.7, 121.4, 114.5, 57.8, 55.7, 42.2, 40.6, 25.1, 
23.1, 21.1. 
HRMS (ESI) calc. for C13H17N4O : [M+H+], 245.13969; found: [M+H+], 245.13909. 
 
 
Compounds 1.46a, 1.46b were prepared according to the general procedure (method D) 
starting from 1.34b, 1.34d (50 mg, 0.15 mmol), p-TsCl (35 mg, 0.18 mmol), 
t-Bu4NHSO4 (10 mg, 0.03 mmol) and 50% NaOH (0.1 mL) in benzene (1 mL) at rt. 
Purification by the flash column chromatography with ethyl acetate/hexane (1:9) as 
eluant afforded 1.46a and 1.46b.  
(±) (1S,2R,6S)-2-(Benzyloxy)-7-(4-chlorophenyl)-7-azabicyclo[4.1.0]heptanes (1.46a) 
71 
 
1H NMR (400 MHz CDCl3): δ 7.49-7.28 (m, 5H), 7.20-7.18 (m, 2H), 6.98-6.96 (m, 2H), 
4.80 (dd, J=12.2, 15.6 Hz, 2H), 3.85-3.80 (m, 1H), 2.53-2.47 (m, 2H), 2.00-1.55 (m, 5H), 
1.30-1.18 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 153.8, 139.2, 128.9, 128.6, 127.7, 127.6, 127.1, 112.1, 
74.6, 70.4, 42.7, 40.9, 25.6, 23.3, 21.3. 
HRMS (ESI) calc. for C19H21ClNO : [M+H+], 314.13062; found: [M+H+], 314.1311. 
(±) (1R,2R,6S)-2-(Benzyloxy)-7-(4-methoxyphenyl)-7-azabicyclo[4.1.0]heptane 
(1.46b) 
1H NMR (400 MHz CDCl3): δ 7.49-7.28 (m, 5H), 6.98 (d, J=6.5 Hz, 2H), 6.79 (d, J=8.6 
Hz, 2H), 4.80 (dd, J=3.2, 12.8 Hz, 2H), 7.49-7.28 (m, 5H), 3.78 (s, 3H), 3.82 (m, 1H), 
2.52-2.42(m, 2H), 1.99-1.83 (m, 2H), 1.70-1.60 (m, 3H), 1.29-1.21 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 155.1, 148.6, 139.4, 128.6, 127.6, 121.5, 114.4, 74.9, 70.3, 
55.8, 42.6, 40.8, 25.8, 23.6, 21.4. 
HRMS (ESI) calc. for C20H24NO2 : [M+H+], 310.18016; found: [M+H+], 310.1806. 
 
 
Compounds 1.47a, 1.47b were prepared according to the general procedure (method 
D), starting from 1.31d, 1.31e (50 mg, 0.15 mmol) p-TsCl (35 mg, 0.18 mmol), 
t-Bu4NHSO4 (10 mg, 0.03 mmol) and 0.1 mL 50% NaOH in benzene (1 mL). Purification 
by the flash column chromatography with ethyl acetate/hexane (5:95) as eluant afforded 
1.47a and 1.47b. 
(±) (1R,2R,6R)-2-(Benzyloxy)-7-(4-methoxyphenyl)-7-azabicyclo[4.1.0]heptane (1.47a) 
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1H NMR (400 MHz CDCl3): δ 7.47-7.28 (m, 5H), 6.90-6.87 (m, 2H), 6.81-6.77 (m, 2H), 
4.75 (dd, J=1.9, 11.8 Hz, 2H), 3.91 (dd, J=5.7, 2.4 Hz, 1H), 3.78 (s, 3H), 2.42-2.38 (m, 
2H), 2.12-2.07 (m, 1H), 1.92-1.85 (m, 2H), 1.57-1.56 (m, 1H), 1.38-1.33 (m, 2H). 
13C NMR (100 MHz CDCl3): δ 155.2, 148.3, 138.8, 128.7, 128.0, 127.9, 121.2, 114.4, 
74.6, 71.3, 55.7, 46.6, 42.8, 40.1, 27.6, 24.6, 16.1. 
HRMS (ESI) calc. for C20H24NO2 : [M+H+], 310.18016; found: [M+H+], 310.18005. 
(±) (1R,2R,6R)-2-(Benzyloxy)-7-(4-fluorophenyl)-7-azabicyclo[4.1.0]heptane (1.47b) 
1H NMR (400 MHz CDCl3): δ 7.48-7.33 (m, 5H), 6.96-6.86 (m, 4H), 4.75 (dd, J=11.9, 
20.6 Hz, 2H), 3.93 (dd, J=5.3, 7.7 Hz, 1H), 2.44-2.41 (m, 2H), 2.14-2.08 (m, 1H), 
1.96-1.82 (m, 2H), 1.63-1.55 (m, 1H), 1.44-1.31 (m, 2H). 
13C NMR (100 MHz CDCl3): δ 159.7, 157.3, 151.0, 138.7, 128.7, 127.9, 121.4, 115.8, 
115.5, 74.4, 71.4, 42.9, 40.2, 27.5, 24.5, 16.0. 
HRMS (ESI) calc. for C19H21FNO : [M+H+], 298.16055; found: [M+H+], 298.16017. 
 
(±) N-((2R,6R)-2,6-Diazidocyclohexyl)-4-fluoroaniline 
Compound 1.48a was prepared according to the general procedure (method E) starting 
from 1.45a (50 mg, 0.22 mmol), Yb(OTf)3 (68 mg, 0.11 mmol) and TMSN3 (14 μL, 1.08 
mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (3:97) as eluant gave 1.48a (47 mg, 79%) as a brown oil.   
Or to a stirred solution of the cis-aziridine (50 mg, 0.22 mmol) in the mixture of 
acetonitrile (3.2 mL) and H2O (0.1 mL), was added Yb(OTf)3 (68 mg, 0.11 mmol) and 
NaN3 (17 mg, 0.26 mmol). After stirred at reflux overnight, cooled to rt, then the reaction 
mixture was concentrated under reduced pressure, the residue was purified by the flash 
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column chromatography , eluting with ethyl acetate/hexane (3:97), to give 1.48a (45 mg, 
77%). 
IR: 2101 cm-1 
1H NMR (400 MHz CDCl3): δ 6.96-6.90 (m, 2H), 6.89-6.64 (m, 2H), 4.11 (dd, J = 3.3, 
6.3 Hz, 1H), 3.51 (dt, J=4.3, 10.1 Hz, 1H), 3.29 (dd, J=3.3, 9.8 Hz, 1H), 2.15-2.11 (m, 
1H), 2.07-2.03 (m, 1H), 1.73-1.61 (m, 3H), 1.48-1.36 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 157.8, 155.4, 142.8, 116.2, 116.0, 115.5, 115.4, 61.1, 61.0, 
60.1, 30.8, 28.6, 19.0. 




Compound 1.48b was prepared according to the general procedure (method E) starting 
from 1.45b (50 mg, 0.20 mmol) Yb(OTf)3 (62 mg, 0.10 mmol) and TMSN3 (13 μL, 1 
mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (3:97) as eluant affored 1.48b (45 mg, 77%) as a brown oil.  
IR: 2101 cm-1 
1H NMR (400 MHz CDCl3): δ 6.84-6.80 (m, 2H), 6.73-6.69 (m, 2H), 4.11 (dd, J = 3.3, 
6.5 Hz, 1H), 3.78(s, 3H), 3.50 (dt, J=4.4, 10.6 Hz, 1H), 3.27 (dd, J=3.3, 9.7 Hz,1H), 2.14 
-2.10 (m, 1H), 2.10-2.01 (m, 1H), 1.71-1.66 (m, 3H), 1.63-1.58 (m, 1H).     
13C NMR (100 MHz CDCl3): δ 153.3, 140.5, 116.3, 115.2, 61.0, 60.7, 55.9, 30.8, 28.6, 
19.1. 






Compound 1.49a was prepared according to the general procedure (method E) starting 
from 1.46a (50 mg, 0.16 mmol) Yb(OTf)3 (70 mg, 0.11 mmol) and TMSN3 (110 μL, 0.8 
mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (5:95) as eluant gave 1.49a (41 mg, 72%) as a brown oil.  
IR: 2100 cm-1 
1H NMR (400 MHz CDCl3): δ 1.40-1.35 (m, 2H), 1.71-1.62 (m, 2H), 2.15-2.09 (m, 2H), 
3.25-3.22 (m, 1H), 3.66 (dt, J=21.3, 4.3 Hz, 1H), 3.85-3.83 (m, 1H), 4.44 (dd, J=115.9, 
11.6 Hz, 2H), 6.58-6.55 (m, 2H), 7.14-7.10 (m, 2H), 7.42-7.28 (m, 5H).  
13C NMR (100 MHz CDCl3): δ 146.2, 138.2, 129.2, 128.8, 128.1, 128.0, 122.5, 115.2, 
75.9, 71.0, 62.1, 60.5, 31.0, 27.6, 18.6. 
HRMS (ESI) calc. for C19H22ClN4O : [M+H+], 357.14767; found: [M+H+], 357.14855. 
 
 
(±) N-((1S,2R,6R)-2-Azido-6-(benzyloxy)cyclohexyl)-4-methoxyaniline  
Compound 1.49b was prepared according to the general procedure (method E) starting 
from 1.46b (50 mg, 0.16 mmol), Yb(OTf)3 (70 mg, 0.11 mmol) and TMSN3 (110 μL, 0.8 
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mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (1:19) as eluant gave 1.49b (38 mg, 68%) as a brown oil. 
IR: 2101 cm-1 
1H NMR (400 MHz CDCl3): δ7.42-7.34 (m, 5H), 6.81-6.77 (m, 2H), 6.64-6.60 (m, 2H), 
4.48 (dd, J=100.1, 11.6 Hz, 2H), 3.87-3.84 (m, 1H), 3.78 (s, 3H), 3.64 (dt, J=10.8, 4.3 Hz, 
1H), 3.19 (dd, J=6.9, 3.0 Hz, 1H), 2.13-2.07 (m, 2H), 1.77-1.58 (m, 2H), 1.45-1.30 (m, 
2H). 
13C NMR (100 MHz CDCl3): δ 144.8, 138.5, 128.9, 128.7, 128.1, 128.0, 116.2, 115.1, 
75.7, 71.1, 62.1, 61.9, 56.0, 31.0, 27.7, 8.7. 
HRMS (ESI) calc. for C20H25N4O2 : [M+H+], 353.1972; found: [M+H+], 353.19749. 
 
 
(±) N-((1R,2S,6R)-2-Azido-6-(benzyloxy)cyclohexyl)-4-methoxyaniline  
Compound 1.50a was prepared according to the general procedure (method E) starting 
from 1.47a (50 mg, 0.16 mmol), Yb(OTf)3 (70 mg, 0.11 mmol) and TMSN3 (110 μL, 0.8 
mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (1:19) as eluant afforded 1.50a (38 mg, 70%) as a brown solid. 
IR: 2101 cm-1 
1H NMR (400 MHz CDCl3): δ 7.31-7.28 (m, 5H), 7.21-7.19 (m, 4H), 4.56 (dd, J=11.8, 
50.3 Hz, 1H), 3.78 (s, 3H), 3.22 (ddd, J = 2.9, 5.6, 6.7, 2H), 3.13 (dd, J=9.6, 5.9 Hz,1H), 
2.21-2.17 (m, 1H), 2.09-2.04 (m, 1H), 1.89-1.84 (m, 1H), 1.45-1.28 (m, 3H). 
13C NMR (100 MHz CDCl3): δ 153.4, 143.5, 139.2, 129.4, 128.9, 128.7, 116.9, 115.9, 
82.3, 72.9, 67.0, 66.6, 57.7, 33.0, 32.6, 23.2. 
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Compound 1.50b was prepared according to the general procedure (method E) starting 
from 1.47b (50 mg, 0.17 mmol), Yb(OTf)3 (73 mg, 0.12 mmol) and TMSN3 (110 μL, 
0.84 mmol) in toluene (3.5 mL). Purification by the flash column chromatography with 
ethyl acetate/hexane (1:19) as eluant gave 1.50b (42 mg, 73%) as a brown oil. 
IR: 2102 cm-1 
1H NMR (400 MHz CDCl3): δ 7.38-7.16 (m, 5H), 6.93-6.87 (m, 2H), 6.77-6.72 (m, 2H), 
4.54 (dd, J=11.9, 58.8 Hz, 2H), 3.25-3.14 (m, 3H), 2.24-2.19 (m, 1H), 2.11-2.06 (m, 1H), 
1.91-186 (m, 1H), 1.48-1.31 (m, 3H). 
13C NMR (100 MHz CDCl3): δ 145.2, 138.5, 128.7, 128.6, 128.0, 127.9, 115.8, 115.2, 
81.1, 71.5, 65.6, 64.6, 31.1, 30.7, 21.1. 









toluene, rt, 2 days
 
(±)  (1R,2S,3R)-3-Azido-N2-(4-methoxyphenyl)-N1-phenylcyclohexane-1,2-diamine 
Compound 1.51 was prepared according to the general procedure (method E) starting 
from 1.45b (50 mg, 0.20 mmol), Yb(OTf)3 (13 mg, 0.02 mmol) and aniline (28 μL 0.31 
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mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (1:9) as eluant afforded 1.51 (39 mg, 74%) as a brown solid. 
1H NMR (400 MHz CDCl3): δ 7.22-7.17 (m, 2H), 6.92-6.63 (m. 3H), 6.48-6.28 (m, 4H), 
4.23 (m, 1H), 3.78 (s, 3H), 3.51 (dt, J=3.7, 6.7 Hz, 1H), 3.34 (dd, J=2.8, 7.2 Hz, 1H), 
2.42-2.37 (m, 1H), 2.09-2.04 (m, 1H), 1.79-1.61 (m, 3H), 1.29-1.19 (m, 1H). 
13C NMR (100 MHz CDCl3): δ 153.2, 148.0, 140.8, 129.5, 118.1, 116.1, 115.3, 113.9, 
61.2, 60.4, 56.0, 52.6, 32.8, 29.2, 19.4. 





Compound 1.52 was prepared according to the general procedure (method E) starting 
from 1.47a (50 mg, 0.16 mmol), Yb(OTf)3 (10 mg, 0.02 mmol) and aniline (22 μL, 0.24 
mmol) in toluene (3.5 mL). Purification by the flash column chromatography with ethyl 
acetate/hexane (1:9) as eluant gave 1.52 (38 mg, 58%) as a brown solid. 
1H NMR (400 MHz CDCl3): δ 7.34-7.16 (m, 7H), 6.80-6.57 (m, 7H), 4.62 (dd, J=11.6, 
19.5 Hz, 2H), 3.50-3.47 (m, 1H), 3.71 (s, 3H), 3.42-3.34 (m, 2H), 2.12-2.02 (m, 2H), 
1.87-1.80 (m, 1H), 1.70-1.61 (m, 1H), 1.49-1.34 (m, 2H). 
13C NMR (100 MHz CDCl3): δ 152.7, 147.8, 142.5, 138.7, 129.5, 128.5, 128.0, 127.8, 
117.5, 116.0, 115.0, 113.6, 80.7, 77.7, 71.9, 56.0, 54.8, 29.5, 19.1, 14.3. 
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2.1 Introduction  
Histone deacetylases (HDAC) are enzymes, which can remove acetyl groups from an 
ε-N-acetyl lysine amino acid on a histone. The amine groups on lysine and arginine 
amino acids make histone tails positively charged. These positive charges help the 
binding between histone tails and the negatively charged phosphate groups on the DNA 
backbone. When the amines are changed to amides by acetylation with histone acetyl 
transferases (HATs), the positive charges on the histone are neutralized, thus the bonding 
ability of the histones to DNA is decreased. This decreased binding allows chromatin 
expansion, and the genetic transcription can take place. Histone deacetylases can 
reestablish the positive charge of histone tails by removing those acetyl groups, leading to 
increase the DNA binding condenses to prevent transcription. The competing acetylation 
and deacetylation1 is shown in Figure 2.1. 
 
Figure 2.1  Acetylation/deacetylation reactions on lysine ε-amino groups1 
Histone deacetylase (HDAC) inhibitors can affect the degree of acetylation of these 
molecules and thereby increase or repress their activity to affect gene expression2. It has 
been suggested that deregulation of acetylase and deacetylase activity can induce the 
generation of cancer3. HDAC inhibitors can inhibit deacetylation of histone and therefore 
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have been studied as anticancer agents4,5. Vorinostat (SAHA), one of the HDAC 
inhibitors, has recently been approved for treatment of cutaneous T cell lymphoma 
(CTCL)6. 
The key antitumor activities of HDAC inhibitors are activation of differentiation 
programs, inhibition of the cell cycle, and induction of apoptosis7 as shown in Figure 2.2. 
After a G2 checkpoint, the normal cells survive during the treatment, whereas tumor cells 
can replicate and subsequently undergo apoptosis. 
. 
 
Figure 2.2  Regulation of cell growth and survival by HDAC inhibitors7 
2.2 The mechanism of deacetylation 
The X-ray crystal structure of a deacetylase protein from the hyperthermophilic 
bacterium Aquifex aeolicus with sequence homology to the class I and II HDACs (termed 
histone deacetylase-like protein, HDLP) has been determined alone and in complex with 




Figure 2.3  Computational representation of TSA in the active-site pocket of HDLP8 
This crystal structure has suggested a mechanism for the deacetylation reaction8 
(Figure 2.4). The carbonyl oxygen of the N-acetylamide bond coordinates to the zinc 
cation and is activated for a nucleophilic attack by the water. The water is hydrogen 
bonded with the buried Asp166-His131, which could enhance the nucleophilicity of the 
water molecule by an interaction with the negative charge. The forming oxy-anion 
intermediate is stabilized by the zinc ion, and hydrogen bond to Tyr297. The collapse of 
this intermediate would result in cleavage of the carbon-nitrogen bond, with the nitrogen 
accepting a proton from the His132 residue, and would thereby produce the observed 
acetate and lysine products. 
 
Figure 2.4  Proposed mechanism for HDAC deacetylation8 
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 The mechanism of the inhibition of the deacetylation was also revealed in the same 
paper8 as shown in Figure 2.5, the hydroxamic acid coordinates with the zinc through its 
carbonyl and hydroxyl group in a bidentate fashion. TSA also makes hydrogen bonds 
with both histidines and the Y297 hydroxyl group. The hydroxamate replaces the 
zinc-bound water molecule of the active structure with its hydroxyl group in the inhibitor 
complex with HDAC. 
 
Figure 2.5  Binding of the hydroxamate inhibitor to HDAC8 
2.3 HDAC inhibitor structures 
Based on their structure, HDAC inhibitors can be divided into six groups: hydroxamic 
acid-derived compounds, cyclic tetrapeptides, synthetic pyridyl carbamate derivatives, 
synthetic benzamide derivatives and ketones9. Among them, hydroxamic acid analogues 
of acyclic and heterocyclic compounds are mostly studied10. Natural products such as 
trichostatin A (TSA)11, and unnatural surrogates like suberoylanilide hydroxamic acid 






Figure 2.6  Structures of known hydroxamic acid HDAC inhibitors 
Recently, our laboratory had reported the influence of the chain length of SAHA 
analogues possessing ω-alkoxy substituents on enzyme binding and inhibition13. The 
preferred chain length was found to be with CH2 = 5 and there was no significant 
difference in inhibitory activity between the racemic analogue and the single 
enantiomers. 
Although this special HDAC inhibitor (Figure 2.7) was synthesized successfully by a 
general method for series of inhibitor analogues, the steps were long and the total yields 
were low, especially in the PMB alkylation step14. Here we report a modified method to 
improve the yield for this HDAC inhibitor. 
 
Figure 2.7  Target compound 
2.4 Results and discussion  
2.4.1 Published methods 
  The published methods developed in our laboratory13 to synthesize the intermediates 
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2.6 2.7  
Scheme 2.1  Racemic intermediates 
First, racemic aminopimelic acid 2.2 was subjected to diazotization15, and the resulting 
alcohol was protected as the lactone acetal 2.3. After an Arndt–Eistert extension16 and 
cleavage of the acetonide protection of 2.3, the resulting α-hydroxy acid was converted to 
the anilide by reaction with N-sulfinylaniline 17 , and then alkylated using PMB 
trichloroacetimidate to give compound 2.6. The yield for the alkylation step was only 
39%. In this strategy, 8 steps were used, and the total yield was 19% (Scheme 2.1). 
Another strategy was used to prepare the enantiomerically pure intermediate (Scheme 
2.2): 
TBDPSO





1, AC2O, Py, DMAP
2, TBAF-AcOH, THF
























2, H2 / Pd-C32.8 2.9
2.10
2.11 2.12  
Scheme 2.2  Enantiomerically pure intermediates  
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Cross-metathesis of the known enantiomerically pure alkenol 2.8 with methyl acrylate 
in the presence of Grubbs second generation catalyst 18 , followed by catalytic 
hydrogenation, gave the corresponding hydroxy ester 2.9 in excellent overall yield. 
Acetylation of the alcohol function, cleavage of the TBDPS ether, oxidation19, anilide 
formation, and deacetylation with KCN in MeOH20, gave the amide 2.11, which was 
alkylated to give the PMB intermediate 2.12. In this strategy, 8 steps were used and the 
total yield was 21%. 
2.4.2 Synthetic plan 
Because the alkylation with PMB trichloroacetimidate at the later stage led to a low 
yield, we decided to introduce the PMB group on earlier stage. Our retrosynthesis plan 
leads to the key intermediate 2.3. Several methods to synthesize 2.3 are shown in Scheme 
2.3. 
Scheme 2.3  The synthesis plan 
Initially, we planned to convert 2.16 to the PMB ether, ozonolysis, followed by Wittig 
reaction then conjugate reduction21 to form 2.14. Unfortunately, a model study failed to 




Scheme 2.4  Attempted selective reduction of the double bond 2.18 
Consequently, 2.16 was oxidized to hemiacetal 2.2022 then subjected to several Wittig 
reaction conditions23. None of the expected 2.17 was observed (Scheme 2.5), and this 
route was also abandoned. 
 
Scheme 2.5  Attempted synthesis of 2.17 
We then envisaged a third synthesis by using the cross-metathesis method. First, 
treatment of 2.21 with butenylMgBr formed 2.16, which was reacted with methyl 
acrylate in the presence of the Grubbs’ second generation catalyst, to give the unsaturated 
ester 2.17. Hydrogenation of 2.17 led to 2.22 (Scheme 2.6).  
 
Scheme 2.6  Synthesis of 2.22 by cross-metathesis method 
With intermediate 2.22 in hand, a linear synthesis plan to 2.6 was envisaged relying on 
PMB alkylation and TBDPS deprotection, oxidation to carboxylic acid and, finally, 




Scheme 2.7  Synthesis plan from 2.22 to 2.6 
Treatment of alcohol 2.22 with para-methoxybenzyl bromide in the presence of 
sodium hydride or Ag2O24 led to decomposition. The reaction of alcohol 2.22 with the 
trichloroacetimidate of para-methoxybenzyl alcohol in the presence of TfOH 25 , 
BF3.OEt2 26  and Sc(OTf)3 27  was also tried. The most effective method for PMB 
alkylation was found to be the Sc(OTf)3. According to mechanistic studies by Cramer and 
Hennrich 28 , the following mechanism could be proposed. In the first step, the 
para-methoxybenzyl trichloroacetimidate is protonated or coordinated with BF3.OEt2 or 
Sc(OTf)3 to generate a very reactive electrophile which reacts rapidly with the alcohol 
2.22 to give the PMB ether and trichloroacetamide (Scheme 2.8). 
 
Scheme 2.8  Mechanism of PMB alkylation with PMB trichloroacetimidate 
Treatment of 2.22 with PMB trichloroacetimidate in the presence of Sc(OTf)3, 
followed by TBDPS deprotection afforded the primary alcohol 2.23 in 55% yield over 
two steps (Scheme 2.9).  
 
Scheme 2.9  Synthesis of 2.23 
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One-pot oxidation methods using trichloro isocyanuric acid (TCCA)19 or Jones’ 
oxidation were tried. The former method led to decomposition, while the latter gave a 
very poor yield (10%), possibly due to the formation of substantial amount of esters. 
Therefore we decided to oxidize the alcohol to the aldehyde by Swern oxidation29, and 
then to carboxylic acid by Jones’ oxidation (Scheme 2.10). 
 
Scheme 2.10  Synthesis of 2.25 
Using 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT) 30  as the 
coupling agent, anilide formation of this acid with aniline gave the intermediate 2.6 
(Scheme 2.11).  
 
Scheme 2.11  Synthesis of 2.6 
A mechanism is proposed for this coupling (Scheme 2.12)30. 
 
Scheme 2.12  Mechanism of the coupling reaction using DEBPT 
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Finally, treatment of methyl ester 2.6 with hydroxylamine afforded the target 
compound 2.1 (Scheme 2.13).  
 
Scheme 2.13  Synthesis of target 2.1 
2.5 Conclusion 
We have synthesized racemic p-methoxybenzyl ether analogue 2.6 in 7 steps and 35% 
overall yield from 2.16 to 2.6. The cross-metathesis method was efficient and practical in 
this strategy, and alkylation using PMB trichloroacetimidate in the presence of Sc(OTf)3 
improved the overall yield. This is an improvement over the published method (8 steps, 

























g. h i 75%
(a) TBDPSCl, imidazole, DMAP, DCM, 0 oC to rt, overnight; (b) ButenylMgBr, Li2CuCl4,
THF, -40/-50 oC; (c) Grubbs' 2nd gen. cat., CH2=CHCO2Me, 40 oC, 1 h; (d)
H2, Pd/C, MeOH, rt, overnight; (e) PMB trichloroacetimidate, Sc(OTf)3, toluene, rt;
(f) TBAF, THF, rt; (g) Swern oxidation; (h) Jone's oxidation; (i) DEPBT, DIPEA,












Scheme 2.14  Overview the synthesis of 2.1 
  Compound 2.1 was found to be a potent inhibitor of various isoforms of HDAC, 











DCM, 0 oC to rt, overnight, 95%
 
tert-Butyl(oxiran-2-ylmethoxy)diphenylsilane 
To a stirred solution of glycidol (1.8 g, 24.3 mmol) in anhydrous DCM (100 mL), 
DMAP (297 mg, 2.43 mmol), imidazole (2.48 g, 36.5 mmol) and TBDPSCl (7.5 mL, 
29.2 mmol) were added at 0 oC. The reaction mixture was stirred at rt overnight, then 
quenched with saturated NH4Cl (30 mL), diluted with ether, and treated with water (50 
mL). After stirring for 30 min, the organic layer was separated, dried over Na2SO4, 
concentrated under reduced pressure, and the residue was purified by flash 
chromatography, eluting with ethyl acetate/hexane (5:95), to give glycidol 2.21 (7.16 g, 
95%) as a colorless oil. 
1H NMR (400 MHz CDCl3): δ 7.91 (m, 4H), 7.53 (m, 6H), 4.06 (dd, J = 3.0, 11.8 Hz, 
1H), 3.87 (dd, J = 4.8, 11.8 Hz, 1H), 3.45–3.04 (m, 1H), 2.81 (dd, J = 4.1, 5.2 Hz, 1H), 
2.72 (dd, J = 2.6, 5.3 Hz, 1H), 1.29 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 135.6, 135.5, 133.19, 133.18, 129.8, 129.7, 127.8, 127.7, 










To a solution of glycidol 2.21 (7.16 g, 22.95 mmol) in anhydrous THF (80 mL) at 
-40/-50 oC, Li2CuCl4 (0.1 M in THF, 23 mL) was added. To the yellow-orange solution, 
butenylmagnesium bromide (0.5 M in THF, 55 mL, 27.54 mmol) was quickly added 
under vigorous stirring (the mixture turns from blue to colorless to brown), and the 
mixture was allowed to stir at the same temperature for 30 min. After this time, the 
reaction mixture was quenched with NH4Cl (30 mL) under vigorous stirring, and it was 
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allowed to reach rt. Water (50 mL) was added, to the mixture, which was stirred for 20 
min and extracted with Et2O (60 mL × 3). The combined organic layers were dried over 
Na2SO4, concentrated under reduced pressure, and the residue was purified by flash 
chromatography, eluting with ethyl acetate/hexane (1:9), to give pure alcohol 2.16 (7.69 g, 
91%) as a colorless oil.  
1H NMR (400 MHz CDCl3): δ 7.82 (m, 4H), 7.51 (m, 6H), 5.89 (ddt, J = 6.7, 10.2, 16.9 
Hz, 1H), 5.10 (dd, J = 1.3, 17.1 Hz, 1H), 5.05 (d, J = 10.2 Hz, 1H), 3.85 (m, 1H), 3.79 
(dd, J = 3.5, 10.1 Hz, 1H), 3.65 (dd, J = 7.3, 10.0 Hz, 1H), 2.77 (s, 1H), 2.29–2.08 (d, J = 
6.9, 13.6 Hz, 2H), 1.79–1.60 (m, 1H), 1.60–1.42 (m, 3H), 1.20 (m, 9H).  
13C NMR (100 MHz CDCl3): δ 138.6, 135.6, 133.3, 133.2, 129.9, 127.9, 114.7, 71.8, 68.1, 




To a solution of olefin 2.16 (3.50 g, 9.51 mmol) and methyl acrylate (10.2 mL, 113.9 
mmol), in anhydrous DCM (19 mL), Grubbs’ catalyst second generation (241 mg, 0.28 
mmol) was added in one portion under argon atmosphere. The homogeneous solution 
was warmed to 40 oC, and stirred until complete conversion (TLC check, Rf =0.8 for 2.16, 
0.1 for 2.17). The volatiles were removed under reduced pressure, and the crude residue 
was purified by flash chromatography, eluting with ethyl acetate/hexane (15:85), to give 
the unsaturated methyl ester intermediate 2.17 (3.7 g, 92%) as a colorless oil. 
1H NMR (400 MHz CDCl3): δ 7.70-7.71 (m, 4H), 7.41-7.49 (m, 6H), 6.98 (dt, J =7.0, 
15.6 Hz, 1H), 5.85 (d, J =15.7 Hz, 1H), 3.75 (s, 3H), 3.69 (dd, J = 3.4, 10.1 Hz, 1H), 3.53 
(dd, J = 7.4, 10.1 Hz, 2H), 2.62 (br, 1H), 2.23 (dd, J = 6.5, 13.3 Hz, 2H), 1.75 – 1.35 (m, 
4H), 1.11 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 167.2, 149.3, 135.7, 135.6, 133.2, 130.0, 127.9, 121.3, 
71.7, 68.1, 51.5, 32.3, 32.2, 27.0, 24.1, 19.4. 
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The olefin intermediate 2.17 (3.8 g, 8.92 mmol) was hydrogenated under conventional 
conditions. Olefin was dissolved in MeOH (90 mL) and catalytic 10% palladium on 
carbon was added. The reaction flask was evacuated by aspiration and thoroughly purged 
with H2 (3-6 times) and the resulting heterogeneous mixture was stirred under a balloon 
of H2. After stirred 24 h, the H2 was evacuated, the catalyst was filtered off on a pad of 
Celite, and the filtrate concentrated under reduced pressure and the crude residue was 
purified by flash chromatography, eluting with ethyl acetate/hexane (1:4), to give the 
saturated ester 2.22 (3.6 g, 93%) as a colorless oil. 
1H NMR (400 MHz CDCl3): δ 7.72 (d, J = 6.6 Hz, 4H), 7.50–7.36 (m, 6H), 3.80–3.71 (m, 
1H), 3.71–3.67 (m, 1H), 3.66 (s, 3H), 3.55 (dd, J = 7.3, 9.9 Hz, 1H), 2.68 (s, 1H), 2.31 (t, 
J = 7.5 Hz, 2H), 1.75–1.57 (m, 2H), 1.47 (dd, J = 11.7, 16.7 Hz, 3H), 1.39–1.27 (m, 3H), 
1.12 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 174.1, 135.6, 135.5, 133.2, 129.8, 127.8, 71.8, 68.1, 51.4, 
34.0, 32.6, 29.1, 26.9, 25.2, 24.8, 19.3. 




A solution of p-methoxybenzyl alcohol (5.2 g, 37.6 mmol) in ether (35 mL) was added 
to a suspension of sodium hydride (90 mg, 3.8 mmol) in ether (40 mL) at room 
temperature. The resulting mixture was stirred at room temperature for 30 min and cooled 
to 0 oC. Trichloroacetonitrile (3.8 mL, 37.6 mmol) was added, and the reaction mixture 
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was allowed to warm slowly to room temperature for 4 h. The solution was concentrated 
to an orange syrup, which was dissolved in petroleum ether (50 mL) containing methanol 
(0.2 mL, 4.0 mmol). This suspension was filtered through Celite, and the filtrate was 
concentrated to a yellow syrup. The crude imidate was dissolved in toluene (120 mL), 
and treated with a solution of the alcohol 2.22 (3.5 g, 8.18 mmol) in toluene (30 mL), 
followed by Sc(OTf)3 (400 mg, 0.8 mmol) at 0 oC. The reaction mixture was allowed to 
reach room temperature. After stirring for 12 h, the reaction mixture was concentrated 
under reduced pressure and the residue was purified by flash column chromatography, 
eluting with ethyl acetate/hexane (2:98), to give the PMB ether 2.14 (2.6 g, 58%, usually 
with minor impurities) as a yellow oil. 
1H NMR (400 MHz CDCl3): δ 7.75–7.69 (m, 4H), 7.49–7.38 (m, 6H), 7.29–7.23 (m, 2H), 
6.88 (d, J = 8.6 Hz, 2H), 4.63 (d, J = 11.3 Hz, 1H), 4.48 (d, J = 8.9 Hz, 1H), 3.83 (s, 3H), 
3.76 (dd, J = 5.8, 10.6 Hz, 1H), 3.69 (s, 3H), 3.65 (dd, J = 4.8, 10.6 Hz, 1H), 3.50 (dd, J = 
5.1, 12.4 Hz, 1H), 2.31 (t, J = 7.6 Hz, 2H), 1.69 – 1.36 (m, 5H), 1.29 (dd, J = 6.7, 10.7 Hz, 
3H), 1.10 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 174.4, 159.2, 135.8, 133.8, 133.7, 131.3, 129.8, 129.6, 
127.9, 113.9, 113.8, 79.4, 72.0, 66.5, 55.4, 51.6, 34.2, 31.7, 29.4, 27.0, 25.2, 25.1, 19.4. 
MS (ESI) m/z: 571.2 [M+Na+]. 
Note: when preparing the PMB trichloroacetimidate, it is better to wash the NaH (60% in 




To a solution of the PMB ether 2.14 (5.7 g, 10.4 mmol) in THF (60 mL) at 0 oC, TBAF 
(1.0 M in THF, 20.8 mL) was added. The reaction mixture was stirred at rt for 4 h, 
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quenched with saturated NH4Cl (40 mL) and extracted with ethyl acetate (30 mL× 3). 
The organic layers were dried over Na2SO4, concentrated under reduced pressure. The 
residue was purified by flash chromatography, eluting with ethyl acetate/hexane (3:7), to 
give the primary alcohol 2.23 (3.05 g, 95%) as a colorless oil.  
1H NMR (400 MHz CDCl3): δ 7.33–7.23 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 
4.50 (q, J = 11.2 Hz, 2H), 3.79 (s, 3H), 3.71–3.62 (m, 4H), 3.53-3.45 (m, 2H), 2.29 (t, J = 
7.5 Hz, 2H), 2.25 (br, 1H), 1.71–1.55 (m, 3H), 1.55–1.23 (m, 5H).  
13C NMR (100 MHz CDCl3): δ 174.3, 159.3, 130.6, 129.5, 113.9, 79.3, 71.3, 64.2, 55.3, 
51.6, 34.0, 30.8, 29.3, 25.1, 24.9. 




To a solution of oxalyl chroride (1.0 mL, 11.07 mmol) in DCM at -78 oC under an 
argon atmosphere, DMSO (1.1 mL, 14.76 mmol) was added dropwise in ca. 5 min. 
Stirring was continued at -78 oC for 10 min, followed by addition of a solution of alcohol 
2.23 (1.15 g, 3.7 mmol) in DCM (20 mL) in ca. 15 min at the same temperature. After 1 h, 
Et3N (5.1 mL, 36.9 mmol) was added at -78 oC, the reaction mixture was allowed to reach 
0 oC and stirred untill complete conversion was observed by TLC. The reaction mixture 
was quenched with saturated NH4Cl (20 mL) and stirred for 15 min, treated with water 
(60 mL) and extracted with DCM (50 mL × 3). The combined organic layers were dried 
over Na2SO4, concentrated under reduced pressure. The resulting residue was purified by 
flash chromatography, eluting with ethyl acetate/hexane (3:7), to give the pure aldehyde 
intermediate 2.24 (1.13 g, 99%) as a colorless oil.  
 99 
 
1H NMR (400 MHz CDCl3): δ 9.62 (d, J = 2.2, 1H), 7.38–7.25 (m, 2H), 6.98–6.81 (m, 
2H), 4.61 (d, J = 11.4 Hz, 1H), 4.48 (d, J = 11.4 Hz, 1H), 3.82 (s, 3H), 3.73 (td, J = 2.1, 
6.5 Hz, 1H), 3.67 (s, 3H), 2.30 (t, J = 7.5 Hz, 2H), 1.77–1.54 (m, 4H), 1.54–1.20 (m, 4H). 
13C NMR (100 MHz CDCl3): δ 204.2, 174.2, 159.7, 129.9, 129.5, 114.1, 83.1, 72.4, 55.4, 
51.7, 34.0, 30.0, 29.0, 24.8, 24.6. 




To a solution of this aldehyde intermediate 2.24 (1.13 g, 3.67 mmol) in THF (36.0 mL), 
Jones reagent (4.8 mL, prepared from 25.0 g of chromium (VI) oxide, 25 mL of H2SO4, 
and 75.0 mL of water) was quickly added along the walls of the flask at 0 oC under 
vigorous stirring. After 5-10 min, the excess reagent was destroyed by adding cold 
i-PrOH (180 mL) with stirring at 0 oC. The greenish mixture was diluted with cold ethyl 
acetate (300 mL), and washed with small portions of 10% aqueous NaHSO4 (5 mL × 4) 
until complete separation of the deep green aqueous layer, then with 10% aqueous 
Na2S2O3 (5 mL × 4) until the aqueous layer was completely colorless, then with water (20 
mL ×3), and brine (20 mL × 2). The separated organic layer was dried over Na2SO4, 
filtered and the filtrate was concentrated under reduced pressure at rt (not over 25 oC), 
co-evaporating away traces of i-PrOH with cyclohexane (10 mL × 3), to give the 
carboxylic acid 2.25 (1.18 g, 99%) which was immediately used for the coupling reaction 
without further purification.  






To an ice-bath cooled solution of carboxylic acid 2.25 (1.5 g, 4.63 mmol) in anhydrous 
THF (150 mL), DEPBT (2.77 g, 9.26 mmol) was added, followed by DIPEA (1.6 mL, 
9.26 mmol), and the mixture was stirred for 15 min at rt under argon atmosphere. To the 
resulting bright yellow solution, the aniline (0.6 mL, 6.95 mmol) was added at 0 oC, and 
the mixture was stirred for 48 h at rt (monitored by MS analysis). The reaction mixture 
was quenched with saturated NH4Cl (80 mL), and extracted with ethyl acetate (50 mL × 
3). The organic layer was washed with NaHCO3 (50 mL × 2), and brine (50 mL × 3), 
dried over Na2SO4, concentrated under reduced pressure, then the residue was purified by 
flash chromatography, eluting with ethyl acetate/hexane (1:3), to give the amide 2.6 
(1.39g, 75%) as a yellow oil.  
1H NMR (400 MHz CDCl3): δ 8.40 (s, 1H), 7.62–7.52 (m, 2H), 7.39–7.25 (m, 4H), 7.13 
(t, J = 7.4 Hz, 1H), 6.98–6.89 (m, 2H), 4.57 (s, 2H), 3.97 (dd, J = 4.4, 7.1 Hz, 1H), 3.83 
(s, 3H), 3.67 (s, 3H), 2.30 (t, J = 7.5 Hz, 2H), 1.84 (m, 2H), 1.72–1.56 (m, 2H), 1.46 (m , 
2H), 1.39–1.24 (m, 2H).  
13C NMR (100 MHz CDCl3): δ 174.2, 171.2, 159.8, 137.4, 130.0, 129.2, 124.5, 119.7, 
114.2, 80.2, 72.9, 55.4, 51.6, 34.1, 32.8, 29.0, 24.9, 24.7. 
MS (ESI) m/z: 400.1 [M+H+]. 
Note: Excess of aniline can be removed by washing with 1N HCl during the workup (10 






To a solution of methyl ester 2.6 (105 mg, 0.26 mmol) in MeOH (2 mL) at 0 oC, 
HONH2 (50% aqueous solution, 220 µL, 15 equiv.) was added, followed by 1.0 N NaOH 
(100 µL, 10 equiv.). The mixture was stirred at 0 oC for 3 h, warmed slowly to rt, and 
stirred overnight. After careful neutralization with 1.0 N HCl, the resulting mixture was 
extracted with ethyl acetate (5 mL ×3). The combined organic layers were dried over 
Na2SO4 and concentrated under reduced pressure. The residue was purified by flash 
chromatography, eluting with ethyl acetate/hexane (9:1), to give the hydroxamic acid 2.1 
(77 mg, 73%) as a pale yellow oil. 
1H NMR (400 MHz CD3OD): δ 7.57 (d, J = 8.1 Hz, 2H), 7.36-7.32 (m, 4H), 7.14 (t, J = 
7.4 Hz, 1H), 6.93 (d, J = 8.6 Hz, 2H), 4.63 (d, J = 11.5 Hz, 1H), 4.48 (d, J = 11.6 Hz, 1H), 
3.93 (t, J = 6.1 Hz, 1H), 3.80 (s, 3H), 2.08 (t, J = 7.4 Hz, 2H), 1.77 (m, 2H), 1.61 (m, 2H), 
1.46 (m, 2H), 1.33 (m, 2H).  
13C NMR (100 MHz CD3OD): δ 171.0, 170.9, 159.3, 136.7, 129.6, 128.7, 128.6, 124.2, 
119.3, 113.8, 79.3, 72.4, 55.0, 33.6, 32.1, 27.9, 24.6, 23.8. 




To a stirred solution of 2.16 (1.9 g, 5.16 mmol) in DCM (150 mL) at −78 oC, O3 was 
bubbled through until the reaction mixture became light blue. Dimethyl sulfide (3.8 mL, 
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51.6 mmol) was added to the reaction mixture, which was allowed to warm to ambient 
temperature and stirred overnight. The volatiles were removed under reduced pressure to 
leave a creamy oil which was purified by flash column chromatography, eluting with 
ethyl acetate/hexane (1:9), to give 2.20 (1.7 g, 92%), as a colorless oil, which was a 
mixture of acetal (major) and aldehyde (minor). 
1H NMR (400 MHz CDCl3): δ 9.77 (m, 1H minor), 7.71-7.61 (m, 4H), 7.47-7.38 (m, 6H), 
5.31 (br, 1H minor), 4.71-4.68 (dd, J=1.8, 7.4 Hz, 1H minor), 4.08 (dtd, J=2.2, 5.7. 7.5 
Hz, 2H minor), 3.81-3.48 (m, 2H major and 1H minor), 2.85 (s, 1H), 2.55(s, 1H), 
2.47-2.44 (m, 1H), 1.91-1.19 (m, 6H major and 6 H minor), 1.09 (s, 9H minor), 1.08 (s, 
9H). 
13C NMR (100 MHz CDCl3): δ 135.9, 135.8, 129.8, 128.0, 127.8, 104.0, 96.5, 92.0, 77.0, 
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Pactamycin, a structurally unique aminocyclitol antibiotic isolated from Streptomyces 
pactum1, consists of a 5-membered ring aminocyclitol unit, two aromatic rings (6-methyl 
salicylic acid and 3-aminoacetophenone) and a 1,1-dimethylurea2. The structure of this 
compound was elucidated from NMR analyses and chemical degradation3. However, 
X-ray crystallographic analysis of pactamycate, a chemical transformation product led to 





























Pactamycin Pactamycate  
Figure 3.1  The structure of pactamycin and pactamycate 
Pactamycin shows potent in vitro and in vivo antitumor activity as well as 
antimicrobial activity5. The mechanism of action is inhibition of protein synthesis6 
through binding to the ribosomal small subunit7 (Figure 3.2).   
 
Figure 3.2  Stereofigure of pactamycin bound at the 30S E site with rings I, II, and III. 
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3.2 Efforts toward the synthesis of pactamycin 
The total synthesis of pactamycin, a unique member of the aminocyclitol family of 
antibiotics, presents synthetic challenges that include a highly functionalized 
cyclopentane core, unusual substitution patterns and stereogenic carbons that accentuate 
the need for functional group compatibility.  
Efforts by Isobe8 and Knapp9 respectively are summarized below in schematic 
format (Scheme 3.1 and 3.2). Further details can be found in the M. Sc. thesis of 
Stephane Dorich10.  
Scheme 3.1   Isobe’s approach 
Scheme 3.2  Knapp’s approach 
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Before I took part in this total synthesis of pactamycin, Drs. Banerjee Shayampada, 
Juan R. Del Valle, Fabien Lecomte, Ramkrishna Reddy Vakiti and graduate student 
Stephane Dorich had each made major contributions10. 
3.2.1 The synthetic plan for pactamycin  
Analysis of the structure and six chiral centers in pactamycin led us to consider the 
disconnections shown in Scheme 3.3.  
 
Scheme 3.3  Synthetic plan for pactamycin 
First, the aldehyde 3.5 was synthesized starting from trimethyl phosphonoacetate and 
formaldehyde, following the procedure for the synthesis of the analogous ethyl ester11 to 
afford methyl (2-hydroxymethyl)acrylate 3.2. After protection of the hydroxyl group as 
the TBDPS ether and ester reduction with DIBAL-H12, the resulting alcohol 3.4 was 
oxidized to aldehyde 3.5 by Swern oxidation13(Scheme 3.2). 
Scheme 3.4  The synthesis of the aldehyde 3.5 
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The oxazoline 3.8 was prepared starting from L-threonine10. Condensation with 
benzyl alcohol gave the benzyl ester 3.6, which was converted to the PMP amide 3.7. 
Cyclization with inversion of configuration was achieved by treating with SOCl214 to 
afford oxazoline 3.8 (Scheme 3.5). The products in all these three steps did not require 
purification by chromatography, which facilitated scale-up. 
 
Scheme 3.5  The synthesis of the oxazoline 3.8 
A proposed mechanism for the cyclization using SOCl215 is shown in Scheme 3.6. 
The p- methoxyphenyl group enhances the reactivity of the carbonyl group in an 
intramolecular attack on the chlorosulfite intermediate 3.9 to give an oxazolinium ion 
3.10 (path a) and the oxazoline 3.8. Displacement by chloride ion would give 3.11, 
which can also give 3.8. It is likely that path a predominates over the alternative path b 
(which would lead to 3.12), because inversion takes place rather than cyclization.  
 
Scheme 3.6  The proposed mechanism of the cyclization to form the oxazoline 
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The aldol reaction16 of oxazoline 3.8 and aldehyde 3.5 afforded alcohol 3.13 as a 
single isomer. The stereochemistry can be explained using the Zimmerman–Traxler 
model (Scheme 3.7). In this transition state, the methyl group was placed far from the 
electrophile to facilitate the approach and to avoid the syn-pentane interactions between 
the OBn and the R groups (highlighted in blue). Transition state A is favored over B 
because of the 1,3 non-bonded interaction in the latter. The diastereoisomer 3.14 was not 
observed. 
 
Scheme 3.7  The proposed mechanism of the aldol reaction 
The resulted hydroxyl group of the 3.13 was protected with a TES group to prevent a 
retro-aldol reaction, which formed the 3.15. Compound 3.15 was reduced with DIBAL-H 
to form a mixture of aldehyde 3.16 and hemiacetal 3.17, which was treated with MeMgBr 
to give 3.18 as a mixture of epimers at the alcohol center. Swern oxidation to ketone 3.19, 
followed by ozonolysis17of the double bond afforded the dione 3.20. The cyclization 
product 3.21 was obtained by a Mukaiyama aldol reaction18  as a single isomer. 
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Treatment of alcohol 3.21 with trichloroacetyl chloride and pyridine in DCM afforded the 
enone 3.22 (Scheme 3.8). 
 
Scheme 3.8  The synthesis of the enone 3.22 
The nucleophilic epoxidation of the enone with H2O2 formed the epoxy ketone 3.23, 
which was reduced to epoxy alcohol 3.24 under Luche reduction19 conditions. The epoxy 
alcohol 3.24 was treated with premixed triflic anhydride and pyridine20 in DCM to form 
the triflate 3.25, which was replaced by azide by adding tetrabutylammonium azide21 to 
give the epoxy azide 3.26. The TES protecting group was selectively deprotected22 with 
TFA in a mixture of acetonitrile and water to afford epoxy alcohol 3.27 (Scheme 3.9). 
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Scheme 3.9  The synthesis of the epoxy alcohol 3.27 
Compound 3.27 was oxidized to the ketone 3.28 with Dess-Martin periodinane23. 
Treatment of epoxy ketone 3.28 with MeMgBr gave the tertiary alcohol 3.29, which, 
after treatment with TBAF afforded the epoxy diol 3.30. In the presence of acetic acid 
and Zn(OTf)2, a mixture of monoacetate 3.31 and diacetate 3.32 was formed. Cleavage of 




























































Scheme 3.10  The synthesis of the tetrol 3.33 
114 
 
The primary alcohol of 3.33 was selectively protected with TBDPS to give triol 3.34  
Treatment of the triol 3.34 with triflic anhydride and pyridine in DCM afforded the “up” 
epoxide 3.35, which was opened with 3-(prop-1-en-2-yl)aniline in the presence of 
Yb(OTf)3 to give the amino alcohol 3.36 as a single diastereoisomer (Scheme 3.11).  
 
Scheme 3.11  The synthesis of the amino alcohol 3.36 
  The absolute stereochemistry of 3.35 was confirmed by X-ray analyze. 
 
Figure 3. 3 X-ray of 3.35 
The regioselectivity of the epoxide opening reaction may be rationalized by the attack of 
the aniline at C-2 on the chelate structure 3.35A (Scheme 3.12). Complete C-2 




Scheme 3.12  The regioselectivity of epoxide opening-reaction of 3.35 
3.2.2 Conclusion 
The methodology described in this thesis allows for a synthesis the key intermediate 
amino alcohol 3.36 (1.55 g) starting from L-threonine over 27 steps with a 2% overall 
yield. The advanced intermediate 3.36 contains all the required stereochemistry present in 
pactamycin. Subsequent steps envisaged for the completion of the synthesis are shown in 
Scheme 3.13.  








A mixture of phosphonoacetate 3.1 (22.6 g, 124.1 mmol) and a 30% aqueous solution  
of formaldehyde (40 mL) was stirred at rt and treated slowly (30 min.) with a saturated 
solution of K2CO3 (24.0 g, 173.9 mmol). At the end of the addition, the temperature was 
reached 30-35 oC and stirring was continued for 1 h. Saturated NH4Cl solution (40 mL) 
was added slowly to the mixture, which was extracted with ether (50 mL x 3). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. Flash column chromatography using ethyl acetate/hexane (1:4) as 
eluant afforded the unsaturated ester 3.2 (10.0 g, 70%) as a colorless liquid.  
IR 1722.1, 3440.3 cm-1.  
1H NMR (400 MHz CDCl3): δ 6.21 (s, 1H), 5.81 (d, J = 1.3 Hz, 1H), 4.26 (s, 2H), 3.72 (s, 
3H), 3.26 (s, 1H).  




To a stirred solution of alcohol 3.2 (10.0 g, 87.0 mmol) in DCM (150 mL) and DMF 
(10 mL), imidazole (8.9 g, 8.5 mmol) and DMAP (10 mg) were added as solids at 0 oC 
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and the mixture was stirred for 10 min, treated dropwise with TBDPSCl (26.6 mL, 104.3 
mmol) at 0 oC and stirred for 2 h at rt. The mixture was diluted with ether (400 mL) and 
washed with water (20 mL) and brine (20 mL). The organic layer was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. Flash column 
chromatography of the crude using ethyl acetate/hexane (9:1) as eluant afforded the 
TBDPS ether 3.3 (21.0 g, 70%) as a colorless viscous liquid.  
IR 1638.5, 1720.9 cm-1. 
1H NMR (400 MHz CDCl3): δ 7.82 – 7.65 (m, 4H), 7.62 – 7.35 (m, 6H), 6.40 (d, J = 1.3 
Hz, 1H), 6.19 (d, J = 1.9 Hz, 1H), 4.49 (s, 2H), 3.74 (d, J = 0.6 Hz, 3H), 1.15 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 267.0,166.4, 139.5, 135.6, 133.4, 130.0, 128.0, 124.3, 






-78 oC, 2 h, 76%
3.3 3.4  
2-((tert-Butyldiphenylsilyloxy)methyl)prop-2-en-1-ol 
To a magnetically stirred solution of unsaturated ester 3.3 (10.0 g, 28.3 mmol) in 
anhydrous DCM (100 mL) at -78 oC, DIBAL-H (1.0 M solution in toluene, 56.6 mL, 56.6 
mmol) was added slowly over 1 h. The mixture was stirred for an additional 1 h, 
quenched with saturated NH4Cl (20 mL), and treated with 20% sodium potassium 
tartarate solution (50 mL) with stirring for 3 h at rt. The organic layer was separated.  
The aqueous layer was extracted with ethyl acetate (50 mL x 2). The combined organic 
layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure. Flash 
column chromatography using a gradient of ethyl acetate/hexane (5:95 to 2:8) as eluant 
afforded the alcohol 3.4 (7.0 g, 76%) as a colorless viscous liquid. 
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1H NMR (400 MHz CDCl3): δ 7.73 – 7.70 (m, 4H), 7.47 – 7.42 (m, 6H),.5.20 – 5.17 (m, 
1H), 5.14 (dd, J = 1.2, 2.4 Hz, 1H), 4.29 (s, 2H), 4.21 (s, 2H), 1.10 (s, 10H).  





To a solution of oxalyl chloride (5.9 mL, 68.1 mmol) in DCM (300 mL) in a round 
bottom flask at -78 oC , DMSO ( 10.3 mL, 145.2 mmol) was added dropwise over ca. 10 
min. Stirring was continued at -78 oC for 15 min. The alcohol 3.4 ( 14.8 g, 45.4 mmol) in 
DCM (50 mL) was added to the reaction mixture over ca. 20 min. The reaction mixture 
was stirred for 30 min, and treated with triethylamine (31.6 mL, 226.9 mmol) over ca. 10 
min. with stirring at -78 oC. The cooling bath was removed. Saturated NH4Cl solution 
(150 mL) was added to the mixture at -78 oC. After warming to rt, the mixture was 
treated with H2O (50 mL). Stirring was continued for ca. 30 min. and organic layer was 
separated, dried over anhydrous Na2SO4, and the volatiles was removed under reduced 
pressure to afford the aldehyde 3.5 (13.3 g, 90%) as a colorless liquid after flash column 
chromatography using ethyl acetate/ hexane (1:19) as eluant.  
IR 1695.4 cm-1. 
1H NMR (400 MHz CDCl3): δ 9.63 (s, 1H), 7.84 – 7.61 (m, 4H), 7.59 – 7.36 (m, 6H), 
6.75 (dd, J = 2.0, 3.3 Hz, 1H), 6.19 (dd, J = 1.9, 3.1 Hz, 1H), 4.51 (t, J = 2.0 Hz, 2H), 
1.14 (d, J = 3.0 Hz, 9H).  






A suspension of L-threonine (24.0 g, 201.1 mmol) in 200 mL of 4:1 benzene:BnOH 
was treated with p-toluenesulfonic acid monohydrate (42.1 g, 222.1 mmol). The flask 
was fitted with a Dean-Stark trap and heated at a reflux for 24 h (~115 oC) with 
azeotropic removal of water. The reaction was cooled to rt. The benzene was removed 
under reduced pressure. To the mixture, water (200 mL) was added. The aqueous layer 
was separated and washed with ethyl acetate (200 mL × 2). The organic washes were 
back-extracted with water (100 mL × 4) and the pH of the combined aqueous layers was 
made basic (pH > 9) with solid KOH (about 13.0 g). The aqueous solution was extracted 
with ethyl acetate (200 mL × 5). The organic extractions were combined, dried over 
Na2SO4 and evaporated to give the crude amino ester as a colorless oil. To the oil was 
added petroleum ether (100 mL) with stirring. The desired ester crystallized out of the 
turbid mixture over 48 h at 4 oC. After decanting the solution, the crystals were dried to 
give the pure benzyl ester 3.6 (27.0 g, 64%) as a white solid. 
Melting point: 67-68 oC 
[α]D20  -4.2 (c 1, MeOH) 
1H NMR (400 MHz CDCl3): δ 7.44 – 7.33 (m, 5H), 5.21 (s, 2H), 4.14 – 3.71 (m, 1H), 
3.32 (d, J = 5.3 Hz, 1H), 2.19 (s, 3H), 1.23 (d, J = 6.3 Hz, 3H).  
13C NMR (100 MHz CDCl3): δ 174.3, 135.6, 128.9, 128.7, 128.6, 68.5, 67.2, 60.2, 20.0.    




















A solution of benzyl ester 3.6 (27.0 g, 126.1 mmol) in anhydrous DCM (370 mL) was 
added triethylamine (175.1 mL, 151.3 mmol, 1.20 equiv.) and p-anisoyl chloride (32.6 g, 
132.4 mmol, 1.05 equiv.) at rt. The conversion of starting material to product was 
followed by TLC until no more starting material and was finished after approximately 
two hours. A saturated solution of NH4Cl (150 mL) was then added to the mixture. The 
phases were separated and the aqueous phase were extracted with DCM (100 mL × 3). 
The combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure to afford colorless crystals 3.7 (58.3 g), which were used to the next step without 
any purification. An analytical sample was isolated by preparative TLC purification.  
1H NMR (400 MHz CDCl3): δ 7.82 (d, J = 8.8 Hz, 2H), 7.38 – 7.32 (m, 5H), 7.05 (d, J = 
8.7 Hz, 1H), 6.89 (d, J = 8.8 Hz, 2H), 5.26 – 5.17 (dd, J=12.3, 4.5 Hz, 2H), 4.86 (dd, J = 
2.5, 8.8 Hz, 1H), 4.46 (d, J = 4.4 Hz, 1H), 3.84 (s, 3H), 2.93 (s, 1H), 1.26 (d, J = 6.4 Hz, 
3H).  
13C NMR (100 MHz CDCl3): δ 171.3, 167.8, 162.6, 135.4, 129.3, 128.8, 128.6, 128.3, 
126.1, 113.9, 68.5, 67.5, 58.0, 55.6, 20.3.  




A solution of amino alcohol 3.7 (crude) in acetonitrile (300 mL) was treated with 
thionyl chloride (11.3 mL, 151.3 mmol) at 0 oC and left to stir overnight at rt. The 
reaction was quenched with saturated NaHCO3 (200 mL) and extracted with ethyl acetate 
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(150 mL × 3). The combined organic layers were dried over Na2SO4, and concentrated 
under reduced pressure to afford a yellow solid, which was crystallized by adding ethyl 
acetate (50 mL) and cooling at 4 oC for 16 h. After filtration, oxazole 3.8 (28.7 g, 73% 
over two steps) was obtained as a white crystal powder. 
Melting point: 85.5 - 87.1 oC 
[α]D20 15.2 (c 1, CHCl3).  
1H NMR (400 MHz CDCl3): δ7.91 (d, J = 8.9 Hz, 2H), 7.40 – 7.22 (m, 5H), 6.86 (s, 1H), 
6.84 (s, 1H), 5.27 – 5.09 (dd, J=12.1, 3.1 Hz, 2H), 5.04 – 4.85 (m, 2H), 3.72 (s, 3H), 1.35 
– 1.16 (m, 3H). 
13C NMR (100 MHz CDCl3): δ 169.7, 165.7, 162.2, 135.1, 130.0, 128.4, 128.3, 128.2, 
119.4, 113.4, 76.8, 71.2, 66.5, 55.0, 15.9 






A solution of LiHMDS (1.0M in hexane, 7.4 mL, 7.4 mmol) in THF (30 mL) was 
cooled to -78 oC and treated dropwise with a solution of oxazoline 3.8 (2.0 g, 6.2 mmol) 
in THF (30 mL). After stirring for 45 min at -78 oC, a solution of α,β-unsaturated 
aldehyde 3.5 (3.0 g, 9.2 mmol) in THF (30 mL) was added dropwise at -78 oC. The 
mixture was stirred for 25 min and quenched rapidly with saturated aqueous NH4Cl 
solution (20 mL) at -78 oC. The cooling bath was removed and the reaction mixture was 
allowed to warm to rt (40 min). The aqueous layer was extracted with ether (100 mL x 3). 
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The combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure. A crude viscous yellowish paste was obtained and dried by dissolving in 
toluene and evaporating the azeotrope twice. Without further purification, the crude 
allylic alcohol was dissolved in anhydrous DCM (20 mL), cooled to 0 oC, and treated 
with 2,6-lutidine (1.4 mL, 12.3 mmol) and TESOTf (1.4 mL, 7.4 mmol) at. After stirring 
for 30 min, the reaction mixture was quenched with saturated NH4Cl (20 mL), and 
washed with 0.1 N HCl (50 mL x 3) and brine (50 mL). The organic layer was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified by 
flash column chromatography, eluting with ethyl acetate/hexane (1:19), to afford the 
silylether 3.15 (3.1 g, 67%, 2 steps) as a colorless viscous liquid.  
1H NMR (400 MHz CDCl3): δ 7.86 (d, J = 8.8 Hz, 2H), 7.69 (d, J = 6.6 Hz, 2H), 7.59 (d, 
J = 6.8 Hz, 2H), 7.52 – 7.18 (m, 11H), 6.83 (d, J = 8.8 Hz, 2H), 5.64 (s, 1H), 5.33 (s, 1H), 
5.25 (q, J = 12.3 Hz, 2H), 4.83 (q, J = 6.4 Hz, 1H), 4.74 (s, 1H), 4.45 (dd, J = 15.4, 52.3 
Hz, 2H), 4.16 (q, J = 7.2 Hz, 1H), 3.81 (s, 3H), 2.06 (s, 1H), 1.29 (t, J = 5.9 Hz, 3H), 1.09 
(s, 9H), 0.98 (t, J = 7.9 Hz, 9H), 0.65 (q, J = 7.8 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 170.3, 164.4, 162.1, 147.5, 135.52, 135.46, 135.3, 133.6, 
133.5, 130.3, 129.5, 129.4, 128.6, 128.3, 128.1, 127.54, 127.46, 119.9, 114.2, 113.4, 85.7, 
79.5, 79.4, 66.7, 63.4, 55.1, 26.8, 19.2, 17.3, 6.9, 4.7.  
HRMS (ESI) calc. for C45H58NO6Si2 : [M+H+], 764.37972; found: [M+H+], 764.38087. 
 
 
To a magnetically stirred solution of benzyl ester 3.15 (19.2 g, 25.2 mmol) in 
anhydrous DCM (500 mL) at -78 oC, DIBAL-H (1.0 M solution in toluene, 56.0 mL, 56.0 
mmol) was added dropwise, additional DIBAL-H portions (0.5 equiv.) were added every 
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30 min. until complete consumption of starting material. The reaction mixture was 
quenched with 20% potassium sodium tartrate solution (200 mL) and allowed to reach rt. 
Et2O (150 mL) was added to the mixture, which was stirred for 2 h at rt. The organic 
layer was separated. The aqueous layer was extracted with ether (200 mL x 2). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The crude was dried overnight under high vacuum. It is a mixture of 
aldehyde 3.16 and hemiacetal 3.17. This mixture was used directly without purification in 
the next step. 
 
 
To a stirred solution of aldehyde and hemiacetal in ether (100 mL), MeMgBr (3.0 M 
solution in ether, until 5 equiv.) was added dropwise at 0 oC. The reaction mixture was 
stirred for 30 min at 0 oC and quenched with saturated aqueous NH4Cl (50 mL). After the 
layers were separated, the aqueous layer was extracted with ether (50 mL x 2), and the 
combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash column chromatography using ethyl 
acetate /hexane (1:19) as eluant afforded the alcohol 3.18 (19.2 g, 97%) as a colorless 
viscous liquid (mixture of two epimers).  






A solution of oxalyl chloride (4.8 mL, 54.6 mmol) in DCM (200 mL) was cooled to 
-78 oC, treated with DMSO ( 8.3 mL, 116.4 mmol) dropwise over 10 min, stirred for 10 
min., treated with a solution of the alcohol 3.18 ( 24.5 g, 36.4 mmol) in DCM (50 mL) 
over 20 min, stirred for 30 min, treated with triethylamine (25.4 mL, 181.9 mmol) over 
15 min, warmed to reach 0 oC, stirred for 2 h, warmed to rt, treated with water (50 mL) 
and stirred for 1 h. The organic layer was separated, dried over anhydrous Na2SO4 and 
evaporated under reduced pressure to afford 3.19 (21.7 g, 89%) as a colorless liquid after 
flash column chromatography using ethyl acetate/ hexane (1:19) as eluant.  
[α]D20 -18.2 (c 1, CHCl3).    
1H NMR (400 MHz CDCl3):  δ 7.86 – 7.76 (m, 2H), 7.66 – 7.58 (m, 2H), 7.53 (m, 2H), 
7.42 (m, 1H), 7.40 – 7.32 (m, 3H), 7.26 (m, 2H), 6.84 (d, J = 8.9 Hz, 2H), 5.57 (d, J = 1.9 
Hz, 1H), 5.23 (d, J = 1.2 Hz, 1H), 4.72 (q, J = 6.6 Hz, 1H), 4.63 (s, 1H), 4.34 (dd, J = 
15.5, 35.8 Hz, 2H), 3.87 (s, 3H), 2.27 (s, 3H), 1.24 (d, J = 6.6 Hz, 3H), 1.02 (s, 9H), 0.92 
(t, J = 7.9 Hz, 9H), 0.56 (q, J = 7.9 Hz, 6H)  
13C NMR (100 MHz CDCl3): δ 211.6, 164.4, 162.3, 147.7, 135.7, 135.5, 133.9, 133.7, 
130.3, 130.0, 129.5, 127.7, 120.4, 114.2, 113.7, 88.7, 80.7, 80.4, 63.4, 55.5, 31.5, 27.0, 
19.4, 17.9, 7.0, 4.8. 





A solution of olefin 3.19 (5.0 g, 7.5 mmol) in DCM (200 mL) was treated with O3 gas 
bubbles at -78 oC until a blue color was observed. The excess O3 gas was purged with 
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argon gas. The ozonide was decomposed with Me2S (6 mL, 75 mmol) at -78 oC. The 
mixture was stirred overnight at rt. The solvent was removed under reduced pressure and 
the residue was purified by flash column chromatography using ethyl acetate/hexane 
(1:19) as eluant to afford the diketone 3.20 (3.75 g, 75%) as a colorless viscous liquid.  
[α]D20 27.0 (c 1, CHCl3).  
1H NMR (400 MHz CDCl3): δ 7.94 (d, J = 8.8 Hz, 2H), 7.65 (ddd, J = 1.4, 7.9, 17.8 Hz, 
4H), 7.52 – 7.31 (m, 6H), 7.02 – 6.78 (m, 2H), 5.34 (q, J = 6.7 Hz, 1H), 4.67 (s, 1H), 4.50 
(dd, J = 18.4, 47.7 Hz, 2H), 3.88 (s, 3H), 2.25 (s, 3H), 1.30 (d, J = 6.7 Hz, 3H), 1.04 (s, 
9H), 0.78 (t, J = 7.9 Hz, 9H), 0.42 (q, J = 7.8 Hz, 6H).  
13C NMR (100 MHz CDCl3): δ 210.4, 208.1, 165.9, 162.6, 135.8, 133.2, 133.1, 130.5, 
130.0, 129.9, 127.9, 120.1, 113.9, 88.1, 78.9, 76.3, 69.2, 60.6, 55.6, 30.5, 26.9, 19.5, 17.6, 
14.4, 6.8, 4.8. 






To a magnetically stirred solution of diketone 3.20 (1.0 g, 1.5 mmol) in anhydrous 
DCM (50 mL), diisopropyl ethylamine (1 mL, 4.6 mmol) and TMSCl (10 drop) were 
added at 0 oC and the mixture was stirred for 5 min. at 0 oC, treated with TiCl4 (1.8 mL, 
1.0 M in DCM) dropwise and stirred for 15 min. The reaction mixture was quenched with 
cold water (30 mL) and extracted with ether (60 mL x 2), the combined organic layers 
were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude 
product was purified by flash column chromatograhpy, eluting with ethyl acetate/hexane 
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(2:8), to give the hydroxy ketone 3.21 with minor enone product 3.22 (which was 
characterized in the next step. 
1H NMR (400 MHz CDCl3): δ 7.85 (d, J = 8.8 Hz, 2H), 7.73 – 7.66 (m, 4H), 7.50 – 7.39 
(m, 7H), 6.89 (d, J = 8.8 Hz, 2H), 4.85 (q, J = 6.6 Hz, 1H), 4.50 (s, 1H), 4.02 (d, J = 10.2 
Hz, 1H), 3.86 (s, 3H), 3.78 (s, 1H), 3.46 (d, J = 10.3 Hz, 1H), 2.74 (dd, J = 19.7, 131.9 
Hz, 2H), 1.12 (s, 9H), 1.05 (d, J = 6.6 Hz, 3H), 0.83 (t, J = 7.9 Hz, 9H), 0.52 (q, J = 8.0 
Hz, 6H).  
13C NMR (100 MHz CDCl3): δ 211.2, 165.5, 162.5, 135.9, 135.8, 132.8, 132.7, 130.5, 
130.3, 130.2, 128.2, 128.1, 119.6, 113.8, 85.0, 82.2, 78.0, 76.9, 66.5, 55.5, 48.2, 27.1, 
19.5, 17.1, 6.8, 5.0. 




A solution of hydroxy ketone (2.0 g, 2.6 mmol) in DCM (10 mL) was treated with 
pyridine (2.5 mL) and trichloroacetyl chloride (0.6 mL, 5.3 mmol) dropwise at rt and 
stirred for overnight. The reaction mixture was diluted with ether and washed with 
CuSO4 (10% solution) until constant color persisted. The organic layer was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified by 
flash column chromatography using ethyl acetate/hexane (1:19) as eluant to afford the 
cyclopentenone 3.22 (1.29 g, 75%, two steps) as a colorless viscous liquid. 
 [α]D20  108.8 (c 1, CHCl3). 
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1H NMR (400 MHz CDCl3): δ 7.92 (d, J = 8.7 Hz, 2H), 7.68 (t, J = 7.8 Hz, 4H), 7.57 – 
7.34 (m, 6H), 6.90 (d, J = 8.8 Hz, 2H), 6.54 (s, 1H), 5.12 (q, J = 6.5 Hz, 1H), 4.99 (s, 1H), 
4.56 (dd, J = 18.9, 81.6 Hz, 1H), 3.81 (s, 3H), 1.35 (d, J = 6.6 Hz, 3H), 1.13 (s, 9H), 0.76 
(t, J = 7.9 Hz, 10H), 0.54 – 0.33 (m, 6H).  
13C NMR (100 MHz CDCl3): δ 200.5, 178.1, 166.5, 162.4, 135.5, 135.4, 132.8, 132.7, 
130.3, 130.1, 128.0, 127.8, 119.9, 113.7, 86.0, 77.6, 62.6, 55.4, 26.8, 19.4, 17.2, 6.6, 4.7. 





To a stirred solution of enone 3.22 (6.5 g, 9.9 mmol) in MeOH-DCM (100 mL, 8 mL) 
at 0 oC, H2O2 (30% in water, 28.2 mL) and NaOH (20% aqueous solution, 7 mL) were 
added dropwise together and the mixture was stirred for 30 min. The reaction mixture 
was quenched with saturated Na2SO3 solution (100 mL) and extracted with ether (100 
mL x 3). The organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash column chromatography using ethyl 
acetate/hexane (1:9) as eluant to afford the epoxy ketone 3.23 (5.1 g, 70%) as a colorless 
liquid.  
[α]D20  3.6 (c 1, CHCl3).  
1H NMR (400 MHz CDCl3): δ 7.90 (d, J = 4.4 Hz, 2H), 7.63-7-67 (m, 4H), 7.28-7.48 (m, 
6H), 6.89 (d, J = 4.4 Hz, 2H), 5.22 (q, J = 4.1 Hz, 1H), 4.63 (s. 1H), 3.99 (dd, J = 85.2, 
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8.3 Hz, 2H), 3.86 (s. 3H), 3.24 (s, 1H), 1.23 (d, J = 3.3 Hz, 3H), 1.08 (s, 9H), 0.82 (t, J = 
2.7 Hz, 9H), 0.51 (q, J = 4.0 Hz, 6H). 
13C NMR (100 MHz CDCl3): δ 204.0, 165.9, 161.9, 135.3, 135.1, 132.2, 132.1, 130.0, 
129.8, 129.7, 127.6, 127.4, 119.5, 113.2, 82.5, 74.3, 69.0, 59.1, 58.3, 55.0, 29.3, 26.4, 
18.8, 16.2, 6.2, 4.4, 4.3. 





To a magnetically stirred solution of epoxy ketone 3.23 (540 mg, 0.84 mmol) in 
MeOH-DCM (10 mL, 1:1) at 0 oC, NaBH4 (32 mg, 0.84 mmol) was added portion-wise 
and stirred for 1 h. The reaction mixture was quenched with saturated aqueous NH4Cl (5 
mL) and extracted with ethyl acetate (5 mL x 3). The combined organic layers were dried 
over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was 
purified by flash column chromatography using ethyl acetate/hexane (1:9) as eluant to 
afford the epoxy alcohol 3.24 (500 mg, 92%) as a viscous liquid.  
[α]D20  36.4 (c 1, CHCl3).   
1H NMR (400 MHz CDCl3): δ 7.69 (t, J = 6.9 Hz, 6H), 7.53 – 7.32 (m, 6H), 6.86 (d, J = 
8.7 Hz, 2H), 5.13 (q, J = 6.7 Hz, 1H), 5.06 (s, 1H), 4.54 (s, 1H), 4.21 (s, 1H), 4.15 (d, J = 
11.7 Hz, 1H), 3.86 (s, 3H), 3.71 (d, J = 11.7 Hz, 1H), 3.39 (s, 1H), 1.52 (d, J = 6.8 Hz, 
3H), 1.11 (s, 9H), 0.79 (t, J = 7.9 Hz, 9H), 0.45 (dd, J = 7.8, 15.0 Hz, 6H).  
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13C NMR (100 MHz CDCl3): δ 165.1, 162.3, 135.9, 135.7, 133.4, 133.1, 130.5, 130.2, 
130.1, 128.0, 120.2, 113.7, 79.7, 77.8, 77.3, 77.0, 63.4, 60.3, 58.4, 55.5, 27.1, 19.4, 17.2, 
6.8, 5.0. 






To a solution of pyridine (5 mL) in anhydrous DCM (50 mL) at -78 oC, triflic 
anhydride (1.5 mL, 2 equiv.) was added dropwise. The mixture was stirred for 15 min, 
treated with a solution of epoxy alcohol 3.24 (2.90 g, 10.6 mmol) in DCM (5 mL) and 
stirred at 0 oC until the triflate was totally formed (no more starting material). The 
mixture was then quenched with a saturated solution of NaHCO3 (20 mL), diluted with 
ether (100 mL), and washed with CuSO4 (10% solution) until a persistent color, followed 
by H2O (20 mL) and brine (20 mL). The organic layer was dried over Na2SO4, 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel using ethyl acetate/hexane (1:9) as eluant to give the triflate 3.25 as a pale 
yellow oil. 
1H NMR (400 MHz CDCl3): δ 7.88 (d, J = 8.9 Hz, 2H), 7.67 (m, 4H), 7.59 – 7.37 (m, 
6H), 6.93 (d, J = 8.9 Hz, 2H), 5.41 (s, 1H), 5.21 (q, J = 6.9 Hz, 1H), 4.39 (s, 1H), 4.21 (d, 
J = 11.8 Hz, 1H), 3.88 (s, 3H), 3.55 (d, J = 11.9 Hz, 1H), 3.20 (s, 1H), 1.56 (d, J = 6.9 Hz, 
3H), 1.12 (s, 9H), 0.85 (t, J = 7.9 Hz, 9H), 0.53 (m, 6H). 
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13C NMR (100 MHz CDCl3): δ 165.1, 162.4, 135.8, 135.7, 132.9, 130.5, 130.3, 130.2, 
128.2, 120.3, 113.9, 91.7, 78.9, 75.8, 64.8, 59.9, 56.1, 55.6, 27.1, 19.4, 17.2, 6.8, 5.0. 






A solution of epoxy triflate in toluene (120 mL), was treated with activated 4Å 
molecular sieves (4 g, flame dried) and tetrabutylammonium azide (5.1 g, 5.0 equiv.), 
stirred for 7 days, and filtered. The filtrate was treated with H2O (50 mL) and extracted 
with ether (50 mL x 3). The combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
on silica gel using ethyl acetate/hexane (5:95) as eluant to afford azide 3.26 (2.4 g, 85%) 
as a white foam.  
IR 1645.7, 2110.2 cm-1.  
[α]D20 -44.4 (c 1, CHCl3).  
1H NMR (400 MHz CDCl3): δ  7.96 (d, J = 8.2 Hz, 2H), 7.72 (t, J = 7.5 Hz, 4H), 7.63 – 
7.37 (m, 6H), 6.94 (d, J = 8.3 Hz, 2H), 5.16 (q, J = 6.1 Hz, 1H), 4.66 (s, 1H), 4.17 (d, J = 
13.2 Hz, 2H), 3.87 (s, 3H), 3.61 (d, J = 11.7 Hz, 1H), 3.25 (s, 1H), 1.31 (t, J = 10.8 Hz, 
3H), 1.13 (s, 9H), 0.83 (t, J = 7.8 Hz, 9H), 0.50 (q, J = 5.3 Hz, 6H).  
13C NMR (100 MHz CDCl3): δ 163.9, 162.2, 136.0, 135.7, 133.3, 132.9, 130.4, 130.1, 











TFA : MeCN: H2O
(2:8:1)











Azido-epoxide 3.26 (2.4 g, 3.5 mmol) was dissolved in a 2:8:1 mixture of 
TFA:MeCN:H2O (80 mL) at 0 oC and stirred at rt untill no more starting material (5 h). 
The reaction mixture was slowly neutralized with a saturated solution of NaHCO3 (100 
mL) at 0 oC. The reaction mixture was extracted with ethyl acetate (150 mL x 3), the 
combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure, the residue was purified by flash chromatography on silica gel using ethyl 
acetate/hexane (4:6) as eluant to afford 3.27 (2.0 g, 99%) as a colorless foam.  
[α]D20 -75.3 (c 1, CHCl3).   
1H NMR (400 MHz CDCl3): δ 7.95 (d, J = 8.9 Hz, 2H), 7.71 (m, 4H), 7.62 – 7.36 (m, 
6H), 6.92 (d, J = 8.9 Hz, 2H), 5.20 (q, J = 6.5 Hz, 1H), 4.67 (d, J = 3.3 Hz, 1H), 4.19 (s, 
1H), 4.08 (d, J = 11.9 Hz, 1H), 3.96 (d, J = 11.9 Hz, 1H), 3.86 (s, 3H), 3.38 (d, J = 0.7 Hz, 
1H), 2.80 (s, br, 1H), 1.36 (d, J = 6.6 Hz, 4H), 1.09 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 164.4, 162.5, 135.8, 132.6, 130.6, 130.2, 128.1, 120.2, 
113.8, 81.3, 78.0, 65.8, 63.1, 62.7, 56.9, 55.6, 27.0, 19.4, 17.2.  






To a stirred solution of azide epoxy alcohol 3.27 (5.25 g, 9.0 mmol) in DCM (70 mL) 
was added Dess-Martin periodinane (5.75 g, 13.5 mmol) at 0 oC and the reaction mixture 
was stirred at rt for 2 h. The reaction mixture was quenched with Na2S2O3/NaHCO3 (7:1) 
saturated solution (30 mL). The mixture was stirred vigorously until the two layers were 
clear. The crude product was extracted with ether (50 mL x 3). The combined organic 
layers were washed with brine, dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash column chromatography using ethyl 
acetate/hexane (1:9) as eluant, to afforded the ketone 3.28 (3.3 g, 79%) as a colorless 
viscous foam.  
[α]D20 -143.0 (c 1, CHCl3).  
1H NMR (400 MHz CDCl3): δ 8.24 – 7.89 (m, 2H), 7.68 (m, 4H), 7.59 – 7.37 (m, 6H), 
7.06 – 6.74 (m, 2H), 4.69 (q, J = 6.5 Hz, 1H), 4.46 (s, 1H), 4.19 (q, J = 12.9 Hz, 2H), 
4.11 (d, J = 0.8 Hz, 1H), 3.87 (s, 3H), 1.48 (d, J = 6.5 Hz, 3H), 1.07 (s, 9H). 
13C NMR (100 MHz CDCl3): δ 204.1, 166.9, 162.9, 135.8, 135.7, 132.8, 132.6, 130.8, 
130.1, 128.1, 128.0, 119.4, 113.9, 82.7, 81.7, 62.9, 59.9, 59.6, 56.8, 55.6, 26.9, 19.4, 17.7. 







To a stirred solution of azide epoxy ketone 3.28 (4.1 g, 6.9 mmol) in anhydrous THF 
(70 mL), MeMgBr (3.0 M solution in ether, 5 equiv. max) was added at -78 oC and 
stirred for 30 min. The reaction was quenched with saturated aqueous NH4Cl solution (50 
mL) and stirred further for 30 min, then extracted with ethyl acetate (50 mL x 3). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash column chromatography using ethyl 
acetate/hexane (2:8) as eluant to afford 3.29 (2.8 g, 97%) as a foam.  
[α]D20 -54.8 (c 1, CHCl3).  
1H NMR (400 MHz CDCl3): δ  7.98 (d, J = 8.8 Hz, 2H), 7.73 (dd, J = 1.5, 7.7 Hz, 4H), 
7.61 – 7.39 (m, 6H), 6.93 (d, J = 8.9 Hz, 2H), 5.33 (q, J = 6.5 Hz, 1H), 4.39 (d, J = 12.1 
Hz, 1H), 4.10 (s, 1H), 3.87 (s, 3H), 3.76 (d, J = 12.1 Hz, 1H), 3.45 (d, J = 0.5 Hz, 1H), 
3.12 (s, 1H), 1.55 (s, 3H), 1.38 (d, J = 6.6 Hz, 3H), 1.10 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 165.3, 163.9, 137.5, 139.1, 139.0, 133.0, 132.3, 132.2, 
129.9, 122.5, 115.6, 88.1, 83.3, 81.8, 74.2, 64.0, 61.4, 57.5, 30.0, 35.2, 21.6.  







To a solution of 3.29 (3.84 g, 6.4 mmol) in THF (40 mL) was added AcOH (7.7 mL, 1 
equiv.) first, then TBAF (7.7 mL, 1.0 M in THF, 1.2 equiv.) was added at 0 oC. The 
mixture was stirred at rt till no more starting material. Saturated NH4Cl (20 mL) was then 
added and 5 min. later, H2O (25 mL) was added, the mixture was extracted with ethyl 
acetate (30 mL x 3), the combined organic layers were dried over Na2SO4, concentrated 
under reduced pressure. The residue was purified by flash chromatography on silica gel 
using ethyl acetate/hexane (5:5) to give the desired product 3.30 (2.3 g, 99%) as a 
colorless oil. 
[α]D20 -71.5 (c 1, CHCl3). 
1H NMR (400 MHz CDCl3): δ 7.95 (d, J = 8.8 Hz, 2H), 6.93 (d, J = 8.8 Hz, 2H), 5.15 (q, 
J = 6.6 Hz, 1H), 4.26 (d, J = 12.7 Hz, 1H), 4.06 (s, 1H), 3.85 (s, 3H), 3.63 (s, 1H), 2.52 (s, 
1H), 2.36 (s, br,1H), 1.49 (s, 3H), 1.38 (d, J = 6.6 Hz, 3H).  
13C NMR (100 MHz CDCl3 ): δ 163.9, 162.5, 130.5, 120.2, 113.9, 86.9, 80.7, 79.2, 70.2, 
62.6, 59.8, 59.3, 55.6, 21.1, 17.6.  







To a stirred solution of epoxy alcohol 3.30 (2.28 g, 6.5 mmol) in AcOH (50 mL), was 
added Zn(OTf)2 (4.7 g, 12.9 mmol). After stirred at 80 oC for 2 days, another portion 
Zn(OTf)2 (2.4 g, 1 equiv.) was added, the reaction mixtures was stirred till no more 
starting material. The reaction mixture was cooled to 0 oC, then quenched with saturated 
NaHCO3 (100 mL), extracted with ethyl acetate (80 mL x 3). The combined organic 
layers were dried over Na2SO4, concentrated under reduced pressure. The residue was 
purified by flash chromatography on silica gel, eluting with ethyl acetate/hexane (1:9 to 
1:1), to afford a solid diacetate 3.32 (1.8 g, 60%）as the major product and minor 
monoacetate product 3.31 (300 mg, 11%).  
Melting point: 95.1-96.9 oC 
1H NMR (400 MHz CDCl3 ): δ 7.86 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.8 Hz, 2H), 5.64 (d, 
J = 6.0 Hz, 1H), 5.59 (s, 1H), 4.88 (q, J = 6.6 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 4.26 (d, 
J = 11.9 Hz, 1H), 3.89 (d, J = 6.0 Hz, 1H), 3.85 (s, 3H), 3.26 (s, 1H), 2.14 (d, J = 3.8 Hz, 
7H), 1.57 (d, J = 6.6 Hz, 3H), 1.24 (s, 4H). 
13C NMR (100 MHz CDCl3): δ 172.5, 169.9, 164.7, 163.0, 130.7, 118.7, 114.0, 85.3, 83.0, 
82.6, 81.8, 78.8, 68.2, 63.8, 55.6, 21.2, 21.0, 17.5, 17.0. 







The diacetate 3.32 (1.79 g, 3.9 mmol) was dissolved in MeOH (20 mL), then K2CO3 
(1.6 g, 11.4 mmol) was added at rt. After strirred 30 min., the reaction mixture was 
quenched with a saturated solution of NH4Cl (20 mL), extracted with ethyl acetate (20 
mL x 3). The combined organic layers were dried over anhydrous Na2SO4, concentrated 
under reduced pressure, and the residue was purified by flash chromatography on silica 
gel using ethyl acetate/hexane (3:7) as eluant to afford tetrol 3.33 (1.39 g, 95%) as a 
colorless foam. (The monoacetate 3.31 was treated in the same way to afford 3.33). 
[α]D20 55 (c 1, CHCl3). 
1H NMR (400 MHz CDCl3 ): δ 7.87 (d, J = 8.8 Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 5.71 
(s,br, 1H), 4.90 (q, J = 6.5 Hz, 1H), 4.54 (d, J = 4.6 Hz, 1H), 4.34 (s,br, 1H), 4.05 (dd, J = 
8.0 Hz, 17.9, 2H), 3.95 (d, J = 5.5 Hz, 2H), 3.85 (s, 3H), 3.74 (s, br, 1H), 1.58 (d, J = 6.5 
Hz, 3H), 1.25 (s, 3H).  
13C NMR (100 MHz CDCl3): δ 164.3, 163.0, 131.0, 119.0, 114.0, 85.1, 84.4, 83.7, 81.5, 
78.9, 70.5, 63.2, 55.6, 17.3. 





A solution of tetrol 3.33 (1.34 g, 3.5 mmol) in DCM (60 mL) was added 
triethylamine (2.5 mL. 17.7 mmol, 5.0 equiv.), DMAP (43 mg, 10 mol%) and TBDPSCl 
(1.4 mL, 5.3 mmol, 1.50 equiv.) at 0 oC. The reaction mixture was stirred at rt until there 
was total conversion of the starting material. The reaction mixture was quenched with a 
saturated solution of NH4Cl (20 mL) and extracted with ethyl acetate (20 mL x 3). The 
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combined organic layers were dried over Na2SO4, concentrated under reduced pressure, 
and the residue was purified by flash chromatography on silica gel using ethyl 
acetate/hexane (4:6) as eluant to give 3.34 (2.05 g, 94%) as a white solid.  
[α]D20 41.2 (c 1.43, CHCl3). 
1H NMR (400 MHz CDCl3 )：δ 7.88 (d, J = 8.8 Hz, 2H), 7.84 – 7.78 (m, 2H), 7.74 (m, 
2H), 7.57 – 7.38 (m, 6H), 6.94 (d, J = 8.8 Hz, 2H), 5.55 (s, 1H), 4.93 (q, J = 6.6 Hz, 1H), 
4.56 (t, J = 5.6 Hz, 1H), 4.11 (q, J = 11.0 Hz, 2H), 3.98 (d, J = 4.9 Hz, 1H), 3.87 (s, 3H), 
3.64 (s, 1H), 3.38 (d, J = 6.3 Hz, 1H), 1.60 (d, J = 6.6 Hz, 3H), 1.17 (s, 3H), 1.13 (s, 9H).   
13C NMR (100 MHz) δ 164.0, 162.9, 136.0, 135.8, 132.1, 131.6, 130.7, 130.4, 128.2, 
119.1, 114.0, 85.4, 85.2, 84.3, 80.9, 78.9, 71.0, 66.2, 55.6, 27.1, 19.3, 17.5, 17.3. 




To a solution of triol 3.34 (2.0 g, 3.3 mmol) in anhydrous DCM (15 mL) was added 
pyridine (2 mL) and triflic anhydride (1.7 mL, 9.9 mmol, 3 equiv.) at 0 oC. The reaction 
was then continued at 0 oC until all the triflate was converted in situ to the epoxide. The 
reaction mixture was quenched with a saturated solution of NaHCO3 (10 mL) and kept it 
at 0 oC for 30 min, and extracted with DCM (10 mL x 3). The combined organic layers 
were dried over Na2SO4, concentrated under reduced pressure. The residue was purified 
by flash chromatography on silica gel using ethyl acetate/hexane (2:8) as eluant to give 
3.35 (1.8 g, 93%) as a turbid oil.  
[α]D20 102.7 (c 1, CHCl3).   
138 
 
1H NMR (400 MHz CDCl3 ): δ 7.90 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 6.7 Hz, 3H), 7.56 – 
7.32 (m, 7H), 7.35 – 7.23 (m, 3H), 7.17 (t, J = 7.9 Hz, 1H), 6.92 (dd, J = 8.4, 14.9 Hz, 
3H), 6.81 (s, 1H), 6.65 (dd, J = 1.9, 8.1 Hz, 1H) 5.65 (s, 1H), 5.32 (s, 1H), 5.04 (m, 1H), 
4.98 (q, J = 7.2 Hz, 1H), 4.91 (s, 1H), 4.48 (d, J = 9.2 Hz, 1H), 4.43 – 4.33 (m, 1H), 4.16 
(d, J = 11.2 Hz, 1H), 3.97 (d, J = 6.6 Hz, 1H), 3.87 (s, 3H), 3.84 (d, J = 11.1 Hz, 1H), 
2.11 (s, 3H), 1.61 (d, J = 6.5 Hz, 4H), 1.19 (s, 3H), 1.12 (s, 9H).  
13C NMR (100 MHz CDCl3): δ 164.3, 162.4, 135.7, 132.0, 131.6, 130.8, 130.6, 130.5, 
128.2, 120.2, 113.7, 83.7, 81.0, 78.5, 62.8, 62.7, 62.5, 55.5, 27.0, 19.2, 17.7. 






To a stirred solution of epoxyalcohol 3.35 (1.75 g, 2.9 mmol) in toluene (50 mL) at rt, 
the aniline derivative (3.9 g, 29.3 mmol, 10 equiv.) and Yb(OTf)3 (0.91 g, 1.5 mmol, 0.50 
equiv.) were added and heated at 80 oC for 5 h. The reaction mixture was cooled to rt, 
quenched with water (10 mL) and extracted with DCM (10 mL x 3). The combined 
organic layers were dried over anhydrous Na2SO4 and concentrated under reduced 
pressure. The residue was purified by flash column chromatography using ethyl 
acetate/hexane (3:17) as eluant to afford the amino alcohol 3.36 (1.55 g, 72%) as a pale 
yellow viscous liquid.  
[α]D20 6.7 (c 1, CHCl3).   
139 
 
1H NMR (400 MHz CDCl3): δ 7.90 (d, J = 8.5 Hz, 2H), 7.66 (d, J = 6.7 Hz, 3H), 7.56 – 
7.32 (m, 7H), 7.35 – 7.23 (m, 3H), 7.17 (t, J = 7.9 Hz, 1H), 6.92 (dd, J = 8.4, 14.9 Hz, 
3H), 6.81 (s, 1H), 6.65 (dd, J = 1.9, 8.1 Hz, 1H) 5.65 (s, 1H), 5.32 (s, 1H), 5.04 (m, 1H), 
4.98 (q, J = 7.2 Hz, 1H), 4.91 (s, 1H), 4.48 (d, J = 9.2 Hz, 1H), 4.43 – 4.33 (m, 1H), 4.16 
(d, J = 11.2 Hz, 1H), 3.97 (d, J = 6.6 Hz, 1H), 3.87 (s, 3H), 3.84 (d, J = 11.1 Hz, 1H), 
2.11 (s, 3H), 1.61 (d, J = 6.5 Hz, 4H), 1.19 (s, 3H), 1.12 (s, 9H). 
13C NMR (100 MHz CDCl3) δ 164.3, 162.9, 147.2, 143.8, 142.7, 136.0, 135.8, 131.3, 
130.7, 130.5, 130.2, 129.5, 128.2, 128.1, 119.2, 115.6, 114.0, 112.3, 112.2, 111.0, 84.8, 
80.4, 78.9, 71.2, 68.3, 66.7, 55.6, 27.1, 22.0, 19.2, 17.6, 17.3. 
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      Table 1.  Crystal data and structure refinement for C12 H15 N O2.  
   
   
      Identification code               HAN435  
   
      Empirical formula                 C12 H15 N O2  
   
      Formula weight                    205.25  
   
      Temperature                       220(2)K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Triclinic  
   
      Space group                       P-1  
   
      Unit cell dimensions              a =  6.6735(4) Å    α = 101.109(3)°  
                                        b =  7.6585(5) Å    β =  96.392(3)°  
                                        c = 13.2130(8) Å    γ = 112.598(3)°  
   
      Volume                            598.83(6)Å3  
   
      Z                                 2  
   
      Density (calculated)              1.138  g/cm^3  
   
      Absorption coefficient            0.624 mm-1  
   
      F(000)                            220  
   
      Crystal size                      0.32 x 0.19 x 0.10 mm  
   
      Theta range for data collection   3.48 to 71.87°  
   
      Index ranges                      -6 ≤ h ≤ 7, -9 ≤ k ≤ 9, -16 ≤ l ≤ 16  
   
      Reflections collected             6828  
   
      Independent reflections           2243 [Rint = 0.047]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.9400 and 0.5700  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    2243 / 0 / 162  
   
      Goodness-of-fit on F2             1.067  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0545, wR2 = 0.1473  
   
      R indices (all data)              R1 = 0.0574, wR2 = 0.1517  
   




         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C12 H15 N O2.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          O(1)         3050(2)      -2106(1)        152(1)       25(1)  
          O(2)        -2085(2)      -4126(1)       -328(1)       29(1)  
          O(3)         9302(2)       7806(2)       5106(1)       39(1)  
          N(1)         4019(2)       1967(2)       1463(1)       22(1)  
          C(1)         2465(2)         87(2)       1631(1)       20(1)  
          C(2)         1537(2)      -1402(2)        546(1)       19(1)  
          C(3)         -633(2)      -2962(2)        659(1)       23(1)  
          C(4)        -1588(2)      -1816(2)       1398(1)       27(1)  
          C(5)          350(2)        187(2)       1950(1)       26(1)  
          C(6)         3599(2)       -657(2)       2410(1)       28(1)  
          C(7)         5418(2)       3460(2)       2385(1)       22(1)  
          C(8)         7687(2)       4023(2)       2598(1)       26(1)  
          C(9)         9060(2)       5488(2)       3488(1)       28(1)  
          C(10)        8141(2)       6399(2)       4187(1)       27(1)  
          C(11)        5877(3)       5875(2)       3969(1)       38(1)  
          C(12)        4528(3)       4433(2)       3079(1)       37(1)  
          C(13)       11649(3)       8545(2)       5295(1)       40(1)  





         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C12 H15 N O2.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          H(1)         2900         -3124           330          37  
          H(2)        -2603         -3457          -599          43  
          H(1A)        4960(30)      1690(30)      1078(15)      32(4)  
          H(2A)        1144          -726            42          23  
          H(3)         -265         -3843          1027          27  
          H(4A)       -2177         -2521          1919          32  
          H(4B)       -2787         -1636           995          32  
          H(5A)          88          1241          1724          31  
          H(5B)         500           438          2717          31  
          H(6A)        4885          -760          2175          42  
          H(6B)        2568         -1933          2447          42  
          H(6C)        4064           251          3101          42  
          H(8)         8318          3401          2131          31  
          H(9)        10599          5857          3613          34  
          H(11)        5250          6509          4431          45  
          H(12)        2997          4106          2941          44  
          H(13A)      12096          7499          5360          60  
          H(13B)      12277          9582          5943          60  
          H(13C)      12178          9058          4713          60  





    Table 4.  Anisotropic parameters (Å2 x 103) for C12 H15 N O2.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    O(1)     28(1)      21(1)      28(1)       7(1)      13(1)      10(1)  
    O(2)     26(1)      20(1)      33(1)       3(1)      -5(1)       7(1)  
    O(3)     38(1)      37(1)      26(1)      -6(1)      -1(1)       7(1)  
    N(1)     23(1)      20(1)      19(1)       3(1)       5(1)       6(1)  
    C(1)     21(1)      20(1)      17(1)       5(1)       4(1)       7(1)  
    C(2)     22(1)      19(1)      17(1)       5(1)       4(1)       9(1)  
    C(3)     21(1)      20(1)      25(1)       6(1)       2(1)       7(1)  
    C(4)     22(1)      28(1)      31(1)      10(1)       9(1)      10(1)  
    C(5)     25(1)      30(1)      24(1)       4(1)       8(1)      12(1)  
    C(6)     29(1)      31(1)      22(1)      10(1)       2(1)      12(1)  
    C(7)     26(1)      20(1)      19(1)       4(1)       4(1)       7(1)  
    C(8)     28(1)      25(1)      23(1)       5(1)       6(1)      11(1)  
    C(9)     25(1)      28(1)      28(1)       6(1)       2(1)       8(1)  
    C(10)    32(1)      22(1)      20(1)       3(1)       2(1)       5(1)  
    C(11)    33(1)      35(1)      35(1)      -7(1)       9(1)      11(1)  
    C(12)    25(1)      35(1)      39(1)      -7(1)       6(1)       9(1)  
    C(13)    37(1)      37(1)      30(1)       2(1)      -7(1)       6(1)  





      Table 5.  Bond lengths [Å] and angles [°] for C12 H15 N O2  
    ______________________________________________________________________   
 
    O(1)-C(2)              1.4175(15)  
    O(2)-C(3)              1.4285(15)  
    O(3)-C(10)             1.3708(16)  
    O(3)-C(13)             1.419(2)  
    N(1)-C(7)              1.4324(16)  
    N(1)-C(1)              1.4915(15)  
    C(1)-C(6)              1.5299(17)  
    C(1)-C(2)              1.5391(16)  
    C(1)-C(5)              1.5422(18)  
    C(2)-C(3)              1.5275(17)  
    C(3)-C(4)              1.5392(18)  
    C(4)-C(5)              1.5467(19)  
    C(7)-C(8)              1.383(2)  
    C(7)-C(12)             1.3961(19)  
    C(8)-C(9)              1.3937(19)  
    C(9)-C(10)             1.387(2)  
    C(10)-C(11)            1.385(2)  
    C(11)-C(12)            1.382(2)  
   
    C(10)-O(3)-C(13)       117.33(12)  
    C(7)-N(1)-C(1)         116.86(10)  
    N(1)-C(1)-C(6)         112.28(10)  
    N(1)-C(1)-C(2)         106.95(9)  
 
 
    C(6)-C(1)-C(2)         110.83(10)  
    N(1)-C(1)-C(5)         112.87(10)  
    C(6)-C(1)-C(5)         111.18(11)  
    C(2)-C(1)-C(5)         102.18(10)  
    O(1)-C(2)-C(3)         115.65(10)  
    O(1)-C(2)-C(1)         114.75(10)  
    C(3)-C(2)-C(1)         105.01(10)  
    O(2)-C(3)-C(2)         113.37(10)  
    O(2)-C(3)-C(4)         115.00(11)  
    C(2)-C(3)-C(4)         104.37(10)  
    C(3)-C(4)-C(5)         106.43(10)  
    C(1)-C(5)-C(4)         106.76(10)  
    C(8)-C(7)-C(12)        118.01(12)  
    C(8)-C(7)-N(1)         121.39(12)  
    C(12)-C(7)-N(1)        120.57(12)  
    C(7)-C(8)-C(9)         121.66(13)  
    C(10)-C(9)-C(8)        119.60(13)  
    O(3)-C(10)-C(11)       115.79(13)  
    O(3)-C(10)-C(9)        125.07(14)  
    C(11)-C(10)-C(9)       119.14(13)  
    C(12)-C(11)-C(10)      120.92(14)  
    C(11)-C(12)-C(7)       120.61(14)  
   
    
______________________________________________________________________  
   
   





         Table 6.  Torsion angles [°] for C12 H15 N O2.  
  ______________________________________________________________________________   
 
  C(7)-N(1)-C(1)-C(6)      -46.15(15)  
  C(7)-N(1)-C(1)-C(2)     -167.94(10)  
  C(7)-N(1)-C(1)-C(5)       80.47(13)  
  N(1)-C(1)-C(2)-O(1)       73.96(12)  
  C(6)-C(1)-C(2)-O(1)      -48.73(14)  
  C(5)-C(1)-C(2)-O(1)     -167.25(10)  
  N(1)-C(1)-C(2)-C(3)     -157.93(10)  
  C(6)-C(1)-C(2)-C(3)       79.37(12)  
  C(5)-C(1)-C(2)-C(3)      -39.15(12)  
  O(1)-C(2)-C(3)-O(2)      -71.19(13)  
  C(1)-C(2)-C(3)-O(2)      161.25(10)  
  O(1)-C(2)-C(3)-C(4)      162.93(10)  
  C(1)-C(2)-C(3)-C(4)       35.38(12)  
  O(2)-C(3)-C(4)-C(5)     -142.16(11)  
  C(2)-C(3)-C(4)-C(5)      -17.32(13)  
  N(1)-C(1)-C(5)-C(4)      142.45(11)  
  C(6)-C(1)-C(5)-C(4)      -90.34(13)  
 
 
  C(2)-C(1)-C(5)-C(4)       27.94(13)  
  C(3)-C(4)-C(5)-C(1)       -6.86(14)  
  C(1)-N(1)-C(7)-C(8)      111.61(14)  
  C(1)-N(1)-C(7)-C(12)     -70.40(17)  
  C(12)-C(7)-C(8)-C(9)       1.3(2)  
  N(1)-C(7)-C(8)-C(9)      179.32(12)  
  C(7)-C(8)-C(9)-C(10)       0.7(2)  
  C(13)-O(3)-C(10)-C(11)  -172.79(14)  
  C(13)-O(3)-C(10)-C(9)      7.6(2)  
  C(8)-C(9)-C(10)-O(3)     177.58(12)  
  C(8)-C(9)-C(10)-C(11)     -2.1(2)  
  O(3)-C(10)-C(11)-C(12)  -178.21(15)  
  C(9)-C(10)-C(11)-C(12)     1.5(2)  
  C(10)-C(11)-C(12)-C(7)     0.5(3)  
  C(8)-C(7)-C(12)-C(11)     -1.9(2)  
  N(1)-C(7)-C(12)-C(11)   -179.95(14)  
   
  
______________________________________________________________________________  
   
   





   Table 7. Bond lengths [Å] and angles [°] related to the hydrogen  
   bonding for C12 H15 N O2.  
   ______________________________________________________________________  
   
        D-H         ..A       d(D-H)      d(H..A)     d(D..A)     <DHA  
   
     O(1)-H(1)      O(2)#1     0.83        1.96       2.7676(13)  163.4  
     O(2)-H(2)      N(1)#2     0.83        2.14       2.9686(15)  173.5  
     N(1)-H(1A)     O(1)#3     0.91(2)     2.20(2)    3.0405(14)  152.50(16)  
   
   ______________________________________________________________________  
   
    Symmetry transformations used to generate equivalent atoms:  
   





   
 
   
 
  ORTEP view of the C12 H15 N O2 compound with the numbering scheme  
  adopted. Ellipsoids drawn at 30% probability level. Hydrogen atoms are  
  represented by sphere of arbitrary size.  
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Structure  solved and refined in the laboratory of X-ray 





   
      Table 1.  Crystal data and structure refinement for C19 H22 Cl N O2.  
   
   
      Identification code               han446  
   
      Empirical formula                 C19 H22 Cl N O2  
   
      Formula weight                    331.83  
   
      Temperature                       100(2)K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Monoclinic  
   
      Space group                       C2/c  
   
      Unit cell dimensions              a = 33.7807(4) Å    α = 90°  
                                        b = 5.7461(1) Å    β = 133.992(1)°  
                                        c = 24.1148(3) Å    γ = 90°  
   
      Volume                            3367.58(10)Å3  
   
      Z                                 8  
   
      Density (calculated)              1.309  g/cm3  
   
      Absorption coefficient            2.077 mm-1  
   
      F(000)                            1408  
   
      Crystal size                      0.13 x 0.09 x 0.06 mm  
   
      Theta range for data collection   3.64 to 67.86°  
   
      Index ranges                      -40 ≤ h ≤ 40, -6 ≤ k ≤ 6, -27 ≤ l ≤ 26  
   
      Reflections collected             26556  
   
      Independent reflections           2813 [Rint = 0.032]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.8828 and 0.8382  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    2813 / 0 / 216  
   
      Goodness-of-fit on F2             1.063  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0304, wR2 = 0.0845  
   
      R indices (all data)              R1 = 0.0320, wR2 = 0.0857  
   




         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C19 H22 Cl N O2.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          Cl(1)       10439(1)      12602(1)       1127(1)       32(1)  
          O(1)         7519(1)       3904(1)        741(1)       24(1)  
          O(2)         7938(1)       5125(2)         92(1)       24(1)  
          N(1)         9023(1)       6203(2)       1044(1)       25(1)  
          C(1)         7941(1)       5651(2)       1099(1)       20(1)  
          C(2)         8267(1)       5047(2)        895(1)       20(1)  
          C(3)         8734(1)       6808(2)       1273(1)       21(1)  
          C(4)         9107(1)       6795(2)       2142(1)       27(1)  
          C(5)         8781(1)       7420(2)       2347(1)       28(1)  
          C(6)         8304(1)       5716(2)       1959(1)       25(1)  
          C(7)         7066(1)       4568(2)        648(1)       25(1)  
          C(8)         6962(1)       2815(2)       1000(1)       22(1)  
          C(9)         7335(1)       1097(2)       1506(1)       26(1)  
          C(10)        7215(1)       -491(2)       1807(1)       31(1)  
          C(11)        6716(1)       -383(2)       1599(1)       33(1)  
          C(12)        6345(1)       1352(3)       1103(1)       37(1)  
          C(13)        6464(1)       2939(3)        804(1)       30(1)  
          C(14)        9334(1)       7813(2)       1051(1)       22(1)  
          C(15)        9516(1)       7198(2)        696(1)       24(1)  
          C(16)        9849(1)       8661(2)        715(1)       24(1)  
          C(17)       10004(1)      10787(2)       1087(1)       24(1)  
          C(18)        9819(1)      11472(2)       1424(1)       23(1)  
          C(19)        9484(1)       9994(2)       1404(1)       22(1)  





         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C19 H22 Cl N O2.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          H(2)         7753(7)       3830(30)      -120(11)      46(5)  
          H(1)         8830(6)       5250(30)       640(10)      27(4)  
          H(1A)        7764          7207           876          24  
          H(2A)        8426          3453          1090          24  
          H(3)         8571          8397          1072          26  
          H(4A)        9408          7932          2382          32  
          H(4B)        9273          5233          2348          32  
          H(5A)        9026          7357          2913          34  
          H(5B)        8636          9025          2173          34  
          H(6A)        8451          4139          2175          30  
          H(6B)        8082          6191          2069          30  
          H(7A)        6731          4728            92          30  
          H(7B)        7145          6102           894          30  
          H(9)         7677          1002          1649          32  
          H(10)        7476         -1655          2157          37  
          H(11)        6630         -1489          1795          40  
          H(12)        6006          1456           967          44  
          H(13)        6206          4121           463          36  
          H(15)        9409          5745           438          29  
          H(16)        9971          8215           475          29  
          H(18)        9921         12947          1668          28  
          H(19)        9355         10472          1633          27  





    Table 4.  Anisotropic parameters (Å2 x 103) for C19 H22 Cl N O2.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    Cl(1)    32(1)      30(1)      41(1)       0(1)      28(1)      -6(1)  
    O(1)     24(1)      23(1)      29(1)      -5(1)      20(1)      -6(1)  
    O(2)     29(1)      24(1)      20(1)      -3(1)      17(1)      -6(1)  
    N(1)     28(1)      22(1)      33(1)      -5(1)      24(1)      -5(1)  
    C(1)     22(1)      18(1)      21(1)      -1(1)      15(1)      -3(1)  
    C(2)     22(1)      20(1)      19(1)       1(1)      14(1)      -1(1)  
    C(3)     22(1)      20(1)      24(1)       0(1)      16(1)      -1(1)  
    C(4)     22(1)      29(1)      24(1)       1(1)      14(1)      -3(1)  
    C(5)     28(1)      33(1)      19(1)      -4(1)      15(1)      -6(1)  
    C(6)     26(1)      28(1)      24(1)      -1(1)      18(1)      -3(1)  
    C(7)     23(1)      27(1)      28(1)       1(1)      19(1)       0(1)  
    C(8)     24(1)      25(1)      19(1)      -6(1)      15(1)      -6(1)  
    C(9)     32(1)      26(1)      29(1)      -1(1)      24(1)       1(1)  
    C(10)    46(1)      25(1)      33(1)       1(1)      32(1)       3(1)  
    C(11)    48(1)      33(1)      33(1)      -7(1)      34(1)     -11(1)  
    C(12)    31(1)      52(1)      34(1)      -3(1)      25(1)      -9(1)  
    C(13)    24(1)      41(1)      25(1)       2(1)      17(1)      -1(1)  
    C(14)    19(1)      21(1)      22(1)       3(1)      14(1)       2(1)  
    C(15)    25(1)      22(1)      25(1)      -1(1)      17(1)       1(1)  
    C(16)    24(1)      28(1)      25(1)       4(1)      18(1)       4(1)  
    C(17)    20(1)      24(1)      26(1)       5(1)      15(1)       0(1)  
    C(18)    21(1)      22(1)      22(1)       0(1)      13(1)      -1(1)  
    C(19)    21(1)      24(1)      22(1)       1(1)      15(1)       1(1)  





      Table 5.  Bond lengths [Å] and angles [°] for C19 H22 Cl N O2  
    ______________________________________________________________________   
 
    Cl(1)-C(17)            1.7497(12)  
    O(1)-C(7)              1.4352(14)  
    O(1)-C(1)              1.4407(14)  
    O(2)-C(2)              1.4118(17)  
    N(1)-C(14)             1.3917(16)  
    N(1)-C(3)              1.4577(16)  
    C(1)-C(6)              1.509(2)  
    C(1)-C(2)              1.5246(17)  
    C(2)-C(3)              1.5320(16)  
    C(3)-C(4)              1.520(2)  
    C(4)-C(5)              1.5298(19)  
    C(5)-C(6)              1.5295(17)  
    C(7)-C(8)              1.5077(18)  
    C(8)-C(9)              1.3838(19)  
    C(8)-C(13)             1.3971(18)  
    C(9)-C(10)             1.3901(19)  
    C(10)-C(11)            1.386(2)  
    C(11)-C(12)            1.383(2)  
    C(12)-C(13)            1.385(2)  
    C(14)-C(19)            1.3982(18)  
    C(14)-C(15)            1.4041(19)  
    C(15)-C(16)            1.3789(18)  
    C(16)-C(17)            1.3862(19)  
    C(17)-C(18)            1.3813(19)  
    C(18)-C(19)            1.3906(17)  
   
    C(7)-O(1)-C(1)         114.33(9)  
    C(14)-N(1)-C(3)        122.35(10)  
    O(1)-C(1)-C(6)         111.21(10)  
    O(1)-C(1)-C(2)         106.50(9)  
 
 
    C(6)-C(1)-C(2)         111.74(10)  
    O(2)-C(2)-C(1)         112.18(9)  
    O(2)-C(2)-C(3)         107.42(10)  
    C(1)-C(2)-C(3)         109.52(10)  
    N(1)-C(3)-C(4)         112.86(10)  
    N(1)-C(3)-C(2)         107.52(10)  
    C(4)-C(3)-C(2)         110.01(11)  
    C(3)-C(4)-C(5)         110.52(10)  
    C(6)-C(5)-C(4)         110.02(11)  
    C(1)-C(6)-C(5)         111.16(11)  
    O(1)-C(7)-C(8)         112.04(10)  
    C(9)-C(8)-C(13)        118.66(12)  
    C(9)-C(8)-C(7)         123.15(11)  
    C(13)-C(8)-C(7)        118.19(12)  
    C(8)-C(9)-C(10)        120.75(12)  
    C(11)-C(10)-C(9)       120.24(13)  
    C(12)-C(11)-C(10)      119.33(13)  
    C(11)-C(12)-C(13)      120.50(13)  
    C(12)-C(13)-C(8)       120.48(13)  
    N(1)-C(14)-C(19)       123.64(12)  
    N(1)-C(14)-C(15)       118.25(11)  
    C(19)-C(14)-C(15)      118.09(11)  
    C(16)-C(15)-C(14)      121.34(12)  
    C(15)-C(16)-C(17)      119.37(12)  
    C(18)-C(17)-C(16)      120.73(11)  
    C(18)-C(17)-CL1        120.23(10)  
    C(16)-C(17)-CL1        119.04(10)  
    C(17)-C(18)-C(19)      119.79(12)  
    C(18)-C(19)-C(14)      120.62(12)  
   
    
______________________________________________________________________  
   
     
   





         Table 6.  Torsion angles [°] for C19 H22 Cl N O2.  
  ______________________________________________________________________________  
 
  C(7)-O(1)-C(1)-C(6)       77.62(12)  
  C(7)-O(1)-C(1)-C(2)     -160.41(10)  
  O(1)-C(1)-C(2)-O(2)       62.10(12)  
  C(6)-C(1)-C(2)-O(2)     -176.27(9)  
  O(1)-C(1)-C(2)-C(3)     -178.72(9)  
  C(6)-C(1)-C(2)-C(3)      -57.09(13)  
  C(14)-N(1)-C(3)-C(4)     -81.32(15)  
  C(14)-N(1)-C(3)-C(2)     157.18(12)  
  O(2)-C(2)-C(3)-N(1)      -56.31(12)  
  C(1)-C(2)-C(3)-N(1)     -178.39(10)  
  O(2)-C(2)-C(3)-C(4)     -179.58(10)  
  C(1)-C(2)-C(3)-C(4)       58.34(13)  
  N(1)-C(3)-C(4)-C(5)     -179.48(10)  
  C(2)-C(3)-C(4)-C(5)      -59.40(13)  
  C(3)-C(4)-C(5)-C(6)       57.55(14)  
  O(1)-C(1)-C(6)-C(5)      175.05(10)  
  C(2)-C(1)-C(6)-C(5)       56.18(13)  
  C(4)-C(5)-C(6)-C(1)      -55.66(14)  
  C(1)-O(1)-C(7)-C(8)     -125.86(11)  
  O(1)-C(7)-C(8)-C(9)       14.56(18)  
  O(1)-C(7)-C(8)-C(13)    -165.51(12)  
 
 
  C(13)-C(8)-C(9)-C(10)      0.7(2)  
  C(7)-C(8)-C(9)-C(10)    -179.33(13)  
  C(8)-C(9)-C(10)-C(11)      0.4(2)  
  C(9)-C(10)-C(11)-C(12)    -1.5(2)  
  C(10)-C(11)-C(12)-C(13)    1.3(2)  
  C(11)-C(12)-C(13)-C(8)    -0.1(2)  
  C(9)-C(8)-C(13)-C(12)     -0.9(2)  
  C(7)-C(8)-C(13)-C(12)    179.17(14)  
  C(3)-N(1)-C(14)-C(19)     12.3(2)  
  C(3)-N(1)-C(14)-C(15)   -168.98(12)  
  N(1)-C(14)-C(15)-C(16)  -176.70(12)  
  C(19)-C(14)-C(15)-C(16)    2.10(19)  
  C(14)-C(15)-C(16)-C(17)   -0.41(19)  
  C(15)-C(16)-C(17)-C(18)   -1.35(19)  
  C(15)-C(16)-C(17)-CL1    178.55(10)  
  C(16)-C(17)-C(18)-C(19)    1.36(19)  
  CL1-C(17)-C(18)-C(19)   -178.54(9)  
  C(17)-C(18)-C(19)-C(14)    0.40(19)  
  N(1)-C(14)-C(19)-C(18)   176.65(12)  
  C(15)-C(14)-C(19)-C(18)   -2.08(19)  
   
  
______________________________________________________________________________  
   
         
   





   Table 7. Bond lengths [Å] and angles [°] related to the hydrogen  
   bonding for C19 H22 Cl N O2.  
   ______________________________________________________________________  
   
        D-H         ..A       d(D-H)      d(H..A)     d(D..A)     <DHA  
   
     O(2)-H(2)      O(1)#1     0.871(19)   1.91(2)    2.7329(12)  156.9(18)  
   
   ______________________________________________________________________  
   
    Symmetry transformations used to generate equivalent atoms:  
   





   
   
   
   
 
   
ORTEP view of the C19 H22 Cl N O2 compound with the numbering 
scheme adopted. Ellipsoids drawn at 50% probability level. 
Hydrogen atoms are represented by sphere of arbitrary size.  
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Structure solved and refined in the laboratory of X-ray 





      Table 1.  Crystal data and structure refinement for C12 H15 Cl N4 O.  
   
      Identification code               bent42  
   
 
      Empirical formula                 C12 H15 Cl N4 O  
   
      Formula weight                    266.73  
   
      Temperature                       150K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Monoclinic  
   
      Space group                       P21/c  
   
      Unit cell dimensions              a = 23.9893(4) Å    α = 90°  
                                        b = 5.0402(1) Å    β = 117.471(1)°  
                                        c = 23.3512(4) Å    γ = 90°  
   
      Volume                            2505.06(8)Å3  
   
      Z                                 8  
   
      Density (calculated)              1.414  g/cm3  
   
      Absorption coefficient            2.659 mm-1  
   
      F(000)                            1120  
   
      Crystal size                      0.21 x 0.14 x 0.09 mm  
   
      Theta range for data collection   2.08 to 72.40°  
   
      Index ranges                      -29 ≤ h ≤ 29, -6 ≤ k ≤ 6, -28 ≤ l ≤ 28  
   
      Reflections collected             27674  
   
      Independent reflections           4911 [Rint = 0.043]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.7872 and 0.4873  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    4911 / 1 / 335  
   
      Goodness-of-fit on F2             0.983  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0461, wR2 = 0.1214  
   
      R indices (all data)              R1 = 0.0598, wR2 = 0.1274  
   





         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C12 H15 Cl N4 O.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          Cl(1)        3002(1)      12607(1)      11511(1)       34(1)  
          C(11)        4297(1)       7401(4)       8459(1)       24(1)  
          C(12)        4448(1)       6826(4)       9160(1)       21(1)  
          C(13)        3975(1)       8140(4)       9342(1)       21(1)  
          C(14)        3311(1)       7187(4)       8876(1)       26(1)  
          C(15)        3149(1)       7930(4)       8184(1)       28(1)  
          C(16)        3619(1)       6702(5)       7987(1)       28(1)  
          C(17)        3853(1)       8712(4)      10341(1)       21(1)  
          C(18)        3454(1)      10903(4)      10100(1)       23(1)  
          C(19)        3195(1)      12106(4)      10461(1)       25(1)  
          C(110)       3332(1)      11104(5)      11062(1)       25(1)  
          C(111)       3724(1)       8935(5)      11311(1)       28(1)  
          C(112)       3980(1)       7731(4)      10952(1)       24(1)  
          N(11)        4422(1)      10295(4)       8428(1)       28(1)  
          N(12)        4522(1)      10858(4)       7965(1)       28(1)  
          N(13)        4618(1)      11598(4)       7558(1)       39(1)  
          N(14)        4162(1)       7592(3)      10020(1)       23(1)  
          O(11)        5083(1)       7454(3)       9591(1)       23(1)  
          Cl(2)        1994(1)       2335(1)       3392(1)       34(1)  
          C(21)         697(1)       7648(4)       -878(1)       23(1)  
          C(22)         549(1)       8211(4)       -319(1)       21(1)  
          C(23)        1028(1)       6913(4)        312(1)       21(1)  
          C(24)        1689(1)       7894(4)        465(1)       25(1)  
          C(25)        1847(1)       7163(4)        -78(1)       27(1)  
          C(26)        1371(1)       8381(4)       -716(1)       28(1)  
          C(27)        1148(1)       6301(4)       1422(1)       21(1)  
          C(28)        1552(1)       4118(4)       1560(1)       24(1)  
          C(29)        1809(1)       2906(4)       2161(1)       24(1)  
          C(210)       1665(1)       3854(4)       2631(1)       25(1)  
          C(211)       1267(1)       6006(5)       2508(1)       27(1)  
          C(212)       1015(1)       7233(4)       1913(1)       24(1)  
          N(21)         576(1)       4746(4)      -1028(1)       27(1)  
          N(22)         479(1)       4185(4)      -1584(1)       28(1)  
          N(23)         380(1)       3444(4)      -2082(1)       40(1)  
          N(24)         846(1)       7451(4)        815(1)       24(1)  
          O(21)         -83(1)       7537(3)       -484(1)       24(1)  





         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C12 H15 Cl N4 O.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          H(11A)       4587          6346          8348          28  
          H(12)        4402          4867          9192          26  
          H(13)        3994         10102          9289          25  
          H(14A)       3287          5237          8910          31  
          H(14B)       3004          8004          8994          31  
          H(15A)       3153          9885          8145          33  
          H(15B)       2720          7296          7889          33  
          H(16A)       3570          4749          7966          34  
          H(16B)       3525          7340          7551          34  
          H(18)        3357         11581          9685          28  
          H(19)        2927         13602         10295          30  
          H(111)       3816          8272         11727          33  
          H(112)       4245          6226         11121          29  
          H(11)        5151          9060          9549          35  
          H(14C)       4315(12)      6070(50)     10154(12)      34(7)  
          H(21A)        403          8694         -1263          28  
          H(22)         588         10172          -245          25  
          H(23)        1013          4950           243          25  
          H(24A)       1710          9844           521          30  
          H(24B)       2002          7087           874          30  
          H(25A)       1844          5209          -121          32  
          H(25B)       2273          7811            29          32  
          H(26A)       1462          7756         -1066          34  
          H(26B)       1416         10336          -690          34  
          H(28)        1651          3457          1237          28  
          H(29)        2083          1431          2248          29  
          H(211)       1168          6639          2834          32  
          H(212)        748          8727          1834          28  
          H(21)        -134          5895          -547          36  
          H(24C)        684(12)      8940(50)       801(12)      31(7)  





    Table 4.  Anisotropic parameters (Å2 x 103) for C12 H15 Cl N4 O.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    Cl(1)    33(1)      41(1)      36(1)      -4(1)      22(1)       5(1)  
    C(11)    30(1)      19(1)      26(1)      -2(1)      16(1)       1(1)  
    C(12)    22(1)      19(1)      24(1)       1(1)      11(1)      -1(1)  
    C(13)    21(1)      22(1)      21(1)       0(1)      10(1)      -1(1)  
    C(14)    20(1)      27(1)      28(1)      -3(1)      10(1)      -3(1)  
    C(15)    23(1)      29(1)      26(1)      -1(1)       7(1)      -2(1)  
    C(16)    36(1)      26(1)      23(1)      -4(1)      13(1)      -2(1)  
    C(17)    19(1)      20(1)      22(1)       0(1)       9(1)      -2(1)  
    C(18)    25(1)      23(1)      22(1)       2(1)      12(1)       2(1)  
    C(19)    21(1)      25(1)      29(1)       0(1)      12(1)       1(1)  
    C(110)   22(1)      31(1)      27(1)      -5(1)      14(1)      -1(1)  
    C(111)   32(1)      31(1)      23(1)       2(1)      15(1)       1(1)  
    C(112)   26(1)      22(1)      23(1)       3(1)      11(1)       1(1)  
    N(11)    39(1)      22(1)      29(1)       1(1)      21(1)       0(1)  
    N(12)    30(1)      25(1)      29(1)       3(1)      14(1)       1(1)  
    N(13)    48(1)      43(1)      33(1)       8(1)      23(1)      -2(1)  
    N(14)    25(1)      20(1)      25(1)       3(1)      14(1)       6(1)  
    O(11)    19(1)      19(1)      30(1)       2(1)      10(1)       0(1)  
    Cl(2)    33(1)      41(1)      25(1)       7(1)      11(1)       7(1)  
    C(21)    30(1)      17(1)      23(1)       1(1)      12(1)       0(1)  
    C(22)    21(1)      19(1)      22(1)       0(1)       9(1)       1(1)  
    C(23)    21(1)      21(1)      21(1)       0(1)       9(1)       2(1)  
    C(24)    22(1)      25(1)      27(1)      -1(1)       9(1)      -1(1)  
    C(25)    21(1)      27(1)      33(1)       1(1)      13(1)       0(1)  
    C(26)    35(1)      24(1)      31(1)       1(1)      20(1)      -1(1)  
    C(27)    19(1)      20(1)      23(1)      -1(1)       9(1)      -2(1)  
    C(28)    25(1)      23(1)      23(1)      -2(1)      12(1)       2(1)  
    C(29)    22(1)      24(1)      25(1)      -1(1)      10(1)       2(1)  
    C(210)   21(1)      29(1)      21(1)       1(1)       8(1)       0(1)  
    C(211)   28(1)      31(1)      22(1)      -4(1)      13(1)       0(1)  
    C(212)   24(1)      22(1)      25(1)      -2(1)      11(1)       2(1)  
    N(21)    38(1)      22(1)      23(1)      -1(1)      15(1)       0(1)  
    N(22)    30(1)      25(1)      29(1)      -3(1)      15(1)       1(1)  
    N(23)    49(1)      43(1)      33(1)     -12(1)      23(1)      -2(1)  
    N(24)    27(1)      23(1)      23(1)       1(1)      12(1)       7(1)  
    O(21)    19(1)      20(1)      31(1)      -1(1)       9(1)       1(1)  





      Table 5.  Bond lengths [Å] and angles [°] for C12 H15 Cl N4 O  
    ______________________________________________________________________  
  
 
    Cl(1)-C(110)           1.751(2)  
    C(11)-N(11)            1.498(3)  
 
    C(11)-C(16)            1.527(3)  
    C(11)-C(12)            1.532(3)  
    C(12)-O(11)            1.421(2)  
    C(12)-C(13)            1.533(3)  
    C(13)-N(14)            1.459(3)  
    C(13)-C(14)            1.534(3)  
    C(14)-C(15)            1.524(3)  
    C(15)-C(16)            1.532(3)  
    C(17)-N(14)            1.391(3)  
    C(17)-C(18)            1.399(3)  
    C(17)-C(112)           1.405(3)  
    C(18)-C(19)            1.395(3)  
    C(19)-C(110)           1.381(3)  
    C(110)-C(111)          1.382(3)  
    C(111)-C(112)          1.389(3)  
    N(11)-N(12)            1.243(2)  
    N(12)-N(13)            1.139(3)  
    Cl(2)-C(210)           1.753(2)  
    C(21)-N(21)            1.501(3)  
    C(21)-C(26)            1.527(3)  
    C(21)-C(22)            1.530(3)  
    C(22)-O(21)            1.422(2)  
    C(22)-C(23)            1.535(3)  
    C(23)-N(24)            1.455(3)  
    C(23)-C(24)            1.538(3)  
    C(24)-C(25)            1.524(3)  
    C(25)-C(26)            1.526(3)  
    C(27)-N(24)            1.386(3)  
    C(27)-C(28)            1.402(3)  
    C(27)-C(212)           1.405(3)  
    C(28)-C(29)            1.386(3)  
    C(29)-C(210)           1.379(3)  
    C(210)-C(211)          1.385(3)  
    C(211)-C(212)          1.381(3)  
    N(21)-N(22)            1.240(2)  
    N(22)-N(23)            1.138(3)  
   
    N(11)-C(11)-C(16)      111.10(18)  
    N(11)-C(11)-C(12)      106.41(16)  
    C(16)-C(11)-C(12)      112.13(18)  
    O(11)-C(12)-C(11)      111.21(17)  
    O(11)-C(12)-C(13)      113.38(16)  
    C(11)-C(12)-C(13)      111.94(17)  
     
 
    N(14)-C(13)-C(12)      108.84(17)  
    N(14)-C(13)-C(14)      114.19(17)  
    C(12)-C(13)-C(14)      109.02(17)  
    C(15)-C(14)-C(13)      110.52(18)  
    C(14)-C(15)-C(16)      110.79(18)  
    C(11)-C(16)-C(15)      112.10(17)  
    N(14)-C(17)-C(18)      122.74(18)  
    N(14)-C(17)-C(112)     118.92(19)  
    C(18)-C(17)-C(112)     118.18(19)  
    C(19)-C(18)-C(17)      120.98(19)  
    C(110)-C(19)-C(18)     119.4(2)  
    C(19)-C(110)-C(111)    121.0(2)  
    C(19)-C(110)-CL1       119.23(17)  
    C(111)-C(110)-CL1      119.78(17)  
    C(110)-C(111)-C(112)   119.7(2)  
    C(111)-C(112)-C(17)    120.8(2)  
    N(12)-N(11)-C(11)      112.84(18)  
    N(13)-N(12)-N(11)      174.0(2)  
    C(17)-N(14)-C(13)      122.22(17)  
    N(21)-C(21)-C(26)      111.22(18)  
    N(21)-C(21)-C(22)      106.54(16)  
    C(26)-C(21)-C(22)      112.38(18)  
    O(21)-C(22)-C(21)      111.29(17)  
    O(21)-C(22)-C(23)      113.08(16)  
    C(21)-C(22)-C(23)      111.85(17)  
    N(24)-C(23)-C(22)      108.83(17)  
    N(24)-C(23)-C(24)      114.46(17)  
    C(22)-C(23)-C(24)      108.81(17)  
    C(25)-C(24)-C(23)      110.69(18)  
    C(24)-C(25)-C(26)      110.74(18)  
    C(25)-C(26)-C(21)      111.94(18)  
    N(24)-C(27)-C(28)      122.91(19)  
    N(24)-C(27)-C(212)     119.12(19)  
    C(28)-C(27)-C(212)     117.83(19)  
    C(29)-C(28)-C(27)      121.14(19)  
    C(210)-C(29)-C(28)     119.6(2)  
    C(29)-C(210)-C(211)    120.6(2)  
    C(29)-C(210)-CL2       119.66(17)  
    C(211)-C(210)-CL2      119.77(16)  
    C(212)-C(211)-C(210)   119.98(19)  
    C(211)-C(212)-C(27)    120.9(2)  
    N(22)-N(21)-C(21)      112.97(17)  
    N(23)-N(22)-N(21)      173.9(2)  
    C(27)-N(24)-C(23)      122.53(18)  
   
    
______________________________________________________________________  
   





         Table 6.  Torsion angles [°] for C12 H15 Cl N4 O.  
  ______________________________________________________________________________  
  
 
  N(11)-C(11)-C(12)-O(11)  -59.2(2)  
  C(16)-C(11)-C(12)-O(11)  179.13(16)  
  N(11)-C(11)-C(12)-C(13)   68.8(2)  
  C(16)-C(11)-C(12)-C(13)  -52.9(2)  
  O(11)-C(12)-C(13)-N(14)  -51.1(2)  
  C(11)-C(12)-C(13)-N(14) -177.89(17)  
  O(11)-C(12)-C(13)-C(14) -176.23(16)  
  C(11)-C(12)-C(13)-C(14)   57.0(2)  
  N(14)-C(13)-C(14)-C(15)  177.93(17)  
  C(12)-C(13)-C(14)-C(15)  -60.1(2)  
  C(13)-C(14)-C(15)-C(16)   59.0(2)  
  N(11)-C(11)-C(16)-C(15)  -68.1(2)  
  C(12)-C(11)-C(16)-C(15)   50.8(2)  
  C(14)-C(15)-C(16)-C(11)  -54.0(2)  
  N(14)-C(17)-C(18)-C(19) -174.5(2)  
  C(112)-C(17)-C(18)-C(19)   0.9(3)  
  C(17)-C(18)-C(19)-C(110)  -0.5(3)  
  C(18)-C(19)-C(110)-C(111)  0.2(3)  
  C(18)-C(19)-C(110)-CL1  -179.56(17)  
  C(19)-C(110)-C(111)-C(112)-0.4(3)  
  CL1-C(110)-C(111)-C(112) 179.39(17)  
  C(110)-C(111)-C(112)-C(17) 0.8(3)  
  N(14)-C(17)-C(112)-C(111)174.5(2)  
  C(18)-C(17)-C(112)-C(111) -1.1(3)  
  C(16)-C(11)-N(11)-N(12)  -80.2(2)  
  C(12)-C(11)-N(11)-N(12)  157.54(19)  
  C(18)-C(17)-N(14)-C(13)  -16.2(3)  
  C(112)-C(17)-N(14)-C(13) 168.41(19)  
  C(12)-C(13)-N(14)-C(17)  174.47(18)  
  C(14)-C(13)-N(14)-C(17)  -63.5(3)  
  N(21)-C(21)-C(22)-O(21)  -58.5(2)  
   
 
  C(26)-C(21)-C(22)-O(21)  179.42(16)  
  N(21)-C(21)-C(22)-C(23)   69.0(2)  
  C(26)-C(21)-C(22)-C(23)  -53.0(2)  
  O(21)-C(22)-C(23)-N(24)  -51.4(2)  
  C(21)-C(22)-C(23)-N(24) -178.04(16)  
  O(21)-C(22)-C(23)-C(24) -176.78(16)  
  C(21)-C(22)-C(23)-C(24)   56.6(2)  
  N(24)-C(23)-C(24)-C(25)  178.12(17)  
  C(22)-C(23)-C(24)-C(25)  -59.9(2)  
  C(23)-C(24)-C(25)-C(26)   59.2(2)  
  C(24)-C(25)-C(26)-C(21)  -54.2(2)  
  N(21)-C(21)-C(26)-C(25)  -68.1(2)  
  C(22)-C(21)-C(26)-C(25)   51.2(2)  
  N(24)-C(27)-C(28)-C(29) -175.3(2)  
  C(212)-C(27)-C(28)-C(29)   0.4(3)  
  C(27)-C(28)-C(29)-C(210)   0.2(3)  
  C(28)-C(29)-C(210)-C(211) -0.2(3)  
  C(28)-C(29)-C(210)-CL2  -179.60(17)  
  C(29)-C(210)-C(211)-C(212)-0.4(3)  
  CL2-C(210)-C(211)-C(212) 179.02(17)  
  C(210)-C(211)-C(212)-C(27) 1.0(3)  
  N(24)-C(27)-C(212)-C(211)174.9(2)  
  C(28)-C(27)-C(212)-C(211) -1.0(3)  
  C(26)-C(21)-N(21)-N(22)  -79.3(2)  
  C(22)-C(21)-N(21)-N(22)  157.96(19)  
  C(28)-C(27)-N(24)-C(23)  -14.5(3)  
  C(212)-C(27)-N(24)-C(23) 169.80(19)  
  C(22)-C(23)-N(24)-C(27)  172.81(18)  
  C(24)-C(23)-N(24)-C(27)  -65.2(3)  
   
  
______________________________________________________________________________  
   
          





   Table 7. Bond lengths [Å] and angles [°] related to the hydrogen  
   bonding for C12 H15 Cl N4 O.  
   ______________________________________________________________________  
   
        D-H         ..A       d(D-H)      d(H..A)     d(D..A)     <DHA  
   
     O(11)-H(11)    N(14)#1    0.84        2.25       2.970(2)    144.4  
     N(14)-H(14C)   O(11)#2    0.85(2)     2.19(2)    3.009(2)    163(2)  
     O(21)-H(21)    N(24)#3    0.84        2.27       2.993(2)    144  
     N(24)-H(24C)   O(21)#4    0.84(2)     2.19(2)    3.004(2)    164(2)  
   
   ______________________________________________________________________  
   
    Symmetry transformations used to generate equivalent atoms:  
   
         #1 -x+1,-y+2,-z+2    #2 -x+1,-y+1,-z+2      





   
   
   
 
   
ORTEP view of the C12 H15 Cl N4 O compound with the numbering 
scheme adopted. Ellipsoids drawn at 30% probability level. 
Hydrogen atoms are represented by sphere of arbitrary size.  
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Structure  solved and refined in the laboratory of X-ray 





        Table 1.  Crystal data and structure refinement for C15 H19 F N4 O2.  
   
      Identification code               HAN450  
   
      Empirical formula                 C15 H19 F N4 O2  
   
      Formula weight                    306.34  
   
      Temperature                       150(2)K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Monoclinic  
   
      Space group                       P21/n  
   
      Unit cell dimensions              a = 10.7033(14) Å    α = 90°  
                                        b = 11.2000(15) Å    β = 112.692(5)°  
                                        c = 13.8575(19) Å    γ = 90°  
   
      Volume                            1532.6(4)Å3  
   
      Z                                 4  
   
      Density (calculated)              1.328  g/cm3  
   
      Absorption coefficient            0.824 mm-1  
   
      F(000)                            648  
   
      Crystal size                      0.20 x 0.20 x 0.03 mm  
   
      Theta range for data collection   4.48 to 72.59°  
   
      Index ranges                      -12 ≤ h ≤ 13, -13 ≤ k ≤ 13, -17 ≤ l ≤ 17  
   
      Reflections collected             20399  
   
      Independent reflections           3011 [Rint = 0.065]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.9756 and 0.8713  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    3011 / 1 / 205  
   
      Goodness-of-fit on F2             0.910  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0655, wR2 = 0.1653  
   
      R indices (all data)              R1 = 0.1257, wR2 = 0.2058  
   
      Extinction coefficient            0.0032(7)  
   




         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C15 H19 F N4 O2.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          F(1)         7889(2)        614(2)       4038(2)       80(1)  
          O(1)        -1218(2)       1020(2)       1453(2)       57(1)  
          O(2)        -1719(3)       1867(2)       -126(2)       88(1)  
          N(1)         2309(3)        140(2)       2127(2)       61(1)  
          N(2)        -1584(3)      -1221(2)        396(2)       63(1)  
          N(3)        -2664(3)      -1281(2)        501(2)       69(1)  
          N(4)        -3736(4)      -1367(4)        496(2)      100(1)  
          C(1)          -70(3)        390(3)       1381(2)       54(1)  
          C(2)         1215(3)        761(3)       2327(2)       55(1)  
          C(3)         1079(3)        322(3)       3326(2)       58(1)  
          C(4)          808(3)      -1017(3)       3314(2)       60(1)  
          C(5)         -472(3)      -1353(3)       2385(2)       58(1)  
          C(6)         -374(3)       -951(3)       1370(2)       56(1)  
          C(7)         1366(3)       2128(3)       2322(2)       67(1)  
          C(8)         3700(3)        345(3)       2630(2)       55(1)  
          C(9)         4346(3)        785(3)       3652(2)       60(1)  
          C(10)        5736(3)        866(3)       4121(3)       61(1)  
          C(11)        6505(3)        527(3)       3581(3)       64(1)  
          C(12)        5920(3)        110(3)       2572(3)       63(1)  
          C(13)        4529(3)         25(3)       2113(3)       58(1)  
          C(14)       -1949(3)       1759(3)        657(3)       62(1)  
          C(15)       -3012(3)       2376(3)        890(3)       71(1)  





         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C15 H19 F N4 O2.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
 
   
          H(1)         2150(40)         0(30)      1442(8)       91  
          H(1A)          31           615           717          65  
          H(3A)        1922           511          3932          70  
          H(3B)         328           758          3419          70  
          H(4A)        1588         -1460          3275          72  
          H(4B)         711         -1247          3971          72  
          H(5A)        -601         -2229          2372          69  
          H(5B)       -1266          -972          2458          69  
          H(6)          412         -1382          1312          67  
          H(7A)        2233          2363          2866         100  
          H(7B)         624          2505          2458         100  
          H(7C)        1336          2387          1638         100  
          H(9)         3814          1033          4028          72  
          H(10)        6156          1155          4817          74  
          H(12)        6464          -115          2198          76  
          H(13)        4123          -265          1416          70  
          H(15A)      -3535          2889           299         106  
          H(15B)      -2595          2865          1520         106  
          H(15C)      -3615          1786          1006         106  





    Table 4.  Anisotropic parameters (Å2 x 103) for C15 H19 F N4 O2.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    F(1)     59(1)      91(1)      71(1)      -2(1)       3(1)       1(1)  
    O(1)     61(1)      53(1)      50(1)       1(1)      13(1)       3(1)  
    O(2)     90(2)     107(2)      62(2)      26(1)      27(1)      31(1)  
    N(1)     60(2)      66(2)      52(2)      -9(1)      16(2)      -3(1)  
    N(2)     58(2)      69(2)      51(2)      -5(1)       9(1)      -4(1)  
    N(3)     70(2)      73(2)      49(2)      -9(1)       6(2)      -4(2)  
    N(4)     66(2)     151(3)      69(2)     -22(2)      11(2)     -19(2)  
    C(1)     54(2)      55(2)      50(2)      -4(1)      15(2)      -1(1)  
    C(2)     59(2)      51(2)      46(2)      -5(1)      11(2)      -4(1)  
    C(3)     61(2)      54(2)      50(2)      -4(1)      10(2)      -1(1)  
    C(4)     62(2)      60(2)      49(2)       1(2)      11(2)       1(2)  
    C(5)     61(2)      53(2)      51(2)       1(1)      12(2)      -3(1)  
    C(6)     57(2)      53(2)      47(2)      -5(1)       7(2)      -3(1)  
    C(7)     71(2)      54(2)      62(2)      -1(2)      13(2)      -7(2)  
    C(8)     58(2)      50(2)      48(2)       3(1)      10(2)      -1(1)  
    C(9)     65(2)      55(2)      51(2)       0(1)      12(2)      -2(2)  
    C(10)    63(2)      57(2)      50(2)       2(2)       6(2)      -2(2)  
    C(11)    53(2)      59(2)      63(2)       6(2)       4(2)       2(2)  
    C(12)    62(2)      58(2)      58(2)       5(2)      11(2)       5(2)  
    C(13)    61(2)      53(2)      50(2)       0(1)       9(2)       0(2)  
    C(14)    60(2)      63(2)      51(2)       0(2)       8(2)       2(2)  
    C(15)    68(2)      65(2)      65(2)       4(2)      12(2)       3(2)  





      Table 5.  Bond lengths [Å] and angles [°] for C15 H19 F N4 O2  
    ______________________________________________________________________   
 
    F(1)-C(11)             1.372(3)  
    O(1)-C(14)             1.359(4)  
    O(1)-C(1)              1.453(3)  
    O(2)-C(14)             1.208(4)  
    N(1)-C(8)              1.398(4)  
    N(1)-C(2)              1.476(4)  
    N(2)-N(3)              1.222(4)  
    N(2)-C(6)              1.497(4)  
    N(3)-N(4)              1.148(4)  
    C(1)-C(6)              1.535(4)  
    C(1)-C(2)              1.547(4)  
    C(2)-C(3)              1.528(4)  
    C(2)-C(7)              1.540(4)  
    C(3)-C(4)              1.526(4)  
    C(4)-C(5)              1.522(4)  
    C(5)-C(6)              1.520(4)  
    C(8)-C(13)             1.386(4)  
    C(8)-C(9)              1.403(4)  
    C(9)-C(10)             1.378(4)  
    C(10)-C(11)            1.362(4)  
    C(11)-C(12)            1.375(4)  
    C(12)-C(13)            1.379(4)  
    C(14)-C(15)            1.469(5)  
   
    C(14)-O(1)-C(1)        118.5(2)  
    C(8)-N(1)-C(2)         126.7(3)  
    N(3)-N(2)-C(6)         115.6(3)  
    N(4)-N(3)-N(2)         173.1(3)  
    O(1)-C(1)-C(6)         107.1(2)  
 
 
    O(1)-C(1)-C(2)         108.1(2)  
    C(6)-C(1)-C(2)         112.8(2)  
    N(1)-C(2)-C(3)         112.2(2)  
    N(1)-C(2)-C(7)         112.1(3)  
    C(3)-C(2)-C(7)         111.7(2)  
    N(1)-C(2)-C(1)         103.0(2)  
    C(3)-C(2)-C(1)         108.5(2)  
    C(7)-C(2)-C(1)         108.9(2)  
    C(4)-C(3)-C(2)         113.0(2)  
    C(5)-C(4)-C(3)         111.0(2)  
    C(6)-C(5)-C(4)         110.4(2)  
    N(2)-C(6)-C(5)         115.5(2)  
    N(2)-C(6)-C(1)         108.3(2)  
    C(5)-C(6)-C(1)         111.8(2)  
    C(13)-C(8)-N(1)        118.0(3)  
    C(13)-C(8)-C(9)        116.6(3)  
    N(1)-C(8)-C(9)         125.2(3)  
    C(10)-C(9)-C(8)        121.4(3)  
    C(11)-C(10)-C(9)       119.6(3)  
    C(10)-C(11)-F(1)       120.1(3)  
    C(10)-C(11)-C(12)      121.3(3)  
    F(1)-C(11)-C(12)       118.7(3)  
    C(11)-C(12)-C(13)      118.6(3)  
    C(12)-C(13)-C(8)       122.4(3)  
    O(2)-C(14)-O(1)        122.5(3)  
    O(2)-C(14)-C(15)       126.4(3)  
    O(1)-C(14)-C(15)       111.2(3)  
   
    
______________________________________________________________________  
   
   





         Table 6.  Torsion angles [°] for C15 H19 F N4 O2.  
  ______________________________________________________________________________   
 
  C(6)-N(2)-N(3)-N(4)     -177(3)  
  C(14)-O(1)-C(1)-C(6)    -118.0(3)  
  C(14)-O(1)-C(1)-C(2)     120.3(3)  
  C(8)-N(1)-C(2)-C(3)      -76.8(3)  
  C(8)-N(1)-C(2)-C(7)       49.9(4)  
  C(8)-N(1)-C(2)-C(1)      166.8(3)  
  O(1)-C(1)-C(2)-N(1)     -176.1(2)  
  C(6)-C(1)-C(2)-N(1)       65.7(3)  
  O(1)-C(1)-C(2)-C(3)       64.8(3)  
  C(6)-C(1)-C(2)-C(3)      -53.4(3)  
  O(1)-C(1)-C(2)-C(7)      -56.9(3)  
  C(6)-C(1)-C(2)-C(7)     -175.2(3)  
  N(1)-C(2)-C(3)-C(4)      -58.0(3)  
  C(7)-C(2)-C(3)-C(4)      175.1(2)  
  C(1)-C(2)-C(3)-C(4)       55.1(3)  
  C(2)-C(3)-C(4)-C(5)      -57.9(3)  
  C(3)-C(4)-C(5)-C(6)       56.2(3)  
  N(3)-N(2)-C(6)-C(5)       27.9(4)  
  N(3)-N(2)-C(6)-C(1)      -98.3(3)  
  C(4)-C(5)-C(6)-N(2)     -179.4(2)  
 
 
  C(4)-C(5)-C(6)-C(1)      -55.1(3)  
  O(1)-C(1)-C(6)-N(2)       64.4(3)  
  C(2)-C(1)-C(6)-N(2)     -176.8(2)  
  O(1)-C(1)-C(6)-C(5)      -63.9(3)  
  C(2)-C(1)-C(6)-C(5)       54.9(3)  
  C(2)-N(1)-C(8)-C(13)    -156.7(3)  
  C(2)-N(1)-C(8)-C(9)       27.5(5)  
  C(13)-C(8)-C(9)-C(10)     -1.5(4)  
  N(1)-C(8)-C(9)-C(10)     174.4(3)  
  C(8)-C(9)-C(10)-C(11)      0.9(5)  
  C(9)-C(10)-C(11)-F(1)    179.4(3)  
  C(9)-C(10)-C(11)-C(12)     0.3(5)  
  C(10)-C(11)-C(12)-C(13)   -0.8(5)  
  F(1)-C(11)-C(12)-C(13)  -179.9(3)  
  C(11)-C(12)-C(13)-C(8)     0.1(4)  
  N(1)-C(8)-C(13)-C(12)   -175.2(3)  
  C(9)-C(8)-C(13)-C(12)      1.0(4)  
  C(1)-O(1)-C(14)-O(2)       3.6(4)  
  C(1)-O(1)-C(14)-C(15)   -176.4(3)  
   
  
______________________________________________________________________________  
   
   





   Table 7. Bond lengths [Å] and angles [°] related to the hydrogen  
   bonding for C15 H19 F N4 O2.  
   ______________________________________________________________________  
   
        D-H         ..A       d(D-H)      d(H..A)     d(D..A)     <DHA  
   
     N(1)-H(1)      N(2)#1     0.911(15)   2.74(2)    3.493(4)    140(3)  
   
   ______________________________________________________________________  
   
    Symmetry transformations used to generate equivalent atoms:  
   











ORTEP view of the C15 H19 F N4 O2 compound with the numbering 
scheme adopted. Ellipsoids drawn at 50% probability level. 
Hydrogen atoms are represented by sphere of arbitrary size.  
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Structure solved and refined in the laboratory of X-ray 




      Table 1.  Crystal data and structure refinement for C20 H24 N4 O2.  
   
      Identification code               bent39  
   
      Empirical formula                 C20 H24 N4 O2  
   
      Formula weight                    352.43  
   
      Temperature                       175K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Monoclinic  
   
      Space group                       P21/c  
   
      Unit cell dimensions              a = 19.0271(5) Å    α = 90°  
                                        b = 5.6071(1) Å    β = 104.337(1)°  
                                        c = 18.0411(5) Å    γ = 90°  
   
      Volume                            1864.80(8)Å3  
   
      Z                                 4  
   
      Density (calculated)              1.255  g/cm3  
   
      Absorption coefficient            0.668 mm-1  
   
      F(000)                            752  
   
      Crystal size                      0.08 x 0.07 x 0.06 mm  
   
      Theta range for data collection   2.40 to 72.23°  
   
      Index ranges                      -23 ≤ h ≤ 23, -6 ≤ k ≤ 6, -21 ≤ l ≤ 22  
   
      Reflections collected             24026  
   
      Independent reflections           3654 [Rint = 0.037]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.9607 and 0.9007  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    3654 / 0 / 241  
   
      Goodness-of-fit on F2             0.840  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0349, wR2 = 0.0861  
   
      R indices (all data)              R1 = 0.0492, wR2 = 0.0915  
   
      Extinction coefficient            0.0014(2)  
   





         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C20 H24 N4 O2.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          O(1)         8416(1)       -490(2)       5272(1)       40(1)  
          O(2)         5623(1)       7511(2)       6962(1)       44(1)  
          N(1)         7802(1)       1722(2)       6355(1)       37(1)  
          N(2)         9126(1)       2419(2)       7566(1)       45(1)  
          N(3)         8711(1)       1333(2)       7879(1)       47(1)  
          N(4)         8372(1)        491(3)       8245(1)       64(1)  
          C(1)         8504(1)       2043(2)       5379(1)       37(1)  
          C(2)         8471(1)       2601(2)       6201(1)       34(1)  
          C(3)         9133(1)       1600(2)       6779(1)       37(1)  
          C(4)         9836(1)       2488(3)       6619(1)       43(1)  
          C(5)         9866(1)       1821(3)       5807(1)       47(1)  
          C(6)         9217(1)       2871(3)       5222(1)       45(1)  
          C(7)         8003(1)      -1147(3)       4517(1)       45(1)  
          C(8)         7198(1)       -873(2)       4431(1)       38(1)  
          C(9)         6827(1)      -2477(2)       4784(1)       43(1)  
          C(10)        6093(1)      -2215(3)       4729(1)       45(1)  
          C(11)        5717(1)       -324(3)       4323(1)       43(1)  
          C(12)        6075(1)       1281(3)       3971(1)       46(1)  
 
          C(13)        6811(1)       1003(3)       4020(1)       43(1)  
          C(14)        7274(1)       3285(2)       6501(1)       31(1)  
          C(15)        7453(1)       5305(2)       6956(1)       36(1)  
          C(16)        6920(1)       6765(2)       7123(1)       36(1)  
          C(17)        6196(1)       6203(2)       6837(1)       33(1)  
          C(18)        6010(1)       4195(2)       6381(1)       36(1)  
          C(19)        6540(1)       2760(2)       6212(1)       34(1)  
          C(20)        5779(1)       9188(3)       7573(1)       43(1)  





         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C20 H24 N4 O2.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          H(1A)        8093          2871          5016          44  
          H(2)         8478          4374          6261          41  
          H(3)         9120          -183          6760          44  
          H(4A)       10254          1770          6990          52  
          H(4B)        9868          4242          6680          52  
          H(5A)        9863            63          5755          56  
          H(5B)       10321          2432          5705          56  
          H(6A)        9242          4634          5246          54  
          H(6B)        9236          2372          4701          54  
          H(7A)        8110         -2825          4415          54  
          H(7B)        8152          -132          4134          54  
          H(9)         7082         -3775          5067          51  
          H(10)        5847         -3334          4970          54  
          H(11)        5213          -133          4288          51  
          H(12)        5818          2583          3692          55  
          H(13)        7052          2110          3769          52  
          H(15)        7949          5699          7157          44  
          H(16)        7054          8141          7433          43  
          H(18)        5514          3803          6183          43  
          H(19)        6403          1400          5895          41  
          H(20A)       6083         10469          7453          65  
          H(20B)       6037          8386          8045          65  
          H(20C)       5325          9863          7642          65  
          H(1B)        7625(8)        520(30)      6052(8)       47(4)  





    Table 4.  Anisotropic parameters (Å2 x 103) for C20 H24 N4 O2.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    O(1)     42(1)      37(1)      38(1)      -4(1)       4(1)       9(1)  
    O(2)     32(1)      44(1)      56(1)      -9(1)      11(1)       6(1)  
    N(1)     33(1)      32(1)      50(1)     -11(1)      14(1)      -4(1)  
    N(2)     44(1)      50(1)      41(1)      -4(1)      11(1)      -7(1)  
    N(3)     49(1)      51(1)      38(1)      -2(1)       9(1)       0(1)  
    N(4)     71(1)      82(1)      44(1)       3(1)      22(1)     -13(1)  
    C(1)     34(1)      36(1)      39(1)       2(1)       8(1)       7(1)  
    C(2)     31(1)      31(1)      42(1)      -3(1)      11(1)       1(1)  
    C(3)     35(1)      38(1)      37(1)      -2(1)       8(1)       1(1)  
    C(4)     31(1)      49(1)      49(1)       2(1)       7(1)       1(1)  
    C(5)     32(1)      56(1)      54(1)       5(1)      17(1)       5(1)  
    C(6)     42(1)      51(1)      44(1)       5(1)      16(1)       6(1)  
    C(7)     50(1)      46(1)      38(1)      -8(1)       8(1)       9(1)  
    C(8)     44(1)      34(1)      31(1)      -5(1)       4(1)       3(1)  
    C(9)     55(1)      31(1)      37(1)       2(1)       1(1)       3(1)  
    C(10)    55(1)      38(1)      39(1)       1(1)       9(1)     -11(1)  
    C(11)    42(1)      41(1)      43(1)      -6(1)       6(1)      -6(1)  
    C(12)    43(1)      38(1)      52(1)       9(1)       1(1)       1(1)  
    C(13)    43(1)      40(1)      44(1)       8(1)       6(1)      -3(1)  
    C(14)    32(1)      29(1)      34(1)       0(1)      11(1)      -1(1)  
    C(15)    27(1)      37(1)      44(1)      -7(1)       6(1)      -3(1)  
    C(16)    35(1)      32(1)      40(1)      -7(1)      10(1)      -2(1)  
    C(17)    31(1)      32(1)      37(1)       3(1)      10(1)       3(1)  
    C(18)    27(1)      37(1)      43(1)      -1(1)       6(1)      -4(1)  
    C(19)    35(1)      29(1)      37(1)      -4(1)       8(1)      -5(1)  
    C(20)    48(1)      40(1)      46(1)      -2(1)      19(1)       8(1)  





      Table 5.  Bond lengths [Å] and angles [°] for C20 H24 N4 O2  
    ______________________________________________________________________  
  
 
    O(1)-C(1)              1.4374(16)  
    O(1)-C(7)              1.4423(16)  
    O(2)-C(17)             1.3766(14)  
    O(2)-C(20)             1.4238(16)  
    N(1)-C(14)             1.4056(16)  
    N(1)-C(2)              1.4546(16)  
    N(2)-N(3)              1.2380(17)  
    N(2)-C(3)              1.4938(17)  
    N(3)-N(4)              1.1344(17)  
    C(1)-C(6)              1.5243(18)  
    C(1)-C(2)              1.5325(18)  
    C(2)-C(3)              1.5298(18)  
    C(3)-C(4)              1.5215(18)  
    C(4)-C(5)              1.526(2)  
    C(5)-C(6)              1.5290(19)  
    C(7)-C(8)              1.5076(19)  
    C(8)-C(13)             1.3884(19)  
    C(8)-C(9)              1.392(2)  
    C(9)-C(10)             1.383(2)  
    C(10)-C(11)            1.383(2)  
    C(11)-C(12)            1.376(2)  
    C(12)-C(13)            1.3896(19)  
    C(14)-C(15)            1.3907(18)  
    C(14)-C(19)            1.3967(17)  
    C(15)-C(16)            1.3926(17)  
    C(16)-C(17)            1.3833(17)  
    C(17)-C(18)            1.3873(18)  
    C(18)-C(19)            1.3810(18)  
   
    C(1)-O(1)-C(7)         113.35(10)  
    C(17)-O(2)-C(20)       117.19(10)  
    C(14)-N(1)-C(2)        121.61(11)  
    N(3)-N(2)-C(3)         116.01(12)  
     
 
    N(4)-N(3)-N(2)         171.50(15)  
    O(1)-C(1)-C(6)         110.82(11)  
    O(1)-C(1)-C(2)         107.42(10)  
    C(6)-C(1)-C(2)         111.61(11)  
    N(1)-C(2)-C(3)         110.89(11)  
    N(1)-C(2)-C(1)         111.35(11)  
    C(3)-C(2)-C(1)         111.19(10)  
    N(2)-C(3)-C(4)         107.18(11)  
    N(2)-C(3)-C(2)         109.62(11)  
    C(4)-C(3)-C(2)         111.36(11)  
    C(3)-C(4)-C(5)         110.25(11)  
    C(4)-C(5)-C(6)         110.59(12)  
    C(1)-C(6)-C(5)         111.05(12)  
    O(1)-C(7)-C(8)         111.96(11)  
    C(13)-C(8)-C(9)        118.15(13)  
    C(13)-C(8)-C(7)        121.55(13)  
    C(9)-C(8)-C(7)         120.28(13)  
    C(10)-C(9)-C(8)        121.10(13)  
    C(11)-C(10)-C(9)       120.00(14)  
    C(12)-C(11)-C(10)      119.69(14)  
    C(11)-C(12)-C(13)      120.25(13)  
    C(8)-C(13)-C(12)       120.81(14)  
    C(15)-C(14)-C(19)      117.89(11)  
    C(15)-C(14)-N(1)       122.46(11)  
    C(19)-C(14)-N(1)       119.58(11)  
    C(14)-C(15)-C(16)      121.44(12)  
    C(17)-C(16)-C(15)      119.80(12)  
    O(2)-C(17)-C(16)       124.98(12)  
    O(2)-C(17)-C(18)       115.71(11)  
    C(16)-C(17)-C(18)      119.30(12)  
    C(19)-C(18)-C(17)      120.77(12)  
    C(18)-C(19)-C(14)      120.78(12)  
   
    
______________________________________________________________________  
     





         Table 6.  Torsion angles [°] for C20 H24 N4 O2.  
  ______________________________________________________________________________  
  
 
  C(3)-N(2)-N(3)-N(4)      171.1(11)  
  C(7)-O(1)-C(1)-C(6)      -94.32(13)  
  C(7)-O(1)-C(1)-C(2)      143.51(11)  
  C(14)-N(1)-C(2)-C(3)     121.82(13)  
  C(14)-N(1)-C(2)-C(1)    -113.80(13)  
  O(1)-C(1)-C(2)-N(1)      -56.05(13)  
  C(6)-C(1)-C(2)-N(1)     -177.72(11)  
  O(1)-C(1)-C(2)-C(3)       68.15(13)  
  C(6)-C(1)-C(2)-C(3)      -53.51(15)  
  N(3)-N(2)-C(3)-C(4)     -160.28(12)  
  N(3)-N(2)-C(3)-C(2)       78.72(15)  
  N(1)-C(2)-C(3)-N(2)      -62.13(14)  
  C(1)-C(2)-C(3)-N(2)      173.41(10)  
  N(1)-C(2)-C(3)-C(4)      179.44(11)  
  C(1)-C(2)-C(3)-C(4)       54.97(15)  
  N(2)-C(3)-C(4)-C(5)     -177.25(12)  
  C(2)-C(3)-C(4)-C(5)      -57.35(15)  
  C(3)-C(4)-C(5)-C(6)       58.20(16)  
  O(1)-C(1)-C(6)-C(5)      -64.97(15)  
  C(2)-C(1)-C(6)-C(5)       54.71(16)  
  C(4)-C(5)-C(6)-C(1)      -57.05(17)  
  C(1)-O(1)-C(7)-C(8)      -79.58(15)  
  O(1)-C(7)-C(8)-C(13)     105.29(15)  
  O(1)-C(7)-C(8)-C(9)      -72.90(17)  
   
 
  C(13)-C(8)-C(9)-C(10)     -0.1(2)  
  C(7)-C(8)-C(9)-C(10)     178.13(12)  
  C(8)-C(9)-C(10)-C(11)     -0.5(2)  
  C(9)-C(10)-C(11)-C(12)     0.5(2)  
  C(10)-C(11)-C(12)-C(13)    0.1(2)  
  C(9)-C(8)-C(13)-C(12)      0.7(2)  
  C(7)-C(8)-C(13)-C(12)   -177.51(13)  
  C(11)-C(12)-C(13)-C(8)    -0.7(2)  
  C(2)-N(1)-C(14)-C(15)    -41.05(18)  
  C(2)-N(1)-C(14)-C(19)    141.91(13)  
  C(19)-C(14)-C(15)-C(16)    0.3(2)  
  N(1)-C(14)-C(15)-C(16)  -176.82(12)  
  C(14)-C(15)-C(16)-C(17)    0.3(2)  
  C(20)-O(2)-C(17)-C(16)   -16.60(18)  
  C(20)-O(2)-C(17)-C(18)   164.07(12)  
  C(15)-C(16)-C(17)-O(2)  -179.78(12)  
  C(15)-C(16)-C(17)-C(18)   -0.48(19)  
  O(2)-C(17)-C(18)-C(19)   179.41(12)  
  C(16)-C(17)-C(18)-C(19)    0.0(2)  
  C(17)-C(18)-C(19)-C(14)    0.6(2)  
  C(15)-C(14)-C(19)-C(18)   -0.70(19)  
  N(1)-C(14)-C(19)-C(18)   176.47(12)  
   
  
______________________________________________________________________________  
     





   Table 7. Bond lengths [Å] and angles [°] related to the hydrogen  
   bonding for C20 H24 N4 O2.  
   ______________________________________________________________________  
   
        D-H         ..A       d(D-H)      d(H..A)     d(D..A)     <DHA  
   
     N(1)-H(1B)     O(1)       0.879(16)   2.369(15)  2.8024(14)  110.6(11)  
   
   ______________________________________________________________________  
     





   
   
   
   
 
   
ORTEP view of the C20 H24 N4 O2 compound with the numbering 
scheme adopted. Ellipsoids drawn at 30% probability level. 
Hydrogen atoms are represented by sphere of arbitrary size.  
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Structure solved and refined in the laboratory of X-ray 





      Table 1.  Crystal data and structure refinement for C19 H23 N5 O.  
   
 
 
      Identification code               bent40  
   
      Empirical formula                 C19 H23 N5 O  
   
      Formula weight                    337.42  
   
      Temperature                       175K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Monoclinic  
   
      Space group                       P21/c  
   
      Unit cell dimensions              a = 11.4990(7) Å    α = 90°  
                                        b = 17.9408(12) Å    β = 101.441(3)°  
                                        c = 8.7339(5) Å    γ = 90°  
   
      Volume                            1766.01(19)Å3  
   
      Z                                 4  
   
      Density (calculated)              1.269  g/cm3  
   
      Absorption coefficient            0.655 mm-1  
   
      F(000)                            720  
   
      Crystal size                      0.18 x 0.07 x 0.05 mm  
   
      Theta range for data collection   3.92 to 72.60°  
   
      Index ranges                      -14 ≤ h ≤ 14, -22 ≤ k ≤ 21, -10 ≤ l ≤ 10  
   
      Reflections collected             23332  
   
      Independent reflections           3475 [Rint = 0.042]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.9678 and 0.7604  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    3475 / 0 / 236  
   
      Goodness-of-fit on F2             1.041  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0368, wR2 = 0.1041  
   
      R indices (all data)              R1 = 0.0471, wR2 = 0.1089  
   




         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C19 H23 N5 O.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          O(1)        12645(1)       9342(1)      10050(1)       41(1)  
          N(1)        10148(1)       5863(1)       7889(1)       44(1)  
          N(2)        11224(1)       5913(1)       8329(1)       47(1)  
          N(3)        12227(1)       5909(1)       8635(2)       72(1)  
          N(4)         9462(1)       7325(1)       6582(1)       34(1)  
          N(5)         7125(1)       6929(1)       5072(1)       37(1)  
          C(1)         9416(1)       6376(1)       8672(1)       36(1)  
          C(2)         8702(1)       6890(1)       7411(1)       31(1)  
          C(3)         7816(1)       6435(1)       6233(1)       32(1)  
          C(4)         7027(1)       5959(1)       7074(2)       39(1)  
          C(5)         7742(1)       5452(1)       8309(2)       43(1)  
          C(6)         8609(1)       5908(1)       9487(2)       42(1)  
          C(7)        10293(1)       7822(1)       7468(1)       31(1)  
          C(8)        11498(1)       7759(1)       7494(2)       38(1)  
          C(9)        12310(1)       8258(1)       8332(2)       39(1)  
          C(10)       11914(1)       8829(1)       9164(1)       33(1)  
          C(11)       10707(1)       8912(1)       9109(1)       33(1)  
          C(12)        9905(1)       8417(1)       8266(1)       32(1)  
 
          C(13)       13884(1)       9203(1)      10301(2)       55(1)  
          C(14)        6447(1)       6674(1)       3679(1)       32(1)  
          C(15)        5548(1)       7128(1)       2843(2)       36(1)  
          C(16)        4886(1)       6903(1)       1416(2)       42(1)  
          C(17)        5101(1)       6224(1)        774(2)       45(1)  
          C(18)        5986(1)       5771(1)       1588(2)       43(1)  
          C(19)        6650(1)       5983(1)       3024(2)       36(1)  





         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C19 H23 N5 O.  
   
         ________________________________________________________________  
   
                         x             y             z           Ueq  
         ________________________________________________________________  
   
          H(1)         9954          6685          9465          43  
          H(2)         8242          7247          7940          37  
          H(3)         8278          6090          5680          38  
          H(4A)        6527          6292          7576          46  
          H(4B)        6493          5651          6295          46  
          H(5A)        7198          5176          8854          51  
          H(5B)        8184          5084          7802          51  
          H(6A)        9098          5569         10248          50  
          H(6B)        8161          6240         10067          50  
          H(8)        11775          7368          6927          46  
          H(9)        13133          8206          8334          47  
          H(11)       10429          9312          9654          39  
          H(12)        9080          8482          8230          38  
          H(13A)      14142          9207          9297          83  
          H(13B)      14055          8715         10799          83  
          H(13C)      14309          9591         10980          83  
          H(15)        5390          7597          3262          43  
          H(16)        4278          7218           873          50  
          H(17)        4650          6071          -208          54  
          H(18)        6142          5305          1153          51  
          H(19)        7246          5660          3568          44  
          H(4C)        9844(13)      7014(9)       6003(18)      48(4)  
          H(5C)        6815(13)      7341(9)       5458(18)      52(5)  





    Table 4.  Anisotropic parameters (Å2 x 103) for C19 H23 N5 O.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    O(1)     33(1)      39(1)      48(1)      -8(1)       1(1)      -5(1)  
    N(1)     37(1)      50(1)      42(1)      -7(1)      -1(1)       7(1)  
    N(2)     44(1)      51(1)      43(1)       7(1)       2(1)       8(1)  
    N(3)     40(1)      90(1)      83(1)       2(1)      -1(1)      13(1)  
    N(4)     36(1)      38(1)      29(1)      -5(1)       7(1)      -6(1)  
    N(5)     35(1)      36(1)      36(1)      -4(1)      -3(1)       2(1)  
    C(1)     37(1)      40(1)      28(1)      -5(1)       2(1)      -2(1)  
    C(2)     31(1)      33(1)      29(1)      -3(1)       5(1)      -2(1)  
    C(3)     30(1)      33(1)      30(1)      -3(1)       2(1)       1(1)  
    C(4)     35(1)      40(1)      41(1)      -6(1)       7(1)      -7(1)  
    C(5)     52(1)      38(1)      38(1)      -1(1)      11(1)      -9(1)  
    C(6)     54(1)      41(1)      30(1)       1(1)       6(1)      -4(1)  
    C(7)     33(1)      34(1)      25(1)       2(1)       4(1)      -3(1)  
    C(8)     37(1)      38(1)      41(1)      -7(1)      10(1)       0(1)  
    C(9)     29(1)      41(1)      48(1)      -4(1)       8(1)      -1(1)  
    C(10)    33(1)      31(1)      33(1)       2(1)       3(1)      -5(1)  
    C(11)    35(1)      32(1)      31(1)       0(1)       7(1)       0(1)  
    C(12)    28(1)      37(1)      29(1)       2(1)       5(1)      -1(1)  
    C(13)    34(1)      44(1)      80(1)     -10(1)      -8(1)      -5(1)  
    C(14)    27(1)      34(1)      33(1)       1(1)       5(1)      -6(1)  
    C(15)    35(1)      36(1)      38(1)       4(1)       6(1)      -2(1)  
    C(16)    36(1)      49(1)      38(1)      11(1)       1(1)       0(1)  
    C(17)    44(1)      54(1)      34(1)      -1(1)      -2(1)      -9(1)  
    C(18)    43(1)      44(1)      39(1)      -7(1)       4(1)      -5(1)  
    C(19)    31(1)      39(1)      37(1)      -2(1)       2(1)       0(1)  





      Table 5.  Bond lengths [Å] and angles [°] for C19 H23 N5 O  
    ______________________________________________________________________  
  
 
    O(1)-C(10)             1.3766(14)  
    O(1)-C(13)             1.4203(16)  
    N(1)-N(2)              1.2238(15)  
    N(1)-C(1)              1.4996(16)  
    N(2)-N(3)              1.1313(16)  
    N(4)-C(7)              1.4184(15)  
    N(4)-C(2)              1.4663(15)  
    N(5)-C(14)             1.3860(15)  
    N(5)-C(3)              1.4579(15)  
    C(1)-C(6)              1.5291(18)  
    C(1)-C(2)              1.5424(16)  
    C(2)-C(3)              1.5321(15)  
    C(3)-C(4)              1.5344(17)  
    C(4)-C(5)              1.5219(18)  
    C(5)-C(6)              1.5209(17)  
    C(7)-C(8)              1.3854(17)  
    C(7)-C(12)             1.3957(17)  
    C(8)-C(9)              1.3918(18)  
    C(9)-C(10)             1.3850(18)  
    C(10)-C(11)            1.3872(17)  
    C(11)-C(12)            1.3825(16)  
    C(14)-C(15)            1.4018(17)  
    C(14)-C(19)            1.4030(18)  
    C(15)-C(16)            1.3850(18)  
    C(16)-C(17)            1.384(2)  
    C(17)-C(18)            1.383(2)  
    C(18)-C(19)            1.3865(17)  
   
    C(10)-O(1)-C(13)       116.79(10)  
    N(2)-N(1)-C(1)         115.81(11)  
    N(3)-N(2)-N(1)         173.55(17)  
    C(7)-N(4)-C(2)         117.90(9)  
     
 
    C(14)-N(5)-C(3)        123.00(11)  
    N(1)-C(1)-C(6)         108.81(11)  
    N(1)-C(1)-C(2)         108.01(9)  
    C(6)-C(1)-C(2)         111.96(10)  
    N(4)-C(2)-C(3)         109.53(9)  
    N(4)-C(2)-C(1)         112.66(10)  
    C(3)-C(2)-C(1)         110.47(10)  
    N(5)-C(3)-C(2)         109.97(10)  
    N(5)-C(3)-C(4)         112.22(10)  
    C(2)-C(3)-C(4)         110.63(10)  
    C(5)-C(4)-C(3)         112.61(11)  
    C(6)-C(5)-C(4)         110.30(11)  
    C(5)-C(6)-C(1)         110.96(10)  
    C(8)-C(7)-C(12)        118.10(11)  
    C(8)-C(7)-N(4)         121.40(11)  
    C(12)-C(7)-N(4)        120.38(11)  
    C(7)-C(8)-C(9)         121.43(12)  
    C(10)-C(9)-C(8)        119.67(12)  
    O(1)-C(10)-C(9)        124.20(11)  
    O(1)-C(10)-C(11)       116.29(11)  
    C(9)-C(10)-C(11)       119.50(11)  
    C(12)-C(11)-C(10)      120.41(11)  
    C(11)-C(12)-C(7)       120.82(11)  
    N(5)-C(14)-C(15)       119.58(12)  
    N(5)-C(14)-C(19)       122.58(12)  
    C(15)-C(14)-C(19)      117.80(11)  
    C(16)-C(15)-C(14)      121.04(12)  
    C(17)-C(16)-C(15)      120.74(13)  
    C(18)-C(17)-C(16)      118.71(12)  
    C(17)-C(18)-C(19)      121.43(13)  
    C(18)-C(19)-C(14)      120.28(12)  
   
    
______________________________________________________________________  
     





         Table 6.  Torsion angles [°] for C19 H23 N5 O.  
  ______________________________________________________________________________  
  
 
  C(1)-N(1)-N(2)-N(3)     -179(10)  
  N(2)-N(1)-C(1)-C(6)     -119.83(13)  
  N(2)-N(1)-C(1)-C(2)      118.43(13)  
  C(7)-N(4)-C(2)-C(3)      175.99(10)  
  C(7)-N(4)-C(2)-C(1)      -60.62(14)  
  N(1)-C(1)-C(2)-N(4)      -58.32(13)  
  C(6)-C(1)-C(2)-N(4)     -178.1(1)  
  N(1)-C(1)-C(2)-C(3)       64.54(12)  
  C(6)-C(1)-C(2)-C(3)      -55.24(13)  
  C(14)-N(5)-C(3)-C(2)     165.35(11)  
  C(14)-N(5)-C(3)-C(4)     -71.05(15)  
  N(4)-C(2)-C(3)-N(5)      -56.82(13)  
  C(1)-C(2)-C(3)-N(5)      178.51(9)  
  N(4)-C(2)-C(3)-C(4)      178.65(10)  
  C(1)-C(2)-C(3)-C(4)       53.98(13)  
  N(5)-C(3)-C(4)-C(5)     -178.98(10)  
  C(2)-C(3)-C(4)-C(5)      -55.75(14)  
  C(3)-C(4)-C(5)-C(6)       56.42(15)  
  C(4)-C(5)-C(6)-C(1)      -55.97(15)  
  N(1)-C(1)-C(6)-C(5)      -62.94(14)  
  C(2)-C(1)-C(6)-C(5)       56.36(15)  
  C(2)-N(4)-C(7)-C(8)      121.82(13)  
  C(2)-N(4)-C(7)-C(12)     -62.07(15)  
   
 
  C(12)-C(7)-C(8)-C(9)       2.20(19)  
  N(4)-C(7)-C(8)-C(9)      178.39(12)  
  C(7)-C(8)-C(9)-C(10)       0.1(2)  
  C(13)-O(1)-C(10)-C(9)     -9.76(18)  
  C(13)-O(1)-C(10)-C(11)   171.19(12)  
  C(8)-C(9)-C(10)-O(1)     178.86(11)  
  C(8)-C(9)-C(10)-C(11)     -2.12(19)  
  O(1)-C(10)-C(11)-C(12)  -179.12(10)  
  C(9)-C(10)-C(11)-C(12)     1.78(18)  
  C(10)-C(11)-C(12)-C(7)     0.59(18)  
  C(8)-C(7)-C(12)-C(11)     -2.55(17)  
  N(4)-C(7)-C(12)-C(11)   -178.78(10)  
  C(3)-N(5)-C(14)-C(15)    161.17(11)  
  C(3)-N(5)-C(14)-C(19)    -21.36(19)  
  N(5)-C(14)-C(15)-C(16)   177.34(11)  
  C(19)-C(14)-C(15)-C(16)   -0.24(18)  
  C(14)-C(15)-C(16)-C(17)   -0.3(2)  
  C(15)-C(16)-C(17)-C(18)    0.3(2)  
  C(16)-C(17)-C(18)-C(19)    0.3(2)  
  C(17)-C(18)-C(19)-C(14)   -0.9(2)  
  N(5)-C(14)-C(19)-C(18)  -176.67(12)  
  C(15)-C(14)-C(19)-C(18)    0.84(19)  
   
  
______________________________________________________________________________  
     





   
   
   
   
 
   
ORTEP view of the C19 H23 N5 O compound with the numbering 
scheme adopted. Ellipsoids drawn at 30% probability level. 
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Structure solved and refined in the laboratory of X-ray 
diffraction Université de Montréal by Michel Simard and 
Benoît Deschênes Simard.  
 
 
      Table 1.  Crystal data and structure refinement for C33 H38 N4 O5 Si.  
     
      Identification code               bent51  
   
      Empirical formula                 C33 H38 N4 O5 Si  
   
      Formula weight                    598.76  
   
      Temperature                       150K  
   
      Wavelength                        1.54178 Å  
   
      Crystal system                    Monoclinic  
   
      Space group                       C2  
   
      Unit cell dimensions              a = 17.8975(7) Å    α = 90°  
                                        b =  7.3027(3) Å    β = 103.955(2)°  
                                        c = 28.5293(11) Å   γ = 90°  
   
      Volume                            3618.7(2)Å3  
   
      Z                                 4  
   
      Density (calculated)              1.099  g/cm3  
   
      Absorption coefficient            0.903 mm-1  
   
      F(000)                            1272  
   
      Crystal size                      0.15 x 0.12 x 0.12 mm  
   
      Theta range for data collection   1.60 to 72.43°  
   
      Index ranges                      -20 ≤ h ≤ 22, -8 ≤ k ≤ 9, -35 ≤ l ≤ 34  
   
      Reflections collected             22572  
   
      Independent reflections           6683 [Rint = 0.045]  
   
      Absorption correction             Semi-empirical from equivalents  
   
      Max. and min. transmission        0.8973 and 0.6820  
   
      Refinement method                 Full-matrix least-squares on F2  
   
      Data / restraints / parameters    6683 / 193 / 441  
   
      Goodness-of-fit on F2             1.048  
   
      Final R indices [I>2sigma(I)]     R1 = 0.0612, wR2 = 0.1641  
   
      R indices (all data)              R1 = 0.0643, wR2 = 0.1676  
   
      Absolute structure parameter      0.16(3)  
   
      Extinction coefficient            0.00095(15)  
   
 




         Table 2.  Atomic coordinates (x 104) and equivalent isotropic  
         displacement parameters (Å2 x 103) for C33 H38 N4 O5 Si.  
   
         Ueq is defined as one third of the trace of the orthogonalized  
         Uij tensor.  
   
         ________________________________________________________________  
   
                    Occ.       x           y           z          Ueq  
         ________________________________________________________________  
   
          Si(1)     1        2002(1)    10545(1)     3694(1)      32(1)  
          O(1)      1        -234(1)     7504(4)      745(1)      52(1)  
          O(2)      1        1675(1)     7144(3)     1864(1)      52(1)  
          O(3)      1         466(1)    10208(3)     2359(1)      42(1)  
          O(4)      1        1835(1)    10346(3)     3102(1)      41(1)  
          O(5)      1       -3869(1)     8295(4)      227(1)      61(1)  
          N(1)      1        -353(1)     8585(4)     1468(1)      44(1)  
          N(2)      1         280(2)    11994(4)     1292(1)      57(1)  
          N(3)      1        -315(2)    12309(5)     1422(1)      60(1)  
          N(4)      1        -863(2)    12844(6)     1489(2)      85(1)  
          C(1)      1        1032(2)     8470(7)      725(1)      64(1)  
          C(2)      1         557(2)     7601(5)     1031(1)      50(1)  
          C(3)      1         478(2)     8580(5)     1508(1)      43(1)  
          C(4)      1         956(2)     7615(4)     1969(1)      41(1)  
          C(5)      1        1122(2)     9110(4)     2351(1)      37(1)  
          C(6)      1        1032(2)    10890(4)     2113(1)      42(1)  
          C(7)      1         802(2)    10584(5)     1572(1)      44(1)  
          C(8)      1         554(2)     5955(5)     2120(1)      54(1)  
          C(9)      1        1673(2)     8719(4)     2831(1)      44(1)  
          C(10)     1        -679(2)     8041(5)     1042(1)      43(1)  
          C(11)     1       -1512(2)     8007(5)      829(1)      47(1)  
          C(12)     1       -2008(2)     8943(6)     1053(1)      59(1)  
          C(13)     1       -2796(2)     8978(6)      846(1)      60(1)  
          C(14)     1       -3087(2)     8079(5)      411(1)      52(1)  
          C(15)     1       -2607(2)     7129(5)      188(1)      51(1)  
          C(16)     1       -1824(2)     7097(5)      399(1)      46(1)  
          C(17)     1       -4180(2)     7549(7)     -247(1)      69(1)  
          C(18)     0.63     1192(6)     9344(18)    3879(4)      37(1)  
          C(19)     0.63     1278(5)     8566(10)    4338(3)      45(2)  
          C(20)     0.63      661(5)     7698(10)    4467(3)      54(2)  
          C(21)     0.63      -40(5)     7466(14)    4129(3)      45(2)  
          C(22)     0.63     -135(5)     8347(10)    3683(3)      43(2)  
          C(23)     0.63      469(7)     9200(20)    3549(4)      40(2)  
          C(34)     0.37     1217(10)    9450(30)    3941(7)      37(1)  
          C(35)     0.37     1245(9)     9090(20)    4427(6)      45(2)  
          C(36)     0.37      660(9)     8254(18)    4593(5)      54(2)  
          C(37)     0.37       -3(10)    7770(30)    4250(6)      45(2)  
          C(38)     0.37      -33(9)     7970(20)    3763(6)      43(2)  
          C(39)     0.37      526(13)    8950(40)    3609(8)      40(2)  
          C(24)     0.53     2971(6)     9460(20)    3973(4)      40(1)  
          C(25)     0.53     3415(6)     8714(10)    3672(4)      42(2)  
          C(26)     0.53     4128(7)     7885(16)    3869(4)      57(3)  
          C(27)     0.53     4408(6)     7755(15)    4358(4)      59(3)  
          C(28)     0.53     3977(4)     8444(13)    4660(3)      68(2)  
          C(29)     0.53     3280(4)     9349(11)    4475(3)      52(2)  
          C(40)     0.47     2954(7)     9410(30)    3939(5)      40(1)  
          C(41)     0.47     3439(7)     9298(13)    3624(5)      42(2)  
          C(42)     0.47     4137(8)     8363(18)    3745(5)      57(3)  
          C(43)     0.47     4335(7)     7454(18)    4185(4)      59(3)  
 
          C(44)     0.47     3879(5)     7611(14)    4505(4)      68(2)  
          C(45)     0.47     3185(5)     8530(12)    4382(4)      52(2)  
          C(30)     0.86     2015(2)    13088(4)     3805(1)      34(1)  
          C(31)     0.86     2253(4)    13477(7)     4346(2)      69(1)  
          C(32)     0.86     1213(3)    13872(6)     3585(2)      59(1)  
          C(33)     0.86     2593(2)    13993(5)     3560(2)      51(1)  
          C(46)     0.14     2052(12)   12980(20)    3930(7)      34(1)  
          C(47)     0.14     2180(20)   12910(30)    4480(6)      69(1)  
          C(48)     0.14     1297(15)   13960(30)    3705(13)     59(1)  
          C(49)     0.14     2726(14)   14020(20)    3811(9)      51(1)  




         Table 3. Hydrogen coordinates (x 104) and isotropic displacement  
         parameters (Å2 x 103) for C33 H38 N4 O5 Si.  
   
         ________________________________________________________________  
   
                    Occ.       x           y           z          Ueq  
         ________________________________________________________________  
   
          H(2)      1        1842        6168        2007         78  
          H(1A)     1         971        7778         423         96  
          H(1B)     1        1575        8464         900         96  
          H(1C)     1         862        9735         651         96  
          H(2A)     1         749        6327        1113         60  
          H(6)      1        1378       11931        2252         50  
          H(7)      1        1285       10597        1454         52  
          H(8A)     1          84        6350        2210         80  
          H(8B)     1         899        5358        2397         80  
          H(8C)     1         420        5090        1850         80  
          H(9A)     1        1441        7811        3012         53  
          H(9B)     1        2156        8196        2778         53  
          H(12)     1       -1807        9564        1349         70  
          H(13)     1       -3132        9613        1002         72  
          H(15)     1       -2809        6503        -107         61  
          H(16)     1       -1492        6436         246         55  
          H(17A)    1       -3923        8113        -477        104  
          H(17B)    1       -4733        7803        -345        104  
          H(17C)    1       -4095        6222        -240        104  
          H(19)     0.63     1763        8629        4564         54  
          H(20)     0.63      719        7262        4787         65  
          H(21)     0.63     -439        6737        4200         54  
          H(22)     0.63     -630        8358        3466         51  
          H(23)     0.63      397        9687        3232         48  
          H(35)     0.37     1696        9438        4660         54  
          H(36)     0.37      711        8022        4927         65  
          H(37)     0.37     -436        7310        4349         54  
          H(38)     0.37     -444        7432        3531         51  
          H(39)     0.37      445        9288        3279         48  
          H(25)     0.53     3229        8775        3331         51  
          H(26)     0.53     4421        7406        3660         69  
          H(27)     0.53     4893        7198        4488         70  
          H(28)     0.53     4159        8299        5000         81  
          H(29)     0.53     3012        9892        4690         62  
          H(41)     0.47     3289        9875        3317         51  
          H(42)     0.47     4471        8347        3532         69  
          H(43)     0.47     4787        6723        4264         70  
          H(44)     0.47     4042        7078        4816         81  
          H(45)     0.47     2863        8558        4603         62  
          H(31A)    0.86     2776       13015        4478        103  
          H(31B)    0.86     1896       12865        4506        103  
          H(31C)    0.86     2242       14800        4401        103  
          H(32A)    0.86     1218       15198        3638         88  
          H(32B)    0.86      838       13300        3740         88  
          H(32C)    0.86     1071       13618        3238         88  
          H(33A)    0.86     2436       13769        3211         77  
          H(33B)    0.86     3106       13474        3690         77  
          H(33C)    0.86     2605       15314        3621         77  
          H(47A)    0.14     2097       14131        4601        103  
          H(47B)    0.14     2701       12496        4626        103  
          H(47C)    0.14     1807       12051        4564        103  
          H(48A)    0.14     1399       15258        3665         88  
 
          H(48B)    0.14      944       13826        3917         88  
          H(48C)    0.14     1064       13414        3390         88  
          H(49A)    0.14     2946       13290        3590         77  
          H(49B)    0.14     3121       14244        4110         77  
          H(49C)    0.14     2542       15191        3659         77  




    Table 4.  Anisotropic parameters (Å2 x 103) for C33 H38 N4 O5 Si.  
   
         The anisotropic displacement factor exponent takes the form:  
   
                 -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
   
    _______________________________________________________________________  
   
              U11        U22        U33        U23        U13        U12  
    _______________________________________________________________________  
   
    Si(1)    23(1)      34(1)      35(1)       2(1)       1(1)       0(1)  
    O(1)     38(1)      75(2)      42(1)     -25(1)       9(1)      -3(1)  
    O(2)     38(1)      61(1)      58(1)      -8(1)      13(1)      15(1)  
    O(3)     35(1)      49(1)      38(1)     -11(1)       1(1)      11(1)  
    O(4)     41(1)      39(1)      38(1)      -1(1)       2(1)      -5(1)  
    O(5)     33(1)      96(2)      47(1)      -4(1)      -4(1)      -8(1)  
    N(1)     32(1)      57(1)      38(1)     -13(1)       1(1)       6(1)  
    N(2)     63(2)      55(2)      45(2)      -1(1)      -4(1)      10(1)  
    N(3)     57(2)      59(2)      53(2)     -12(1)     -10(1)      17(2)  
    N(4)     69(2)      78(2)      95(3)     -16(2)      -7(2)      26(2)  
    C(1)     54(2)      87(3)      56(2)     -25(2)      22(2)     -11(2)  
    C(2)     36(2)      64(2)      49(2)     -21(2)      11(1)      -2(1)  
    C(3)     32(1)      52(2)      45(2)     -15(1)       8(1)       1(1)  
    C(4)     33(1)      42(1)      46(1)     -11(1)       6(1)       3(1)  
    C(5)     26(1)      42(1)      41(1)      -7(1)       7(1)       2(1)  
    C(6)     38(1)      40(2)      43(1)      -7(1)       2(1)       4(1)  
    C(7)     42(1)      46(1)      39(1)      -8(1)       3(1)       4(1)  
    C(8)     47(2)      48(2)      63(2)     -11(1)       8(2)      -4(1)  
    C(9)     33(1)      47(2)      48(2)      -8(1)       2(1)       6(1)  
    C(10)    38(2)      58(2)      35(1)     -17(1)       9(1)      -1(1)  
    C(11)    36(2)      65(2)      37(1)     -12(1)       4(1)      -2(1)  
    C(12)    44(2)      85(3)      42(2)     -26(2)      -1(1)       3(2)  
    C(13)    35(2)     100(3)      42(2)     -16(2)       4(1)       4(2)  
    C(14)    38(2)      73(2)      41(2)       0(1)       1(1)      -6(2)  
    C(15)    49(2)      68(2)      32(1)      -7(1)       2(1)      -9(2)  
    C(16)    45(2)      57(2)      37(1)     -11(1)      12(1)      -6(1)  
    C(17)    43(2)     109(3)      47(2)      -7(2)      -7(2)     -13(2)  
    C(18)    27(1)      35(2)      46(3)       4(2)       5(2)       2(1)  
    C(19)    34(2)      52(5)      49(4)       4(3)       9(2)      -1(3)  
    C(20)    55(2)      53(5)      54(4)      12(3)      11(3)      -6(3)  
    C(21)    33(2)      46(4)      62(5)      -9(3)      21(3)      -7(2)  
    C(22)    26(3)      37(4)      59(4)      10(3)       0(2)      20(2)  
    C(23)    28(2)      39(5)      49(3)       8(2)       3(2)       5(3)  
    C(34)    27(1)      35(2)      46(3)       4(2)       5(2)       2(1)  
    C(35)    34(2)      52(5)      49(4)       4(3)       9(2)      -1(3)  
    C(36)    55(2)      53(5)      54(4)      12(3)      11(3)      -6(3)  
    C(37)    33(2)      46(4)      62(5)      -9(3)      21(3)      -7(2)  
    C(38)    26(3)      37(4)      59(4)      10(3)       0(2)      20(2)  
    C(39)    28(2)      39(5)      49(3)       8(2)       3(2)       5(3)  
    C(24)    26(1)      41(2)      51(2)       8(2)       5(1)       1(1)  
    C(25)    26(2)      29(6)      66(3)      -3(4)       0(2)     -10(3)  
    C(26)    32(2)      49(6)      82(7)      -7(5)      -2(3)       6(3)  
    C(27)    26(2)      40(4)      96(8)      -8(4)     -12(4)       5(2)  
    C(28)    40(3)      75(6)      78(5)      27(4)      -6(3)       4(4)  
    C(29)    40(2)      58(5)      55(3)      19(4)       8(2)      11(3)  
    C(40)    26(1)      41(2)      51(2)       8(2)       5(1)       1(1)  
    C(41)    26(2)      29(6)      66(3)      -3(4)       0(2)     -10(3)  
    C(42)    32(2)      49(6)      82(7)      -7(5)      -2(3)       6(3)  
    C(43)    26(2)      40(4)      96(8)      -8(4)     -12(4)       5(2)  
 
    C(44)    40(3)      75(6)      78(5)      27(4)      -6(3)       4(4)  
    C(45)    40(2)      58(5)      55(3)      19(4)       8(2)      11(3)  
    C(30)    33(1)      35(1)      33(2)       6(1)       5(1)      -1(1)  
    C(31)   112(4)      50(2)      42(2)      -8(2)      15(2)      -7(3)  
    C(32)    42(2)      45(2)      89(4)       6(2)      14(2)       4(2)  
    C(33)    52(2)      38(2)      67(2)       3(2)      20(2)     -10(2)  
    C(46)    33(1)      35(1)      33(2)       6(1)       5(1)      -1(1)  
    C(47)   112(4)      50(2)      42(2)      -8(2)      15(2)      -7(3)  
    C(48)    42(2)      45(2)      89(4)       6(2)      14(2)       4(2)  
    C(49)    52(2)      38(2)      67(2)       3(2)      20(2)     -10(2)  




      Table 5.  Bond lengths [Å] and angles [°] for C33 H38 N4 O5 Si  
    ______________________________________________________________________  
 
    Si(1)-O(4)             1.6498(19)  
    Si(1)-C(40)            1.870(9)  
    Si(1)-C(18)            1.876(7)  
    Si(1)-C(30)            1.883(3)  
    Si(1)-C(34)            1.893(11)  
    Si(1)-C(46)            1.893(14)  
    Si(1)-C(24)            1.898(8)  
    O(1)-C(10)             1.352(4)  
    O(1)-C(2)              1.454(4)  
    O(2)-C(4)              1.432(4)  
    O(3)-C(5)              1.427(3)  
    O(3)-C(6)              1.453(4)  
    O(4)-C(9)              1.408(4)  
    O(5)-C(14)             1.381(4)  
    O(5)-C(17)             1.437(4)  
    N(1)-C(10)             1.279(4)  
    N(1)-C(3)              1.463(4)  
    N(2)-N(3)              1.231(5)  
    N(2)-C(7)              1.487(4)  
    N(3)-N(4)              1.114(5)  
    C(1)-C(2)              1.500(5)  
    C(2)-C(3)              1.574(4)  
    C(3)-C(4)              1.554(4)  
    C(3)-C(7)              1.569(5)  
    C(4)-C(5)              1.520(4)  
    C(4)-C(8)              1.523(5)  
    C(5)-C(6)              1.457(4)  
    C(5)-C(9)              1.510(4)  
    C(6)-C(7)              1.515(4)  
    C(10)-C(11)            1.468(4)  
    C(11)-C(16)            1.389(4)  
    C(11)-C(12)            1.391(4)  
    C(12)-C(13)            1.392(4)  
    C(13)-C(14)            1.389(4)  
    C(14)-C(15)            1.374(5)  
    C(15)-C(16)            1.386(4)  
    C(18)-C(19)            1.401(8)  
    C(18)-C(23)            1.410(8)  
    C(19)-C(20)            1.398(8)  
    C(20)-C(21)            1.396(8)  
    C(21)-C(22)            1.401(9)  
    C(22)-C(23)            1.379(8)  
    C(34)-C(35)            1.400(12)  
    C(34)-C(39)            1.412(12)  
    C(35)-C(36)            1.390(12)  
    C(36)-C(37)            1.388(12)  
    C(37)-C(38)            1.385(13)  
    C(38)-C(39)            1.385(12)  
    C(24)-C(29)            1.408(10)  
    C(24)-C(25)            1.415(10)  
    C(25)-C(26)            1.402(9)  
    C(26)-C(27)            1.365(11)  
    C(27)-C(28)            1.384(11)  
    C(28)-C(29)            1.399(9)  
    C(40)-C(45)            1.392(11)  
    C(40)-C(41)            1.394(11)  
    C(41)-C(42)            1.392(11)  
  
 
    C(42)-C(43)            1.387(12)  
    C(43)-C(44)            1.368(12)  
    C(44)-C(45)            1.380(10)  
    C(30)-C(31)            1.525(5)  
    C(30)-C(33)            1.530(5)  
    C(30)-C(32)            1.532(5)  
    C(46)-C(48)            1.526(13)  
    C(46)-C(49)            1.531(13)  
    C(46)-C(47)            1.532(13)  
   
    O(4)-SI1-C(40)         105.5(5)  
    O(4)-SI1-C(18)         106.6(3)  
    C(40)-SI1-C(18)        112.6(7)  
    O(4)-SI1-C(30)         104.55(12)  
    C(40)-SI1-C(30)        113.5(6)  
    C(18)-SI1-C(30)        113.2(4)  
    O(4)-SI1-C(34)         112.1(6)  
    C(40)-SI1-C(34)        111.4(9)  
    C(30)-SI1-C(34)        109.5(8)  
    O(4)-SI1-C(46)         115.3(6)  
    C(40)-SI1-C(46)        108.7(9)  
    C(18)-SI1-C(46)        108.2(7)  
    C(34)-SI1-C(46)        103.8(10)  
    O(4)-SI1-C(24)         108.3(4)  
    C(18)-SI1-C(24)        112.1(6)  
    C(30)-SI1-C(24)        111.6(6)  
    C(34)-SI1-C(24)        110.6(8)  
    C(46)-SI1-C(24)        106.4(8)  
    C(10)-O(1)-C(2)        106.0(2)  
    C(5)-O(3)-C(6)          60.77(17)  
    C(9)-O(4)-SI1          126.75(19)  
    C(14)-O(5)-C(17)       116.2(3)  
    C(10)-N(1)-C(3)        107.1(2)  
    N(3)-N(2)-C(7)         116.4(3)  
    N(4)-N(3)-N(2)         168.1(5)  
    O(1)-C(2)-C(1)         107.8(3)  
    O(1)-C(2)-C(3)         103.2(2)  
    C(1)-C(2)-C(3)         119.6(3)  
    N(1)-C(3)-C(4)         114.1(3)  
    N(1)-C(3)-C(7)         110.3(2)  
    C(4)-C(3)-C(7)         102.2(2)  
    N(1)-C(3)-C(2)         103.6(2)  
    C(4)-C(3)-C(2)         112.3(2)  
    C(7)-C(3)-C(2)         114.6(3)  
    O(2)-C(4)-C(5)         107.0(2)  
    O(2)-C(4)-C(8)         112.2(3)  
    C(5)-C(4)-C(8)         113.2(3)  
    O(2)-C(4)-C(3)         105.7(2)  
    C(5)-C(4)-C(3)         104.7(2)  
    C(8)-C(4)-C(3)         113.5(2)  
    O(3)-C(5)-C(6)          60.51(19)  
    O(3)-C(5)-C(9)         116.7(2)  
    C(6)-C(5)-C(9)         124.5(2)  
    O(3)-C(5)-C(4)         113.3(2)  
    C(6)-C(5)-C(4)         109.1(2)  
    C(9)-C(5)-C(4)         119.1(2)  
    O(3)-C(6)-C(5)          58.71(18)  
     
 
 
     
    O(3)-C(6)-C(7)         113.1(2) 
    C(5)-C(6)-C(7)         108.4(2)  
    N(2)-C(7)-C(6)         115.2(3)  
    N(2)-C(7)-C(3)         114.6(2)  
    C(6)-C(7)-C(3)         104.9(3)  
    O(4)-C(9)-C(5)         110.0(2)  
    N(1)-C(10)-O(1)        118.9(3)  
    N(1)-C(10)-C(11)       125.6(3)  
    O(1)-C(10)-C(11)       115.5(2)  
    C(16)-C(11)-C(12)      118.4(3)  
    C(16)-C(11)-C(10)      121.6(3)  
    C(12)-C(11)-C(10)      120.0(3)  
    C(11)-C(12)-C(13)      120.5(3)  
    C(14)-C(13)-C(12)      119.6(3)  
    C(15)-C(14)-O(5)       124.8(3)  
    C(15)-C(14)-C(13)      120.7(3)  
    O(5)-C(14)-C(13)       114.5(3)  
    C(14)-C(15)-C(16)      119.1(3)  
    C(15)-C(16)-C(11)      121.6(3)  
    C(19)-C(18)-C(23)      118.0(7)  
    C(19)-C(18)-SI1        122.3(7)  
    C(23)-C(18)-SI1        119.7(7)  
    C(20)-C(19)-C(18)      121.0(7)  
    C(21)-C(20)-C(19)      120.6(7)  
    C(20)-C(21)-C(22)      117.7(7)  
    C(23)-C(22)-C(21)      121.8(7)  
    C(22)-C(23)-C(18)      120.3(7)  
    C(35)-C(34)-C(39)      115.5(11)  
    C(35)-C(34)-SI1        126.6(12)  
    C(39)-C(34)-SI1        117.9(12)  
    C(36)-C(35)-C(34)      124.9(12)  
    C(37)-C(36)-C(35)      117.1(12)  
    C(38)-C(37)-C(36)      120.0(13)  
     
 
    C(37)-C(38)-C(39)      121.1(14)  
    C(38)-C(39)-C(34)      120.2(14)  
    C(29)-C(24)-C(25)      117.2(7)  
    C(29)-C(24)-SI1        123.1(8)  
    C(25)-C(24)-SI1        119.8(7)  
    C(26)-C(25)-C(24)      120.8(9)  
    C(27)-C(26)-C(25)      121.0(10)  
    C(26)-C(27)-C(28)      119.3(9)  
    C(27)-C(28)-C(29)      121.2(8)  
    C(28)-C(29)-C(24)      120.4(8)  
    C(45)-C(40)-C(41)      117.5(8)  
    C(45)-C(40)-SI1        126.1(9)  
    C(41)-C(40)-SI1        116.0(8)  
    C(42)-C(41)-C(40)      122.1(10)  
    C(43)-C(42)-C(41)      118.5(11)  
    C(44)-C(43)-C(42)      120.0(11)  
    C(43)-C(44)-C(45)      121.2(9)  
    C(44)-C(45)-C(40)      120.5(9)  
    C(31)-C(30)-C(33)      109.1(3)  
    C(31)-C(30)-C(32)      110.5(3)  
    C(33)-C(30)-C(32)      108.7(3)  
    C(31)-C(30)-SI1        110.1(3)  
    C(33)-C(30)-SI1        109.3(2)  
    C(32)-C(30)-SI1        109.1(3)  
    C(48)-C(46)-C(49)      109.8(11)  
    C(48)-C(46)-C(47)      109.9(12)  
    C(49)-C(46)-C(47)      108.4(11)  
    C(48)-C(46)-SI1        109.2(11)  
    C(49)-C(46)-SI1        111.1(10)  
    C(47)-C(46)-SI1        108.4(10)  
   
    
______________________________________________________________________  
   
   




         Table 6.  Torsion angles [°] for C33 H38 N4 O5 Si.  
  ______________________________________________________________________________  
 
  C(40)-SI1-O(4)-C(9)       68.8(7)  
  C(18)-SI1-O(4)-C(9)      -51.1(5)  
  C(30)-SI1-O(4)-C(9)     -171.2(2)  
  C(34)-SI1-O(4)-C(9)      -52.7(9)  
  C(46)-SI1-O(4)-C(9)     -171.2(7)  
  C(24)-SI1-O(4)-C(9)       69.7(6)  
  C(7)-N(2)-N(3)-N(4)      167.8(17)  
  C(10)-O(1)-C(2)-C(1)    -136.2(3)  
  C(10)-O(1)-C(2)-C(3)      -8.7(4)  
  C(10)-N(1)-C(3)-C(4)    -131.2(3)  
  C(10)-N(1)-C(3)-C(7)     114.3(3)  
  C(10)-N(1)-C(3)-C(2)      -8.8(4)  
  O(1)-C(2)-C(3)-N(1)       10.6(3)  
  C(1)-C(2)-C(3)-N(1)      130.2(3)  
  O(1)-C(2)-C(3)-C(4)      134.2(3)  
  C(1)-C(2)-C(3)-C(4)     -106.1(4)  
  O(1)-C(2)-C(3)-C(7)     -109.7(3)  
  C(1)-C(2)-C(3)-C(7)       10.0(4)  
  N(1)-C(3)-C(4)-O(2)      159.1(2)  
  C(7)-C(3)-C(4)-O(2)      -81.7(3)  
  C(2)-C(3)-C(4)-O(2)       41.6(3)  
  N(1)-C(3)-C(4)-C(5)      -88.1(3)  
  C(7)-C(3)-C(4)-C(5)       31.1(3)  
  C(2)-C(3)-C(4)-C(5)      154.3(2)  
  N(1)-C(3)-C(4)-C(8)       35.8(3)  
  C(7)-C(3)-C(4)-C(8)      154.9(2)  
  C(2)-C(3)-C(4)-C(8)      -81.8(3)  
  C(6)-O(3)-C(5)-C(9)      116.3(3)  
  C(6)-O(3)-C(5)-C(4)      -99.5(3)  
  O(2)-C(4)-C(5)-O(3)      156.9(2)  
  C(8)-C(4)-C(5)-O(3)      -79.1(3)  
  C(3)-C(4)-C(5)-O(3)       45.0(3)  
  O(2)-C(4)-C(5)-C(6)       91.6(3)  
  C(8)-C(4)-C(5)-C(6)     -144.4(3)  
  C(3)-C(4)-C(5)-C(6)      -20.3(3)  
  O(2)-C(4)-C(5)-C(9)      -59.9(3)  
  C(8)-C(4)-C(5)-C(9)       64.2(3)  
  C(3)-C(4)-C(5)-C(9)     -171.7(3)  
  C(5)-O(3)-C(6)-C(7)       98.2(3)  
  C(9)-C(5)-C(6)-O(3)     -103.8(3)  
  C(4)-C(5)-C(6)-O(3)      106.6(2)  
  O(3)-C(5)-C(6)-C(7)     -106.4(2)  
  C(9)-C(5)-C(6)-C(7)      149.8(3)  
  C(4)-C(5)-C(6)-C(7)        0.2(3)  
  N(3)-N(2)-C(7)-C(6)      -53.5(4)  
  N(3)-N(2)-C(7)-C(3)       68.4(4)  
  O(3)-C(6)-C(7)-N(2)       83.7(3)  
  C(5)-C(6)-C(7)-N(2)      146.7(3)  
  O(3)-C(6)-C(7)-C(3)      -43.3(3)  
  C(5)-C(6)-C(7)-C(3)       19.7(3)  
  N(1)-C(3)-C(7)-N(2)      -36.7(4)  
  C(4)-C(3)-C(7)-N(2)     -158.5(3)  
  C(2)-C(3)-C(7)-N(2)       79.8(3)  
  N(1)-C(3)-C(7)-C(6)       90.7(3)  
  C(4)-C(3)-C(7)-C(6)      -31.1(3)  
  C(2)-C(3)-C(7)-C(6)     -152.9(2)  
  SI1-O(4)-C(9)-C(5)       146.3(2)  
 
 
  O(3)-C(5)-C(9)-O(4)      -46.8(3)  
  C(6)-C(5)-C(9)-O(4)       24.4(4)  
  C(4)-C(5)-C(9)-O(4)      171.2(2)  
  C(3)-N(1)-C(10)-O(1)       3.7(4)  
  C(3)-N(1)-C(10)-C(11)   -173.7(3)  
  C(2)-O(1)-C(10)-N(1)       3.7(4)  
  C(2)-O(1)-C(10)-C(11)   -178.6(3)  
  N(1)-C(10)-C(11)-C(16)  -168.2(4)  
  O(1)-C(10)-C(11)-C(16)    14.3(5)  
  N(1)-C(10)-C(11)-C(12)    13.5(6)  
  O(1)-C(10)-C(11)-C(12)  -164.0(3)  
  C(16)-C(11)-C(12)-C(13)   -0.7(6)  
  C(10)-C(11)-C(12)-C(13)  177.6(4)  
  C(11)-C(12)-C(13)-C(14)   -0.4(7)  
  C(17)-O(5)-C(14)-C(15)    -3.8(5)  
  C(17)-O(5)-C(14)-C(13)   173.7(4)  
  C(12)-C(13)-C(14)-C(15)    1.2(6)  
  C(12)-C(13)-C(14)-O(5)  -176.4(4)  
  O(5)-C(14)-C(15)-C(16)   176.5(3)  
  C(13)-C(14)-C(15)-C(16)   -0.8(6)  
  C(14)-C(15)-C(16)-C(11)   -0.3(5)  
  C(12)-C(11)-C(16)-C(15)    1.1(5)  
  C(10)-C(11)-C(16)-C(15) -177.2(3)  
  O(4)-SI1-C(18)-C(19)     152.8(8)  
  C(40)-SI1-C(18)-C(19)     37.6(12)  
  C(30)-SI1-C(18)-C(19)    -92.8(9)  
  C(46)-SI1-C(18)-C(19)    -82.6(11)  
  C(24)-SI1-C(18)-C(19)     34.5(12)  
  O(4)-SI1-C(18)-C(23)     -26.9(11)  
  C(40)-SI1-C(18)-C(23)   -142.1(12)  
  C(30)-SI1-C(18)-C(23)     87.5(10)  
  C(46)-SI1-C(18)-C(23)     97.7(12)  
  C(24)-SI1-C(18)-C(23)   -145.2(11)  
  C(23)-C(18)-C(19)-C(20)   -1.1(13)  
  SI1-C(18)-C(19)-C(20)    179.2(8)  
  C(18)-C(19)-C(20)-C(21)    4.8(9)  
  C(19)-C(20)-C(21)-C(22)   -8.6(11)  
  C(20)-C(21)-C(22)-C(23)    9.1(15)  
  C(21)-C(22)-C(23)-C(18)   -6(2)  
  C(19)-C(18)-C(23)-C(22)    1.5(19)  
  SI1-C(18)-C(23)-C(22)   -178.8(12)  
  O(4)-SI1-C(34)-C(35)     167.8(13)  
  C(40)-SI1-C(34)-C(35)     49.7(19)  
  C(30)-SI1-C(34)-C(35)    -76.7(17)  
  C(46)-SI1-C(34)-C(35)    -67.1(18)  
  C(24)-SI1-C(34)-C(35)     46.7(18)  
  O(4)-SI1-C(34)-C(39)     -13(2)  
  C(40)-SI1-C(34)-C(39)   -130.7(19)  
  C(30)-SI1-C(34)-C(39)    102.8(18)  
  C(46)-SI1-C(34)-C(39)    112.4(19)  
  C(24)-SI1-C(34)-C(39)   -133.7(19)  
  C(39)-C(34)-C(35)-C(36)    1.6(19)  
  SI1-C(34)-C(35)-C(36)   -178.9(17)  
  C(34)-C(35)-C(36)-C(37)   -1.0(15)  
  C(35)-C(36)-C(37)-C(38)    6(2)  
  C(36)-C(37)-C(38)-C(39)  -12(3)  
  C(37)-C(38)-C(39)-C(34)   13(4)  
   
 
 
  C(35)-C(34)-C(39)-C(38)   -7(3) 
  SI1-C(34)-C(39)-C(38)    173(2)  
  O(4)-SI1-C(24)-C(29)    -178.2(11)  
  C(18)-SI1-C(24)-C(29)    -60.9(14)  
  C(30)-SI1-C(24)-C(29)     67.2(13)  
  C(34)-SI1-C(24)-C(29)    -54.9(15)  
  C(46)-SI1-C(24)-C(29)     57.2(14)  
  O(4)-SI1-C(24)-C(25)       1.8(12)  
  C(18)-SI1-C(24)-C(25)    119.0(10)  
  C(30)-SI1-C(24)-C(25)   -112.8(10)  
  C(34)-SI1-C(24)-C(25)    125.0(12)  
  C(46)-SI1-C(24)-C(25)   -122.8(12)  
  C(29)-C(24)-C(25)-C(26)    0.7(13)  
  SI1-C(24)-C(25)-C(26)   -179.2(11)  
  C(24)-C(25)-C(26)-C(27)    0.8(12)  
  C(25)-C(26)-C(27)-C(28)    0.4(16)  
  C(26)-C(27)-C(28)-C(29)   -3.2(15)  
  C(27)-C(28)-C(29)-C(24)    4.8(15)  
  C(25)-C(24)-C(29)-C(28)   -3.4(17)  
  SI1-C(24)-C(29)-C(28)    176.5(9)  
  O(4)-SI1-C(40)-C(45)    -149.8(14)  
  C(18)-SI1-C(40)-C(45)    -34.0(17)  
  C(30)-SI1-C(40)-C(45)     96.3(15)  
  C(34)-SI1-C(40)-C(45)    -27.9(19)  
  C(46)-SI1-C(40)-C(45)     85.9(17)  
  O(4)-SI1-C(40)-C(41)      23.3(13)  
  C(18)-SI1-C(40)-C(41)    139.1(11)  
  C(30)-SI1-C(40)-C(41)    -90.6(11)  
  C(34)-SI1-C(40)-C(41)    145.2(12)  
  C(46)-SI1-C(40)-C(41)   -101.0(13)  
  C(45)-C(40)-C(41)-C(42)   -1.0(15)  
  SI1-C(40)-C(41)-C(42)   -174.7(13)  
  C(40)-C(41)-C(42)-C(43)    2.9(13)  
  C(41)-C(42)-C(43)-C(44)   -5.2(18)  
  C(42)-C(43)-C(44)-C(45)    5.8(17)  
 
 
  C(43)-C(44)-C(45)-C(40)   -3.8(18)  
  C(41)-C(40)-C(45)-C(44)    1(2)  
  SI1-C(40)-C(45)-C(44)    174.4(11)  
  O(4)-SI1-C(30)-C(31)    -173.8(3)  
  C(40)-SI1-C(30)-C(31)    -59.3(5)  
  C(18)-SI1-C(30)-C(31)     70.7(5)  
  C(34)-SI1-C(30)-C(31)     65.9(7)  
  C(24)-SI1-C(30)-C(31)    -56.9(5)  
  O(4)-SI1-C(30)-C(33)     -53.9(3)  
  C(40)-SI1-C(30)-C(33)     60.5(5)  
  C(18)-SI1-C(30)-C(33)   -169.5(4)  
  C(34)-SI1-C(30)-C(33)   -174.2(7)  
  C(24)-SI1-C(30)-C(33)     63.0(5)  
  O(4)-SI1-C(30)-C(32)      64.8(3)  
  C(40)-SI1-C(30)-C(32)    179.3(5)  
  C(18)-SI1-C(30)-C(32)    -50.7(5)  
  C(34)-SI1-C(30)-C(32)    -55.4(7)  
  C(24)-SI1-C(30)-C(32)   -178.3(5)  
  O(4)-SI1-C(46)-C(48)      57.9(15)  
  C(40)-SI1-C(46)-C(48)    176.2(15)  
  C(18)-SI1-C(46)-C(48)    -61.2(15)  
  C(34)-SI1-C(46)-C(48)    -65.1(15)  
  C(24)-SI1-C(46)-C(48)    178.1(14)  
  O(4)-SI1-C(46)-C(49)     -63.4(13)  
  C(40)-SI1-C(46)-C(49)     54.8(14)  
  C(18)-SI1-C(46)-C(49)    177.5(12)  
  C(34)-SI1-C(46)-C(49)    173.6(13)  
  C(24)-SI1-C(46)-C(49)     56.8(14)  
  O(4)-SI1-C(46)-C(47)     177.6(13)  
  C(40)-SI1-C(46)-C(47)    -64.1(15)  
  C(18)-SI1-C(46)-C(47)     58.5(14)  
  C(34)-SI1-C(46)-C(47)     54.6(15)  
  C(24)-SI1-C(46)-C(47)    -62.2(14)  
   
  
______________________________________________________________________________  
   
   























































ORTEP view of the C33 H38 N4 O5 Si compound with the 
numbering scheme adopted. Ellipsoids drawn at 30% probability 
level. Hydrogen atoms are represented by sphere of arbitrary 
size.  
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